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General Introduction
1.1. The toxicity of oxygen.
Oxygen is required for normal aerobic metabolism to produce energy. During this process 
reactive intermediates of oxygen may escape from this metabolism and may inflict damage. 
During the evolution, cellular life has developed several antioxidant mechanisms to protect 
itself from these oxygen species. An imbalance between the generation and the detoxification of 
reactive oxygen species, also referred as oxidative stress, may have several cellular 
consequences including tissue damage and cell death.
1.1.1. Reactive oxygen species.
The complete reduction of molecular oxygen to water requires the addition of four electrons 
(O2 + 4H++ 4e- -> 2H2O), but because of its molecular structure, oxygen is usually constrained 
to receive these electrons one at a time. Technically speaking, oxygen has two unpaired 
electrons in its molecular orbital, and these two electrons have the same spin quantum number 
(parallel spin). If O2 oxidises another atom or molecule by accepting a pair of electrons, both of 
these electrons must be of a parallel spin. Most biomolecules however, are covalently bonded 
non-radicals, and the electron pairs in their covalent bonds have opposite spins (antiparallel 
spin) and occupy the same orbital. The donation of a pair of antiparallel spin electrons from the 
molecular orbital of a biomolecule to molecular oxygen is thus spin restricted, and, 
consequently, oxygen is more likely to undergo single-electron reduction. In this process, 
several intermediates arise and are of considerable interest and reactivity. These oxygen 
intermediates or reactive oxygen species (ROS) are believed to be the major cause of oxygen ‘s 
toxicity and of oxidative stress.
The first intermediate is superoxide anion radical (O2.-) is formed by the addition of one 
electron to oxygen and is produced in virtually all aerobic cells. The superoxide radical in 
hydrophobic environments (in biological membranes) is a powerful base (proton acceptor), 
nucleophile, and reducing agent 1. It can also act as an oxidising agent, but only with compounds 
that serve as proton donor (examples: ascorbate and vitamin E). Because oxygen is more 
soluble in fatty environments than in water and many of the O2--producing systems reside in cell 
membranes, it is likely that most generation of superoxide occurs in hydrophobic sites 2. In an 
aqueous environment, superoxide undergoes two major reactions: it acts as a single electron 
reducing agents or it reacts with itself to produce oxygen and hydrogen peroxide and oxygen 
(reaction 1, fig.1.1). Despite the occurrence of spontaneous dismutation, the enzyme superoxide 
dismutase (SOD) is present in biological systems to accelerate this reaction 3.
H2O2 is the second ROS and does not have any unpaired electrons and is not a radical. It is 
water soluble and can cross membranes (which superoxide cannot, except through anion 
channels) and has therefor a wide dispersal. Further in the presence of ferrous iron (Fe2+) or 
other transition metal ions, it can accept a single electron to produce the highly reactive 
hydroxyl radical (Reaction 2, fig.1.1).
The hydroxyl radical reacts with almost all types of biomolecules: sugars, amino acids, 
phospholipids, DNA bases, and organic acids. It diffuses only 5 to 10 molecular diameters 
from the site of formation before reacting by abstracting a hydrogen atom, adding on to an 
existing molecule, or transferring an electron 2. Whenever formed in a biological system, the 
hydroxyl radical reacts immediately with whatever biomolecule is in its vicinity, damaging it 
and producing secondary radicals of varying reactivities.
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2O2-+ 2H+ SOD > H2O2 + O2 (1)
Fe2+ + H2O2 -----► Fe3+ + 'OH +*OH (2)
Figure 1.1. Reactions that generate the reactive oxygen intermediates. Reaction 1 is the spontaneous or 
superoxide dismutase-catalysed dismutation of the superoxide radical to hydrogen periode. The iron- 
catalysed reaction 2 is the Fenton reaction that produces the highly reactive hydroxyl radical.
1.1.2. Detoxification of ROS by antioxidants.
Regulation of the concentrations of ROS is accomplished by several enzymatic and non- 
enzymatic mechanisms (Table 1.1). The enzymes responsible for controlling the tissue levels of 
O2- and H2O2 are SOD, catalase and glutathione peroxidase. Although superoxide can dismutate 
spontaneously, considerable levels of superoxide are required for achieving a acceptable rate 
of this reaction and this could have a detrimental effect on the cell. The SOD enzymes are able 
to remarkably accelerate this dismutation reaction. There are two forms of SOD: the cytosolic 
copper-zinc dimeric enzyme and the manganese-containing tetrameric enzyme in the 
mitochondrial matrix 3. Catalase is a large haem-containing enzyme and it is present mainly in 
peroxisomes and mitochondria and is probably expressed in all tissues 2. The major enzymatic 
system for the control of cellular peroxide levels consist of GSH-peroxidases and several 
enzymes required for the reduction of oxidised GSH and the synthesis of GSH.
Table 1.1. Important cellular defence mechanisms against oxygen-derived radicals.
Enzymatic
Superoxide dismutase (SOD) 
Catalase
Glutathione peroxidase (Gpx) 
Glutathione reductase (GR)
Non-Enzymatic
Glutathione (GSH) 
a-Tocopherol (vitamin E) 
Ascorbic acid (Vitamin C) 
B-carotene 
Uric acid
In addition to enzymatic defence mechanisms, there is an intensive non-enzymatic antioxidant 
network composed of several different types of lipid- and water-soluble small molecules that 
have in common the ability to scavenge free radicals. B-carotene and vitamin E are lipid- 
soluble free radical scavengers and among those soluble in water are GSH, vitamin C, uric acid 
and ascorbate. Vitamin E reacts with a variety of free radicals to produce the stabile 
chromanoxyl radical which can react with itself or with ascorbate and GSH to regenerate native
2O-2 + 2H+ ---------- ► H2O2 + O2
2H2O2 ---------- ► 2H2O + O2
2GSH + 2H2O2 ---------- ► GSSG + H2O
GSSG + NADPH + H+ ---------- ► 2GSH + NADP+
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vitamin E. Because of its lipid solubility, vitamin E is important for the inhibition of lipid 
peroxidation in membranes. Ascorbic acid is a non-specific radical scavenger and is capable 
of reacting with the hydroxyl radical to produce a stabile semiquinone radical. This radical can 
in turn reduce other oxidising radicals to give fully oxidised dehydro-ascorbate 4 The reactions 
of GSH are discussed in more detail in paragraph 1.3.
1.1.3. Oxidative Stress.
Any conditions in which the generation of ROS is increased or in which the antioxidant 
defence is diminished creates a situation named “oxidative stress”. Some conditions that may 
result in oxidative stress include: the generation of excessive ROS or depletion of the non- 
enzymatic antioxidants during the metabolism of drugs and xenobiotics, increased levels of 
transitions metals as the result of tissue injury, increased generation of ROS in inflammatory 
processes, ionising radiation or genetic polymorphism of less functional antioxidants enzymes. 
In pathological situations, the antioxidant defence may be insufficient to protect against 
oxidative stress. A variety of diseases are believed to be related to oxidative stress (table 1.2). 
The role of radical-mediated injury in the gastrointestinal tract are discussed in more detail in 
paragraph 1.2.
Table 1.2. Some diseases related with oxygen toxicity.
Gastrointestinal disorders
Pulmonary diseases
Atherosclerosis 
Cardiac ischemia 
Renal ischemia 
Rheumatic diseases 
Neurological disorders
Carcinogenesis
Intestinal ischemia
Inflammatory bowel disease
Pancreatitis
Hepatic diseases
Emphysema
Astmatic disorders
ARDS
Lung injury by air pollutants
Cerebral ischemia 
Alzheimer’s disease 
Parkinson’s disease
1.1.4. Cellular consequences of oxidative stress.
Oxidative stress may cause irreversible cell injury and induce cell death. Two different 
types of cell death are distinguished: necrosis and apoptosis. They are characterised by typical 
morphological, biochemical and molecular events (see figure 1.2 and ref. 5). Necrosis is an 
“imposed” form of cell death and is usually the result of severe exposure to toxicants or serious 
pathological condition like ischemia-reperfusion or escalated inflammation. Necrosis is 
recognisable by the swelling of the cell and organelles, especially the mitochondria, and little 
nuclear changes. The swelling is the result of a disturbed ion balance which may be caused by 
damaged ion transport mechanisms and plasma membranes. As necrosis progresses, the
10
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organelles dissolute, plasma membranes ruptures occur and the nucleus undergoes karyolysis. 
Necrosis is in general a massive event involving the death of many cells in a tissue. The 
cellular debris of necrotic cells usually cause inflammation of the injured tissue.
A B C
Figure 1.2. Morphological features o f necrotic and apoptotic cell death. A normal cell (top, A) 
usually begins the process of necrosis with an initial phase of generalised swelling (top, B) which 
progresses to a dissolution of organelles and rupture of the plasma membranes (top, C). The earliest 
phase of apoptosis (bottom, A) involves retraction from adjacent cells, loss of specialised surface 
structures, shrinkage with condensation of cytoplasm, margination of compacted nuclear chromatin, and 
localised protrusion of the cell surface. Nuclear fragmentation may occur at this time. In the next phase, 
the protuberances of the cell surface separate into multiple membrane-bound bodies (the apoptotic 
bodies) which contain nuclear remnants and intact organelles (bottom, B). The apoptotic bodies are then 
engulfed and further degraded by surrounding cells (bottom, C) or phagocytes (Adapted from Corcoran 
et al 5).
Kerr and co-workers were the first to describe a type of cell death which is morphologically 
totally different from necrosis 6. Apoptosis, also referred to ‘programmed cell death’, has a 
number of features which make it an appropriate mode of death for the regulation of cell number 
during normal growth and development 7 Unlike necrosis, apoptosis is under genetic control 
and can be initiated through receptor-mediated events by a variety of hormones and cytokines. 
This allows apoptosis to be restricted to specific cells at specific times during development. 
Characteristically, apoptotic cells shrink to form apoptotic bodies which rapidly undergo 
phagocytosis by macrophages 8. Apoptotic cells do not release their intracellular content to 
cause an inflammatory response and consequent tissue damage as occurs in necrosis. Apoptosis 
can also occur as the result of exposure to pathophysiological conditions or toxic agents 5,9,1°. 
These toxic agents often induce apoptosis at concentrations that are lower than required for 
inducing necrosis 5. Apoptosis as mode of selective cell killing has gained a lot of attention in 
the field of chemotherapeutics. Ijiri and Potten 11 have demonstrated that a wide variety of 
chemotherapeutic agents induce apoptosis in intestinal epithelial cells which include cytotoxic 
antibiotics (adriamycin, bleomycin and actinomycin), alkylating agents (isopropyl-methane- 
sulphonate, bichloroethylnitroso urea, cyclophosphamide, nitrogen mustard, and triethylene-
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thiophosphamide) and anti-metabolites (5-fluorouracil, hydroxyurea and methotrexate). 
Oxidative stress has been implied to play a role in the induction of apoptosis 12-16. However, a 
role for oxidative stress-induced apoptosis in gastro-intestinal tract is unknown.
1.2. Oxidative stress in the intestine.
Reactive oxygen species are involved in various gastrointestinal pathologies. The origin of 
the ROS can be divided into two categories. Firstly, endogenous production of radicals may be 
of great importance in the development of gastrointestinal injury after intestinal ischemia and 
reperfusion. ROS may also derive or result from the metabolism of exogenous compounds. This 
category can be divided into agents that have an oxidising nature such as lipidperoxides, metals 
and compounds that are capable of generating ROS during the cellular metabolism. In this 
category are the naphthoquinones that were used in this study.
1.2.1. Ischemia-Reperfusion.
Intestinal ischemia occurs predominantly in elderly patients and is generally divided into 
three categories of mesenteric vascular disorders: acute mesenteric ischemia, colonic ischemia 
and chronic mesenteric ischemia, from which the first two are most common. Acute mesenteric 
ischemia involves a reduction of mesenteric blood flow affecting the small intestine and 
possibly also parts of the colon. The disturbance of the mesenteric blood flow may be related to 
cardiovascular disorders. Ischemia emanates when oxygen uptake from the blood is limited by 
a decreased blood supply and the tissue becomes hypoxic 17 This phenomenon is first observed 
in the intestinal villi, in which the reduced blood flow pressure can lead quickly to short- 
circuiting of the intestinal countercurrent exchanger, leading to hypoxic villus tips 18. The first 
effects after a total circulatory arrest is the detachment of the epithelial layer from the villi. 
After prolonged periods of ischemia (approximately one hour) the upper regions of the 
intestinal villi are completely denuded, whereas the lower parts of the mucosa and the 
underlying musculature remain relatively unaffected 19 The major part of the damage in 
ischemic tissue occurs during the reperfusion phase rather than in the ischemic period 20-22 The 
involvement of oxygen radicals in the reperfusion period of ischemic tissue became clear when 
the pretreament of animals with superoxide dismutase was able to prevent the changes in 
intestinal vascular and mucosal permeability which are characteristics of ischemic damage 23. 
Furthermore, an increase of oxidised glutathione and lipid peroxidation products were 
demonstrated during the reperfusion of ischemic rat small intestine 24,25. The major source of 
oxygen radicals in postischemic tissue appears to be the enzyme xanthine oxidase. It is widely 
distributed among tissues and the liver, lung and intestine are particularly rich in sources in 
most species. The enzyme is synthesised as xanthine dehydrogenase and accounts for about 90% 
in healthy tissue 26 Xanthine dehydrogenase cannot transfer electrons to molecular oxygen to 
form the superoxide radical, but can reduce NAD+ according reaction 3:
xanthine + H2O + NAD+ -> uric acid + NADH + H+ (3)
The hydrogenase can convert to the oxidase as the result of sulfhydryl oxidation or limited 
proteolysis 27,28. The intestinal xanthine oxidase cannot be reconverted to the dehydrogenase 
form by thiol reducing agents like dithiothreitol which may indicate that modification in this 
tissue may occur mainly by proteolysis 28. Xanthine oxidase can use molecular oxygen instead 
of NAD+, producing superoxide or hydrogen peroxide or both, as follows:
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xanthine + H2O + 2O2 uric acid + 2O2- + 2H+ (4)
Support for the role of xanthine oxidase in the development of ischemia-reperfusion related 
damage in the intestinal tract follows from the beneficial effect of inhibitors of xanthine oxidase 
like allopurinol or oxypurinol 29. There is considerable evidence that other processes contribute 
as well to the ischemic injury. Release of iron from ferritin (by superoxide and other 
mechanism) with subsequent initiation of lipid peroxidative damage to cell membranes has 
been proposed as an additional mechanism of ischemia-reperfusion 3°-32. Deferoxamine, a 
synthetic iron chelator, was shown to attenuate ischemic injury 33. In addition, the receptor- 
mediated adhesion of neutrophils to the microvasculature in ischemic-reperfused has been 
reported to be a source of free radicals 30,32,34
1.2.2 Exogenous sources of ROS
Several studies have shown that high fat intake can promote cellular damage by increased
o n  i f  q / '
lipid peroxidation and subsequent propagation of oxygen radical , , . Lipid peroxides can 
arise from peroxides in the diet 35 and were found to be absorbed by the intestinal epithelium 37 
Lipid peroxides are directly cytotoxic to a variety of mammalian cell including enterocytes 38-4°. 
An alternative source of ROS is the radicals is the B-oxidation of fatty acids in the 
peroxisomes, where enzymes like glycollate oxidase, urate oxidase and D-aminoacid oxidase 
produce hydrogen peroxide without the intermediacy of O2- 2,4\
Metabolism of xenobiotics has been studied most extensively in the liver, because this organ 
is known to contain high drug-metabolising activities. However, extrahepatic tissue, especially 
the gastro-intestinal tract, also have been recognised as potential sites for drug metabolism 42. 
Several studies have demonstrated the presence of phase I enzymes such as cytochrome P450 
(CYP) 1A1, CYP1A2, CYP2D6 and CYP3A along the mucosa of the human mucosa 43-49. With 
respect to the conjugating phase II enzymes, relatively high levels of glucuronyl transferase, N- 
acetyltransferase and glutathione-S-transferase were detected in rat and human small intestine 
46,49 As a major route of administration and an early site of exposure to orally dosed 
xenobiotics, the intestine has the potential to detoxify, activate and diminish the bioavailability 
of a large number of compounds. The drug metabolising capacity of the intestinal tract may 
produce compounds that are capable of generating oxidative stress 5°-52. An interesting group of 
oxidative stress inducing chemicals are compounds with a quinone moiety which are able to 
reduce oxygen at the expense of cellular reductants such as NADPH (redoxcycling, see 
paragraph 1.3). For this reason, there has been recent interest the redox cycling of the quinones 
formed from diethylstilbestrol and the catechols of estradiol 53. Polycyclic aromatic 
hydrocarbons (PAH) are environmental pollutants that require activation to exert their 
mutagenic and carcinogenic effects 54 PAH like benzo[a]pyrene can be transformed into 
quinones by P450-mediated reactions 55-57 and may be involved in redox cycling 55. The 
mechanism by which quinones elicit their toxicity is discussed in the next paragraph.
1.3. Metabolism and toxicity of quinones.
Human exposure to quinones has a long and colourful history. Man and more likely, women 
first started exploiting the activity of quinones in two ways: as pigments and as drugs. Pigments 
prepared from henna and madder were used as cosmetics or dyes and contain derivatives of 
1,4-naphthoquinone and anthraquinone, respectively. The active ingredient of henna, lawsone 
(2-hydroxy-1,4-naphthoquinone) is widely available in supermarkets as a natural dye. As,
13
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drugs, the use of crude plant preparations as purgatives and emetics has been recorded for over 
4000 years. For example, the principal active constituents of rhubarb are a variety of 
anthraquinones, and the use of rhubarb is described in Chinese herbal medicine since 2700 BC. 
In modern medicine, several cancer chemotherapeutic agents of both clinical and research 
interest contain this quinone nucleus. The quinones of polycyclic hydrocarbons are also 
prevalent as environmental contaminants and provide an additional source of human exposure 
to quinones 58,59 Menadione (2-methyl-1,4-naphthoquinone, vitamin K3, MEN) is a typical 
quinone and is often used as model agent to generate oxidative stress (see fig. 1.3). MEN was 
shown to exhibit anticancer activity in rodents and human cancer cell lines and a variety of 
patient tumor explants 60-62 Menadione has been used in cancer therapy in the form of sodium 
menadiol (Synkayvite®). MEN was combined with mitomycine C in order to modulate the 
glutathione mediated resistance to alkylating agent chemotherapy with modest success in phase
II trials 63,64.
R 1 R2
Naphthoquinone (NQ) : -H -H
Menadione (MEN) : -CH3 -H
Dimethoxynaphthoquinone (DIM) : -o c h 3 -o c h 3
Figure 1.3. Naphthoquinones used in this study. This picture displays three closely related 
naphthoquinones which differ in eliciting toxicity. NQ is capable of arylation at the 2’ and 3’ position, 
whereas MEN can do this only at the 2-position. All three quinones have the capacity to redoxcycle.
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1.3.1. The reductive metabolism of menadione.
Menadione is reduced by the cellular metabolism and is subsequently excreted after 
conjugation. Menadione is also capable of reductive addition to cellular thiols. The reduced 
quinone can escape from excretion and auto-oxidise, thereby oxygen.
Reduction of menadione by flavoenzymes can occur by either one- or two-electron reduction 
(fig. 1.4). One-electron reduction of menadione results in the formation of the menasemiquinone 
radical. This reaction is mainly catalysed by microsomal NADPH cytochrome P450 reductase, 
microsomal NADH cytochrome b5 reductase and mitochondrial NADH:ubiquinone oxido- 
reductase 58. In the presence of molecular oxygen, the semiquinone is reoxidised to the parent 
compound accompanied with simultaneous formation of the superoxide anion radical. The 
process of continuous reduction and the oxidation of the quinone under aerobic conditions with 
generation of superoxide anion radicals is known as redox cycling.
efflux
1
efflux
Figure 1.4. Biochemical metabolism o f menadione. Generation of reactive oxygen species via redox- 
cycling and detoxification (Adapted from Redegeld 65).
Cytosolic NAD(P)H(quinone-acceptor) oxidoreductase or DT-diaphorase reduces the 
quinone to menadiol the hydroquinone of menadione via a two-electron reduction. The two- 
electron reduction pathway is considered to be detoxifying by competing with the one-electron 
reduction. More evidence for this theory follows from experiments in which inhibition of DT- 
diaphorase by dicoumarol potentiated the toxicity of menadione 66. Hydroquinones are less 
reactive than the semi-quinone radical and can be eliminated from the cell after conjugation 
with sulphate or glucuronic acid 67,68. The conjugated forms of menadione are excreted by both 
biliary-faecal and urinary routes 69,70. Menadiol may also undergo auto-oxidation to form 
superoxide anion radicals and contribute to the toxic effect. Superoxide anion radical and 
singlet oxygen are formed during the oxidation process of the hydroquinone and semiquinone 58. 
However, the oxidation of hydroquinones is prevented on a cellular level due to a concerted
15
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action of DT-diaphorase and superoxide dismutase (see fig. 1.5; ref 71). Moreover, the 
arylation reaction (see below) is also prevented, because a hydroquinone cannot arylate 71.
Fig. 1.5. Superoxide radical-mediated propagation o f hydroquinone oxidation. The numbers in the 
picture correspond to the equation 1: Q-+ O2 ^  Q + O2- ; and equation 2: QH- + H++ O2- ^  Q - + H2O2. 
Reaction 2 and thus the propogation of hydroquinone oxidation is inhibited by superoxide dismutase 
which catalyses the fast disproportionation of O2- to H2O2 according the equotion: O2- + O2- ^  H2O2+ 
O2 (Adapted from Cadenas 71).
The arylation reaction between quinones and nucleophiles like GSH is a 1,4-reductive 
addition of the Michael type which reduces the quinone to its corresponding glutathionyl 
hydroquinone 72,73. This conjugation reaction should not be considered as a detoxification 
pathway. In many cases, the formed glutathionyl hydroquinone are more redox labile than its 
parent quinone 71 and is likely subjected to auto-oxidation. Further, GSH conjugates of 
menadione were reported to undergo redoxcycling similar to the parent compound (fig 1.6) 74,75. 
The conjugation of quinones to GSH may be a protective mechanism, since the conjugates are 
rapidly extruded from cells 67.
Figure 1.6. Reductive conjugation o f menadione and subsequent oxidation o f the glutathione 
conjugate o f menadione (Adapted from Redegeld et al 65 ).
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1.3.2. Cytotoxicity of menadione.
MEN is know as a hepatotoxicant and much of the current understanding on the mechanisms 
of cytotoxicity and necrotic cell death comes from the pioneering studies from Orrenius and co­
workers 66,76-83 and the excellent references 58 and 59. Necrosis is not random damage to 
cellular structures but a set of precise biochemical and cellular lesions which summate, leading 
to the destruction of the cell. These events have been characterised in a variety of cell types, 
although a little work has been done using intestinal epithelial cells. Cellular injury induced by 
oxidants or hypoxia is the form of necrosis which has been studied most. The cascade of events 
includes loss of mitochondrial function and swelling, an increase of intracellular free calcium, 
ATP depletion, DNA damage, lipid and protein peroxidation. These events lead to metabolic 
collapse, cytoskeletal damage, blebbing followed by rupture of the plasma membrane, collapse 
of intracellular ion gradients, cell swelling and eventually cellular destruction.
The cytotoxic mechanism of MEN is complex, because both redox cycling and arylation play 
a role in cell killing. MEN can induce cell injury at several places, which makes it difficult to 
address the site of damage which is responsible for cytotoxicity. Nevertheless, there have been 
several attempts to elucidate the importance of the individual events in cell death (fig. 1.7)
Figure 1.7. Summary of biochemical mechanisms of oxidative stress-induced necrosis.
1.3.2.1. Modulation of thiols.
ROS, and hydroxyl radical in particular, are capable of reacting with virtually all types of 
biomolecules. DNA and lipids are generally considered as the significant targets for oxidative 
damage. However, the role of lipid peroxidation in quinone-induced cell death is debatable. 
Some address lipid peroxidation as key event in MEN toxicity 84, whereas other groups 
reported menadione to act as an antioxidant 85. However, cellular thiols (cysteine residues) may 
be another significant target in cytotoxicity by MEN and radicals generated by menadione, in
17
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which thiols may become oxidised by ROS or directly arylated by MEN itself. Thiols in 
proteins are often part of the active site of an enzyme or are involved in the structural of 
proteins. GSH (Glu-Cys-Gly) is the most abundant free thiol in the cell and is involved in many 
cellular functions (for review see Meister and Anderson 86). As a result of redox cycling, a 
number of ROS are formed including H2O2. This reactive oxygen intermediate may be rapidly 
detoxified by catalase and GSH peroxidase, which simultaneously oxidises GSH to GSSG. 
Following exposure of hepatocytes to MEN, a rapid fall in GSH is observed, which generally
/ ' / '  'T 'T 0*7 OQ
precedes a decrease of protein sulfhydryls ” - .
The cytoskeleton consists of several distinct networks of protein structures (microtubuli, 
intermediate filaments and F(ilamentous)-actin) which are involved in several cell functions 
like regulation of the cell volume, maintenance of the brushborder structure, anchoring of 
organelles and proteins, vesicle transport and spindle formation during mitosis. The actin 
protein contains five free cysteine residues which are vulnerable to attack of electrophilic 
compounds 90 Indeed, the exposure of hepatocytes to menadione resulted in alterations of the
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cytoskeleton and in the particular the actin network - , . The resulting blebbing of the cell 
membrane may lead to rupture and cell death.
An other target of menadione are cellular thiols present in enzymes that are part of the energy 
producing systems of the cells. Redegeld et a l 91 demonstrated a loss of ATP preceding cell 
death in menadione-treated hepatocytes. Hyslop et al 92 demonstrated the vulnerability of 
glyceraldehyde-3-phosphate dehydrogenase, an enzymes of the glycolysis, for H2O2. The same 
enzyme, which contains a thiol in the active site, was found to be inhibited by menadione 91. In 
conclusion, GSH is not only a substrate for the GSH-peroxidases but is an essential buffer to 
protect crucial protein thiol against arylation of quinones.
1.3.2.2. Disturbance of calcium homeostasis.
Normally, [Ca2+]i is tightly controlled in the range of 100 nM, which is 10,000 times less 
than the extracellular compartment. It is regulated by transport systems in the plasmamembrane
93, mitochondria 94 and the ER 95. Regulation of [Ca2+]i can be affected by interactions between 
quinones and each of these three systems 96 The elevation of [Ca2+] is related to an efflux of
2+ 97,98
Ca from these cell organelles and influx from the extracellular compartment , . In menadione 
toxicity, a relation was observed between the depletion of protein thiols and an increased 
[Ca2+]i 77,78. This increase of cytosolic Ca2+ may derive from efflux from the ER, where 
oxidative stress was found to impair the function of the Ca2+-ATPase by oxidation of sulfhydryl 
groups 99 It is well documented that MEN interferes with the ability of isolated hepatic 
mitochondria to accumulate and retain calcium 76,81,100 Henry et a l 101 showed that the MEN- 
mediated release of mitochondrial Ca2+ involves a permeability transition pore (PTP) that can 
be inhibited by cyclosporine A. The opening of this pore is mediated by oxidation of vicinal 
thiols by pro-oxidants including MEN.
Elevation of [Ca2+] can activate: 1) phospolipases A and C, which can mediate much of the 
membrane damage that accompanies mitochondrial swelling sand cell membrane decay in
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necrotic cell death . 2) Ca -activated proteases appear capable of modifying the Ca - 
dependent ATPases in the plasma membrane 103 and the cytoskeleton which ultimately results in 
membrane blebbing. 3) Ca2+-activated endonucleases are responsible for additional DNA
damage 7.
1.3.2.3. Disturbance of energy metabolism.
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In many cell types, ATP depletion is the final common pathway leading to irreversible cell 
death 104 A number of procedures have been described which can preserve or restore 
intracellular ATP levels in vivo. The simplest is to infuse the patient with solutions containing 
ATP complexed with MgCl2 105. Animal work has suggested that exogenous ATP administration 
reduces mortality from sepsis and shock 106 ATP depletion occurs for a number of reasons. In 
mild oxidative injury or exposure to menadione, there is inhibition of mitochondrial function in 
hepatocytes which can be rescued by fructose, which acts as a substrate for glycolytic ATP 
formation 107-110 Greater degrees of injury cause an increase in mitochondrial permeability (for 
an extensive review see Gunther et a l 97) which can be inhibited by cyclosporin A or 
trifluoperazine 107,108. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH), the rate limiting 
step of the glycolytic pathway, is particularly sensitive to oxidative injury 92 and menadione 91. 
Four ATP molecules are synthesised distal to this enzyme in the glycolytic pathway, so 
inhibition may critically affect cellular ATP generation.
Inhibition of the mitochondrial function and glycolysis by quinones can occur for another 
reason. Nicotinamide adenine dinucleotide (NAD+) is a co-factor for GAPDH and can be 
consumed by activation of poly(ADP-ribose) polymerase (PARP) 111,112 In oxidative injury, a 
number of types of DNA damage occur including single-strand breaks which activate PARP (fig 
1.8). This enzyme acts as a “nick sensor” binding to single-strand breaks and catalysing the 
ADP-ribosylation of nuclear proteins including histones 113. This causes the DNA to unwind, 
allowing access of DNA repair enzymes to the site of damage 114,115. In some cell types, 
oxidant-induced DNA-damage can cause such intense PARP activation that cellular NAD+ falls 
to levels at which glycolysis and mitochondrial NADH-dehydrogenase are inhibited 92,116. 
Inhibition of PARP by agents such as 3-aminobenzamide or nicotinamide can completely 
protect against oxidant injury in different cell types including lymphocytes 117, hepatocytes 118, 
endothelial cells 119, fibroblasts 118 and the coloncarcinoma cell-line HT-29 120
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Figure 1.8. Model for poly(ADP-ribose) polymerase cycling and DNA repair at strand interruptions in 
DNA. The PARP enzyme has a DNA-binding domain and a catalytic domain linked by an 
automodification region. (a) A DNA strand break is introduced by ionising radiation or oxidative stress. 
(b) PARP binds rapidly to DNA breaks. Inhibitors like 3-aminobenzamide freeze the reaction at this step 
by preventing polymer synthesis. (c) Normally, synthesis of long, branched chains of poly(ADP-ribose) 
is triggered. Following (d) release of the automodified PARP from DNA, (e) most of the poly(ADP- 
ribose) chains are rapidly degraded by poly(ADP-ribose) glycohydrolase (pARG). DNA repair occurs 
during the subsequent interval. Finally, (f) the remaining poly(ADP-ribose) chains are slowly removed 
from the polymerase by the glycohydrolase.
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1.4. Apoptosis.
Apoptosis is a controlled form of cell death that acts as a molecular control point regulating 
physiological processes, and diseases through cell deletion. Apoptosis serves as the 
counterpart to cell division by mitosis. An apogen is a stimulus that induces a cell to undergo 
apoptosis.
Induction phase: 
Apoptosis signalling
Agents
ROS
DNA-damaging agents 
lack of survival signals.
I
Status of the cell
Positive regulator Negative Regulator
o f cell death of cell death
Bax, Bcl-XS Bcl-2, Bcl-XL, Bag,
Bad, Bak, Ceramide DAG, Sphingosine-1-P
Effector phase: 
Protease activation
Pro ICE 
Pro CPP32 
Pro X
Active ICE 
■Active CPP32 
Active X
Irreversible 
commitment to death I
Degradation phase: 
Apoptosis
Proteolysis: PARP, DNA-PK, U1-70 kD, 
actin, fodrin, lamins...
Nucleolysis
Cytolysis
Figure 1.9. Different phases o f apoptosis. During the induction phase, cells receive a signal that will 
elicit the apoptotic process. The death signal will proceed to the effector phase only if the status of the 
cells allows it. During the effector phase, a point of no return is passed and the cell becomes irreversibly 
programmed to death.
Examples of apogens are numerous and include endogenous regulatory proteins and hormones 
as well anoxia, radiation, xenobiotic chemicals and oxidative stress. Although the many 
different stimuli can result in apoptosis of the exposed cell, it seems that only a few apoptotic 
pathways exist that converge towards the end of the apoptotic program. All forms of 
programmed cell death can be divided in three major phases. In the inductor phase, a noxious 
stimulus or the lack of a survival factor starts the apoptotic program (fig.1.9). The status of the 
cell determines whether this program should be executed or aborted. If the balance favours 
apoptosis, a cascade of proteases will be activated in the effector phase and the cell is ready to 
be degraded to apoptotic bodies. These bodies are phagocytized by surrounding cells, 
macrophages or, in case of the intestine, shed to the lumen.
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1.4.1. The induction phase.
Although many signals can induce apoptosis, the most important stimulus may be damage to the 
genetic material of the cell.
p21
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Fig 1.10. The p53 mediated response to DNA damage.
1.4.1.1. p53.
P53 is an important participant in the cellular response to ionising radiation and other DNA 
damaging agents. In normal cells, DNA strand breaks appear to be the necessary signal for 
induction of a p53-mediated response since other forms of DNA damage such as those 
produced by alkylating agents do not result in the accumulation of p53 121. This response can 
result in a transient arrest of the cells in the G  and G2 phases of the cell cycle 122 and in 
apoptotic cells 123. Wild-type p53 possesses features of a transcription factor 124 When bound 
directly to DNA, it activates transcription but it can also repress transcription by binding to a 
promotor 125. The mechanism whereby p53 leads to G1 arrest following DNA damage can be 
attributed to its role as a transcription factor and induces the expression of several proteins 
including p21WAF1/CIP1, GADD45 and Mdm2 (fig 1.10; for review see: Canman and Kastan 126). 
p21WAF1/CIP1 is potent inhibitor of cyclin-dependent kinases and induces a cell cycle arrest at the 
G1/S border 127 The GADD45 (growth arrest and DNA damage) protein can interact directly 
with the essential replication factor PCNA (proliferating cell nuclear antigen) and inhibits 
DNA replication 128. GADD45 may possibly enhance nucleotide excision repair of damaged 
DNA. Mdm2 is not involved in cell cycle arrest but is thought to function in a negative feedback 
loop by binding to p53 and thereby suppressing its transcriptional activity 129 p53 is a positive 
regulator of Bax expression 130 and a negative regulator of Bcl-2 expression 131. Bax acts 
directly as an pro-apoptotic signal, whereas Bcl-2 protects the cell from apoptosis (See 
paragraph 1.4.2.2 and ref. 132)). Further, the expression of p53 is upregulated by preceding
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PARP activity (see also fig 1.8; ref. 133) and a DNA-dependent protein kinase (DNA-PK; ref. 
134), both being proteins responding to DNA
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Sequence-specific 
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Fig 1.11. Structural domains of human p53. The p53 protein is a 53-kd nuclear phosphoprotein 
consisting of a transactivation, a DNA binding- and a oligomerization domain. Boxes II to V (grey) 
represent the conserved regions containing the frequent sites of mutation. The phosphorylation sites are 
indicated above the p53 sequence. Below the representation of p53, the main nuclear localisation signal 
(NLS), and the interactions of various factors with p53. Abbreviations: dsDNA-PK, double stranded 
DNA protein kinase; CKI, casein kinase I; cdc-2, p34cdc2kinase; CKII, casein kinase II; TBP, TATA 
binding protein; mdm-2, murine double minute-2; E1b, adenovirus 5 E1b protein; E6, human papilloma 
virus E6 protein; SV40 Tag, Simian virus 40 large T antigen (Adapted from Prives 134).
The role ofp53 as tumor suppressor was clarified in p53-null mice which develop normally 
but have a high predisposition of developing a variety of tumors by the age of 6 months 135. The 
tumor suppressor gene p53 is often referred as the guardian of the genome 136. The p53 gene is
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located on chromosome 17p13.1 and is mutated in more than 50% of all human tumors .
138 139
Frequently one of the two alleles is lost and the other one is mutated , . Most mutations are 
found in four conserved domains (II: aa 117-142; aa III; 171-181; III: aa 234-258; Iv: aa 270­
286), located in the DNA binding domain of the P53 protein 140 (fig. 1.11).
1.4.2. The effector phase of apoptosis.
Much knowledge about the involvement of genes in programmed cell death was derived 
from genetic studies on the nematode Caenorhabditis elegans. The embryonic development of 
the C. elegans is reproducible and has been precisely mapped. 1090 somatic cells are 
eventually formed in the adult hermaphrodite and of these 131 undergo programmed cell death 
141. Via mutations that affect different stages of programmed cell death, 14 genes have been 
isolated. The genes ced-3, ced-4 and ced-9 are directly involved in the execution of apoptosis. 
The activity of two of these genes, ced-3 and ced-4, is required in dying cells for cell death to 
occur. Ced-3 is homologous to the interleukin-1P -converting enzyme (ICE) family of cysteine 
proteases. The mammalian Ced-4 homologue is unknown. The third gene, ced-9, is required to 
protect cells that should survive from undergoing programmed cell death. Ced-9 encodes a 
protein that is homologous to the Bcl-2 family. 142,143.
1.4.2.1. Caspases.
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Various stimuli of apoptosis lead to the activation of a family of cysteine proteases with 
specificity for aspartic residues, referred to caspases (fig 1.12; ref. 144). The activated 
caspases cleave a variety of target proteins, thereby disabling important cellular processes and 
breaking down structural components of the cell 145. The target of such cleavage events include 
poly(ADP-ribose) polymerase 146,147, sterol regulatory element binding proteins 148, 
retinoblastoma (RB) protein 149,150, nuclear lamins 151-153, DNA-dependent protein kinase 154,155, 
U1 70-K protein 154 and the large subunit of the DNA replication complex C 156 In addition, 
activated caspases lead to cleavage of the 45 kDa subunit of DNA fragmentation factor (DFF- 
45). This cleavage activates a pathway leading to fragmentation of genomic DNA into 
nucleosomal fragments, a hallmark of apoptosis 157
The different caspases seem to form a protease cascade mechanism in which one protease 
cleaves and activates the next downstream precursor protease. Like Ced-3 in C. elegans, 
CPP32 normally exist as an inactive precursor that becomes activated proteolytically in cells 
undergoing apoptosis 148,158. Caspase-3/ CPP32 is the predominant protease in apoptosis of 
human cells 147 Direct evidence for the requirement of CPP32 activity in apoptosis follows 
from in vitro experiments with cytosolic extracts of apoptotic cells and normal nuclei. 
Inhibition of CPP32 with a specific tetrapeptide aldehyde inhibitor blocked the ability of 
inducing apoptotic changes in normal nuclei 146
caspase-5
PH1o
caspase-4 (TX, ICH-2, ICErel-II)
caspase-1 (ICE)
caspase-7 (Mch3, ICE-LAP3, CMH-1)
caspase-3 (CPP32, Yama, apopain)
caspase-6 (Mch2)
caspase-8 (MACH, FLICE, Mch5)
caspase-10 (Mch4)
caspase-2 (ICH-1)
caspase-9 (ICE-LAP6 , Mch6)
Figure 1.12. Schematic representation o f the caspase family. The caspases were arranged by genetic 
sequence homology.
1.4.2.2. Bcl-2-family.
Several mammalian genes have been identified that encode proteins with significant amino 
acid sequence similarity to the C. elegans ced-9 gene. Some of these genes are positive 
regulators of cell death (Bax, bcl-Xs, Bak, Bad) whereas others act as negative regulators of 
cell death (Bcl-2, Bcl-XL. Mcl-1 and Bag). Members of the Ced-9/Bcl-2 family can form 
hetero- and homodimers and it seems that the ratio of apoptosis-inhibiting and promoting 
proteins present may control the apoptotic response 132.
Bcl-2 was the first described as an oncogene in a common form of human B cell lymphoma 
159 and although it is highly expressed in tumor cells, almost any cell has the ability to express 
Bcl-2. The localisation and function of the 26 kDa Bcl-2 protein within the cell has been 
controversial. On the basis of subcellular fractionation and immuno-fluorescence staining, one 
group has reported that that it is associated exclusively with the mitochondrial inner membrane 
160. Other more detailed studies revealed that the protein was localised in the nuclear envelope, 
the endoplasmatic reticulum (ER) and the outer mitochondrial membrane 161.
24
General Introduction
Bcl-2 can block p53 dependent apoptosis, which follows directly from experiments with a 
temperature-sensitive mutant of p53. Transfected cells undergo apoptosis at reaching a 
permissive temperature where p53 adopts the wild-type conformation. Human Bcl-2 
completely prevents this p53-mediated apoptosis and causes cells to remain at a growth- 
arrested state 162 Due to its localisation, it was thought that Bcl-2 may interact with 
mitochondrial function and thus prevent the generation of reactive oxygen species. Apoptosis 
can occur in cells that lack mitochondrial DNA and are defective for most mitochondrial 
functions. Bcl-2 can still prevent apoptosis in this cell type 163. Further, it has been suggested 
that Bcl-2 controls levels of reactive oxygen species through an antioxidant pathway 12,164 This 
hypothesis gained more attention since Bcl-2 also prevented necrosis induced by glutathione 
depletion 165 and azide 166 However this may not be the main mode of action of Bcl-2 since 
apoptosis can occur, and can be prevented by Bcl-2 and Bcl-XL in nearly anaerobic conditions 
which minimise the formation of reactive oxygen species 15,167
The regulation of free intracellular Ca2+ is another apoptosis preventing feature attributed to 
168 2+ 2+ 2+
Bcl-2 . The role of Ca in triggering apoptotic cell by triggering Ca /Mg -dependent
endonucleases is well established 169-172 Treatment with calcium ionophores such as A23187
and ionomycin to artificially raise intracellular Ca2+ concentration leads to apoptosis in
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thymocytes , and hepatocytes . Thapsigargin is a specific inhibitor of the ER-associated 
Ca2+-ATPase, that pumps Ca2+ across a steep concentration gradient from the cytosol into the 
ER-lumen. Inhibition of this Ca2+-ATPase results in an efflux of Ca2+ to the cytosol and induces 
apoptosis in mouse lymphoma cells. Expression of Bcl-2 resulted in a reduced efflux of Ca2+ 176 
The expression of Bcl-2 also enhances the capacity of mitochondria to retain Ca2+ 177 Although 
preventing a rise in cytosolic free Ca2+can inhibit apoptosis 169 and Bcl-2 may contribute to this 
mechanism, in some cases, Bcl-2 was able to prevent apoptosis despite a rise of cytosolic free 
Ca2+ 178, indicating that Bcl-2 is involved in more mechanisms.
Recently, one important mode of action of Bcl-2 was partly elucidated by two independent 
groups. Both groups reported that Bcl-2 prevents the release of cytochrome c from the
179 180
mitochondrion , see fig 1.13). Released cytochrome c is involved in the initiation of 
protease cascade which eventually activates caspase-3/CPP32 181. Apoptotic protease 
activating factors (Apafs) support the activation of these proteases. Caspase-9 binds to Apaf-1 
in a cytochrome c and dATP-dependent fashion and becomes activated under such condition, 
activated caspase-9 in turn cleaves and activates caspase-3 182 ( see fig 1.13). The caspase 
binding site or caspase recruitment domain (CARD) of Apaf-1 also binds other caspases 
including caspase-1/ICE 183 and caspase-2/ICH-1 184 The CARD of Apaf-1 is followed by a 
stretch of 320 amino acids that are homologous to CED-4 and shows another evolutionary 
conserved mechanism.
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Fig 1.13. Schematic representation o f Bcl-2 inhibited caspase cascade activation.
The inability of Bcl-2 to block some forms of apoptosis can be explained by alternative 
routes of protease activation. For instance, Bcl-2 is only partly able to block Fas-ligand/ Fas 
receptor mediated apoptosis 185. In this system, the Fas-ligand/Fas receptor binding recruits the 
pro-protease caspase-8/FLICE to the FADD domain of the receptor. This binding probably 
results in the autocleavage of pro-FLICE which can activate subsequently ICE and CPP32 186,
187 188
, . This proteolytic cascade evades Apaf-1 and therefore the influence of Bcl-2. An other 
example is granzyme B mediated apoptosis. Cytotoxic T lymphocytes deliver granules via 
exocytosis which contain perforins (pore-forming proteins) and granzymes (multiple serine 
proteases). Granzyme B can directly cleave pro-CPP32 and activate the subsequent apoptotic 
program 189-191. It seems that especially cell-mediated form of apoptosis follow Bcl-2 
independent pathways, whereas stress-triggered apoptotic pathway are susceptible for Bcl-2.
1.4.2.3. Mitochondria and apoptosis.
A loss of the mitochondrial membrane potential is an event that correlates with the induction 
of apoptosis, and Bcl-2 protects mitochondria from this effect 192-194 Mitochondrial 
depolarisation in apoptosis appears to be associated with the permeability transition, an event 
involving the formation of a nonspecific pore in the mitochondrial membrane 195, which is also 
blocked by Bcl-2 194 From the experiments of Yang et al 179 and Kluck et al 180, it followed that 
the release of cytochrome c is not directly related to the loss of the mitochondrial membrane 
potential. In fact, the release of cytochrome c proceeded the collapse of the mitochondrial 
membrane potential by hours in staurosporine-induced apoptosis of HL-60 cells. Expression of 
Bcl-2 in Hl-60 cells prevented both events 179 Thus mitochondria of early apoptotic cells can 
release cytochrome c without any noticeable structural changes. The mechanism of cytochrome 
c release is as yet unknown but is probably related to the molecular structure of the Bcl-2 
family. Like Bcl-2, Bcl-XL is structurally related to certain bacterial pore-forming proteins 196 
The level of interactions between the different members of the Bcl-2 family may result in a 
pore-mediated release of cytochrome c or closure of this pore.
Although the loss of the mitochondrial membrane potential is a late event in normal 
apoptosis, it may also play a role in stress-mediated cell killing. Alkylating agents and 
oxidising agents are known to induce permeability transition 195. The same compounds are able
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to induce apoptosis. The loss of the mitochondrial membrane potential and the subsequent 
permeability transition are connected to apoptosis. Kroemer an co-workers showed that a 50 
kD protein, released from mitochondria upon mitochondrial depolarisation, is able to induce 
chromatin condensation and DNA fragmentation when incubated with nuclei 197 Moreover, the 
prevention of permeability transition with cyclosporin A rescued thymocytes from undergoing 
dexamethasone-induced apoptosis 198. Elevation of the mitochondrial membrane potential 
reduces the possibility of a permeability transition 195 and thereby the release of this apoptosis 
inducing factor (AIF). Nigericin is an ionophore of the K+/H+ exchanger and induces an influx 
of protons into the cytosol. This event will increase the mitochondrial membrane potential 199 
Artificial elevation of the mitochondrial membrane potential by nigericin was found to have an 
anti-apoptotic effect 200 Over-expression of Bcl-2 also elevates the mitochondrial membrane 
potential 201 and this mechanism may prevent the release of AIF and thus contribute to the 
inhibition of apoptosis. The AIF-induced apoptosis may be beneficial for an organism, because 
this mechanism may prevent necrotic cell death and inflammatory responses. Apoptosis may 
still change to necrotic cell death in cells that have been pre-emptied of ATP. At least two 
distinct steps in apoptosis, the typical nuclear degradation and the expression of 
phosphatidylserines seem to require energy for execution 202,203. Eguchi et a l 204 showed that 
FAS-mediated apoptosis was completely blocked with an inhibitor of the mitochondrial F0F1- 
ATPases and glucose-free medium. These experiments also showed that the activation of the 
caspases CPP32 and Yama is ATP-dependent. Moreover, treatment with calcium ionophore 
A23187 induced apoptosis under ATP-supplying conditions but induced necrotic cell death 
under ATP-depleting conditions, indicating that ATP-levels are a determinant of type of cell 
death.
1.4.3. Degradation phase of the cell.
Once the cell is committed to undergo apoptosis, proteases and endonucleases cleave 
proteins and DNA respectively, leading to the morphological manifestation of apoptotic cells. 
The formation of distinct DNA fragments of oligonucleosomal size (180-200 bp) is a 
biochemical hallmark of apoptosis. Recent observation suggest that cleavage of DNA into large 
fragments (50-300 kbp) occurs prior to the appearance of oligonucleosomal fragments 205. 
Several endonucleases like DNase I, DNase II and Nuc18 have been proposed as candidate for
206 172
the endonuclease activity during apoptotic activity (for review see: Dini et al; Hale et a l , ).
The fragmentation of the cell into apoptotic bodies is a typical feature of programmed cell 
death. A rearrangement of the cytoskeleton must occur during this process. It seems that 
disruption of the microtubule network on itself can induce apoptosis. Agents like colchicine, 
vinblastine, and nocodazole disrupt the microtubule network and all induced apoptosis in HL-
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60 cells , . Treatment of cells with cytochalasin B prior to an apoptotic stimulus, prevented 
the formation of apoptotic bodies while DNA fragmentation still occurred 209 This 
demonstrates the essential role of actin-filaments in the formation of apoptotic bodies.
During apoptosis, cytosolic transglutaminase catalyses the formation of dipeptide cross links 
in proteins between glutamine and lysine and also catalyse the cross linking of glutamine 
residues through di- and polyamines. The crosslinking of intracellular proteins will stabilise the 
cytoplasm of apoptotic cells, preventing the leakage of harmful intracellular components which 
could lead to an inflammatory response (for review see: Piacentini and Melino 210).
The inflammatory response is also avoided by the expression of cell-surface markers by 
apoptotic cells, which ensure their swift recognition and removal by phagocytes. Phagocytic 
cells recognise the apoptotic cells by changes in the composition of the outer plasma membrane. 
Normally, anionic phosphatidylserine is located at the cytosolic side of the plasma membrane
27
General Introduction
but is exposed at the outer plasma membrane of apoptotic cells 211,212 The vitronectin receptor 
is also involved in the recognition of apoptotic cells by macrophages. Blocking experiments 
with arginine-glycine-aspartic acid sequence (RGD, recognised by vitronectin) containing 
peptides and proteins showed the inhibition of phagocytosis of apoptotic bodies 213.
1.5. Oxidative stress and apoptosis.
1.5.1. Pro-oxidants induce apoptosis.
The evidence for role of reactive oxygen species in inducing or regulating apoptosis is 
considerable. Excessive ROS or the inhibition of antioxidants pathways can induce apoptosis. 
Extracellular sources of ROS like H2O2 and t-butyl hydroperoxide induce apoptosis at
12,13 12,214
subnecrotic doses , . Similarly, redoxcycling quinones such as MEN , and DIM provoke 
programmed cell death. Increasing concentrations (1-100 |iM) of the quinone DIM, stimulated 
growth, triggered apoptosis, or caused necrosis of pancreatic RINm5F cells, depending on the 
dose and duration of the exposure 14 Further, culturing cells under hypoxic condition followed 
by reperfusion induced apoptosis in several cell-lines 15 including the coloncarcinoma cell line 
HT-29 215. Decreasing the activity of antioxidant pathways shifts the intracellular redox status to 
a more oxidative environment and was found to have an pro-apoptotic effect. Down-regulation 
of CuZn superoxide dismutase has been reported to cause apoptotic death in PC12 neuronal 
cells 216 A similar pro-apoptotic effect has been described for dimethylmaleate that depletes 
GSH in a reaction catalysed by glutathione-S-transferase 214 Improvement of antioxidant
13 217 218
capacity has been shown to be protective against apoptosis , , .
1.5.2. Antioxidants can prevent apoptosis.
Some interesting cases of antioxidant-inhibited apoptosis have been described in which 
reactive oxygen species play a role in the mechanism that leads to apoptosis. The choice of an 
antioxidant can reveal the compartments or components of the cell that are involved in the 
apoptotic process. Free radical damage initially induced by radiation can be propagated and 
magnified by lipid peroxidation chain reactions 2 Trolox® is a water-soluble derivative of 
vitamin E and a peroxyl radical scavenger. It rapidly penetrates biological membranes and is a 
powerful inhibitor of membrane lipid peroxidation 2. Irradiated MOLT-4 lymphocytes were 
rescued from apoptosis by trolox indicating that membrane-associated oxidation are 
responsible for radiation-induced apoptosis 219 Trolox also prevented apoptosis in H2O2 
treated mouse thymocytes 220
In some cases, antioxidants can prevent apoptosis that was triggered by a non-oxidative 
mechanism or agent. Transfection of cells with glutathione peroxidase inhibited apoptotic cell 
death after growth factor deprivation of a IL-3 dependent cell-line 12 Obviously, the 
withdrawal of the cytokine triggered a signaling mechanism that depends on the presence of 
reactive oxygen species. Similarly, a hyperproduction of superoxide anion has been described 
in cells that undergo apoptosis. Greenlund et a l 221 showed the increased intracellular 
production of reactive oxygen species in apoptotic neurons after nerve growth factor 
deprivation. Superoxide dismutase was able to protect the cells against apoptosis. TNF-a 
induced cell killing is associated with an increased generation of superoxide anion in
222-224 225
mitochondria - . Anaerobic culture conditions can inhibit TNF-a -induced apoptosis , as
r)r)'7
can antioxidants and mitochondrial inhibitors 226,227.
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1.5.3. Oxidative stress and redox control during apoptosis.
Oxidative stress can activate apoptosis, whereas antioxidants are able to prevents programmed 
cell death. Apoptosis is under tight control of signaling molecules and transcription factors. 
Sublethal oxidative stress will affect the cellular activity of transcription factors because of the 
presence of cysteine residues in the proteins.
Exposure of cells to oxidative stress may result in DNA-damage by attack by a free radical
228,229
of either a sugar or a base residue , . Reactive oxygen species generated by MEN were 
found to induce strand breaks in DNA of hepatocytes 82,230,231, CHO cells 232 and leukemic K562 
cells 233. The resulting DNA strand breaks trigger p53-dependent DNA damage response 
pathways and may result in cell cycle arrest or apoptosis (see §1.4.1.1, ref. 234). Redox 
regulation at a posttranslational level often occurs through the cysteine residues of a protein by 
disruption (reduction) or formation (oxidation) of a disulphide bond. p53 contains 10 cysteine 
residues which are all located in the DNA binding domain 235 and may be of importance of the 
transcriptional activity for p53 in cells suffering from oxidative stress. In vitro experiments 
showed that a reductive environment provided by dithiothreitol (DTT) enhanced DNA-binding 
activity of 53, while oxidation by diamide reduced this activity 236 Surprisingly, transfected 
cells harboring a p53-sensitive reporter gene showed a contrasting result. The p53 
transcriptional activity was assessed in these cells during exposure to reducing agents (DTT, 
GSH, NAC), oxidising agents (H2O2, paraquat, GSSG, diamide, NEM), BSO (to lower the 
intracellular GSH content) or to antioxidants (BHA, PDTC). Most reducing agents reduced the 
transcriptional activity of p53 by two- to threefold, while no effect was observed with the
oxidants 235.
237,227
Reactive oxygen species have been shown to activate the NF-k B transcription factor , . 
A characteristic feature of NF-k B is its activation by posttranslational mechanisms involving 
dissociation of the inhibitory protein IkB. NF-kB activates several genes involved in 
inflammatory and immune responses and the induction of apoptosis - , . TNF-a induced
226,239
apoptosis, which is mediated by NF-kB, was blocked by NAC , indicating a redox 
regulation of NF-k B. This was demonstrated by the expression of thioredoxin, a cellular oxido- 
reductase and antioxidant in HeLa cells which resulted in a dose-dependent inhibition of NF- 
k B DNA binding and transcriptional activity 240
More evidence for redox regulation in apoptosis follows from experiments with Fas-induced 
apoptosis in Jurkat cells that actively excrete reduced GSH in an early phase of apoptosis 241. 
Similar observation were made in U937 cells in which apoptosis was induced by 
topoisomerase and protein synthesis inhibition 242 It seems that in some forms of apoptosis, the 
cell creates an artificial pro-oxidative environment which may have an enhancing effect on the 
signal transduction.
1.5.4. Ceramide and stress activated protein kinases (SAPKs).
The novel lipid mediator ceramide is emerging as a key regulator in several form of stress­
mediated apoptosis which includes cell death induced by ionising radiation, UV-C, Heat Shock, 
TNF-a , Daunorubicin, Fas ligand and HO2 238,243,244 Ceramide is generated in seconds to 
minutes after the stimulation of sphingomyelinase, a specific form of phospholipase that 
catalyses the hydrolysis of sphingomyelin 245-248. Verheij et a l 238 demonstrated that SAPK 
signaling is required for ceramide-mediated apoptosis of U937 cells. SAPKs or c-Jun kinases, 
characterised as members of the mitogen-activated protein kinase family, are activated by the 
same forms of environmental stress that activate ceramide generation 249,250 C-Jun, a major
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substrate of SAPKs, is essential to apoptotic signaling since dominant-negative mutant U937 
cells lacking the N-terminus of C-Jun are resistant to ceramide 238. The mechanism by which c- 
Jun mediates apoptosis is as yet unknown but it is involved in the activation of the apoptotic 
protease cascade. Experiments with protease inhibitors showed that ceramide induces
187 251 253
apoptosis via activation of the caspase-family including CPP32 , - . Recently, Seimiya et 
al 254 showed that SAPKs activate ICE/CED-3-like proteases during anticancer drug-induced 
apoptosis. Over-expression of Bcl-2 was found to interrupt ceramide-mediated apoptosis but 
did not interfere with the production of ceramide 255,256. This indicates that ceramide-induced 
apoptosis requires Apaf-1/cytochrome c activation of the caspase-family (see fig 1.13). 
Although the ceramide/SAPK apoptotic pathway is not fully understood, it appears to be tightly 
coupled to pathways of mitosis. Growth factors or PMA, a protein kinase C activator, can 
activate ceramidase to form sphingosine at the expense of ceramide 257 Sphingosine-1- 
phosphate, the phosphorylated metabolite of sphingosine was found to counteract the activation 
of SAPK by ceramide and suppress ceramide-mediated cell death 258. Thus, the balance of 
intracellular levels of ceramide and sphingosine-1-phosphate determines the fate of the cell.
1.6. Apoptosis in the intestine.
Apoptosis in the intestine can be divided into spontaneous and induced apoptosis, although both 
events seem to share common mechanisms.
1.6.1. Spontaneous apoptosis.
Apoptosis is well known to occur within the proliferative compartment of the small intestine 
at a low spontaneous rate that is only increased after genotoxic insult in a p53-dependent
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manner 259-262. In the colon there is also a low spontaneous rate of apoptosis in the lower parts
263,262of the crypts and this is also increased after genotoxic insult 263,262. Apoptosis is not generally 
recognised elsewhere in the gut epithelium or in the lamina propria (including the villus core). 
Hall et al 264 estimated that the number of apoptotic cells can account for the loss of cells that 
are released from the villi during the continuous renewal process. There is increasing evidence 
that enterocytes become more susceptible to programmed cell death during differentiation along 
the crypt-villus axis. At the present it is only possible to speculate about the mechanism that 
regulates spontaneous apoptosis in the intestine. Although it has been reported that the levels of 
a candidate endonuclease (DNAse I) increases towards the tip of the villus 265.
An alternative model would be the extrinsic regulation of apoptosis by a spatial expression 
of survival factors. TGFa , the EGF receptor and other peptide growth factors have been 
described. In addition, spatially regulated gradients of TGFa expression along the small 
intestinal crypt-villus axis 266 and colonic crypts 267 have been reported. Spontaneous apoptosis 
is also associated with alterations in cell adhesion molecules and substratum along the crypt- 
villus axis. Frisch and Francis 268 demonstrated that normal endothelial and epithelial cells 
undergo apoptosis when the cells are detached from the substrate with RGD peptides or 
attachment is prevented by growing cells in suspension. Beaulieu 269 has proposed that 
differential expression of P1 integrins along the crypt-villus axis facilitates cell loss. Indeed, the 
survival of isolated human colonic crypt cells was dependent on the binding of the p 1 integrin to 
the matrix 270 The importance of adhesions molecules as survival factor is confirmed by the 
finding that HT-29 and COLO 205 coloncarcinoma cells shed the CD44 glycoprotein in FAS­
ligand mediated apoptosis 271. CD44 is a transmembrane glycoprotein involved in homo- and 
heterotypic cell adhesion and cell-matrix interaction 272
30
General Introduction
1.6.2. Induced apoptosis.
Apoptosis in the intestine is induced by several cytotoxic agents and by radiation, but the 
level of apoptotic response differs between the small and large intestine. Spontaneous and 
radiation-induced apoptosis is more abundant in the small intestine compared to the colon and 
has the greatest incidence at the presumed position of the stem cells within the crypts. Damage- 
induced apoptosis in the colon was not associated with stem cells but with cell higher up the
crypt 261,262,273,274. The pattern of radiation-induced apoptosis is dependent on the expression of
p53 , . Merritt et a l demonstrated that the P53 protein was expressed strongly in the stem 
cells of the small intestine but at lower levels in the colon. Analysis of sections of human colon 
and small intestine also showed that the expression of Bcl-2 was confined to the base of the 
colonic crypts whereas the Bcl-2 was absent in the crypts of the small intestine 274. The 
importance of the expression of Bcl-2 in the resistance to apoptosis was confirmed by the rise 
of spontaneous apoptosis in colonic crypts of Bcl-2 deficient mice in comparison with crypts of 
wild type mice 274 The same group revealed a reciprocal expression of Bcl-2 and of P53 in 
normal colorectal tissue and colonic adenomas and carcinomas 276. Bax, a pro-apoptotic protein 
and is expressed only in cells of the small intestine which may enhance the predisposition of 
these cell to apoptosis 277. The higher resistance of colonic cells to apoptosis may promote the 
retention of cell with a damaged genome and is for this reason linked with the 100- fold higher 
incidence of colonic cancer in comparison with the small intestinal malignity’s 261,263.
Although loss of wild type p53 may abrogate G1 arrest, radiation-induced apoptosis can 
occur in human colonic tumour cell-line S/RG/C2 and PC/JW through a p53 independent 
mechanism. Flow cytometry revealed that these cells failed to arrest in the G1 phase of the cell
278 279
cycle after irradiation but accumulated in the G/M  phase . Hague et a l described a p53 
independent induction of apoptosis by sodium butyrate in the same cell-lines. Sodium butyrate, 
a naturally occurring fatty acid, is present in the large intestine as the result of bacterial 
fermentation of dietary fibre. Butyrate is preferentially taken up by colonic epithelium, where it 
is actively metabolised to produce energy. Normal colonic epithelial cells derive 60-70% of 
their energy supply from short-chain fatty acids like butyrate 280. The mechanism by which 
sodium butyrate induces apoptosis is still unclear. Butyrate treatment resulted in the 
hyperacetylation of the histones H3 and H4 due to its inhibition of histone deacytylase 281. This 
leads to changes in to chromatin structure and results in altered gene expression and increased 
accessibility of DNases. An other target of butyrate is the cytoskeleton where it plays a role in
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the modification of the microtubule and microfilament assembly . Heerdt et a l showed that 
butyrate induces apoptosis and differentiation, measured as an increase of alkaline phosphatase 
activity, in the colon carcinoma cell-lines HT-29 and SW620. Hague et al 284 suggested that 
butyrate-induced apoptosis represents the culmination of the colonic differentiation pathway. 
Interestingly, over-expression of Bcl-2 was found to inhibit butyrate-induced apoptosis in 
several colorectal carcinoma cells 285. An other component of the lumenal content is 
deoxycholate, an bile salt. Deoxycholate, at physiological concentrations, is also capable of 
inducing apoptosis in p53-independent manner 284 Bile salts interfere with the lipid membranes 
of the ER and may induce an increase of free cytosolic calcium 286. In hepatocytes, the 
deoxycholate-mediated [Ca2+] increase appeared to activate protein kinase C, which causes an 
Mg2+ influx from the cell exterior and cathepsin B activation and translocation to the nucleus 287­
289 The rise of intracellular Ca2+ and Mg2+ results in activation Ca2+ and Mg2+-dependent 
endonucleases and subsequent DNA digestion , whereas cathepsin B can cleave nuclear 
proteins. Other known cellular effects may be implicated in the apoptotic mechanism of bile 
salts, such as activation of phospholipases, inhibition of GSH-S-tranferases, and interaction 
with the cytoskeleton 290.
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1.7. Conclusions.
Oxidative stress can cause several types of cellular injury which may result in cell death. 
The site and degree of injury are major factors in the decision which type cell death to occur. 
Cell death can occur according two distinct pathway: necrosis and apoptosis. Apoptosis is an 
active process and requires energy (ATP) to complete. The mechanism by which cells are 
induced to undergo apoptosis is complex and there seem as many triggers as there are types of 
cells. Nevertheless, the various apoptotic pathways seem to converge to one distinct route 
which is controlled by caspases.
Moreover, apoptosis and necrosis share events such as permeability transition of the 
mitochondria which releases certain apoptosis-inducing factors. The levels of cellular ATP 
may subsequently determine the type of cell death. Recently, Aw and co-workers 291 showed for 
the first time that ischemia-reperfusion induces apoptosis in rat intestinal mucosa. It was 
generally assumed that necrosis is sole form of cell death involved in this gastro-intestinal 
pathology.
The toxic mechanism of quinones that were used in this study induce potential pro-apoptotic 
conditions such as DNA-damage, intracellular calcium elevation, permeability transition and 
interference with the cytoskeleton. However, quinones may also create pro-necrotic conditions 
like ATP-depletion by interference of the glycolysis and oxidative phosphorylation. Therefore, 
it is necessary to evaluate the toxic metabolism of quinones which depends on the activating 
enzymes and antioxidant mechanisms present in a tissue. In the intestinal mucosa, these 
mechanisms may alter during the differentiation of a crypt stem cells to a mature enterocytes.
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1.8. Scope of this thesis.
The aim of this study was to investigate the relationship between oxidative stress and 
cytotoxicity in intestinal epithelium. A model system consisting of isolated rat small intestinal 
cell and the quinone compounds was used in this study. The quinones are three related 
naphthoquinones menadione (MEN), 1,4-naphthoquinone (NQ) and 2,3-dimethoxy-1,4- 
naphthoquinone (DIM) redoxcycle at similar rates, NQ is a stronger arylator than MEN and 
DIM is not be capable of arylation. The use of these three quinones may give more insight in the 
relative importance of arylation versus oxidation in the mechanism of toxicity. Furthermore, 
much of the research was performed using the colon carcinoma cell-line Caco-2, which 
displays typical characteristics of the human small intestine enterocytes. This cell-line has 
proven to be an excellent model for pharmacological and toxicological studies and possesses 
all major enzymes required for biotransformation of xenobiotics - . The activity of 
bioactivating enzymes and antioxidant capabilities are comparable with the mammalian 
intestinal epithelium.
In Chapter 2, the cytotoxicity of three quinones MEN, NQ and DIM were compared in 
freshly isolated rat enterocytes. The isolation procedure allowed a comparison between 
enterocytes of different sections of the villus-crypt axis. toxicity was evaluated by assessing the 
effects of the quinones on the membrane integrity, thiol and energy homeostasis. Chapter 3 
deals with the cytotoxicity of MEN in the differentiating coloncarcinoma cell-line Caco-2. 
Chapter 4 describes the role of the 2 electron reduction by DT-diaphorase in cytotoxicity in 
coloncarcinoma cell-lines HT-29 and Caco-2. The thiol- and energy metabolism is studied in 
more detail in quinone-treated Caco-2 cells. Chapter 5 discusses the role of DNA-damage, the 
subsequent activation of PARP and calcium in cell killing mediated by oxidative stress. The 
loss of co-factor NAD+ and the consequences for the mitochondrial function are described in 
Chapter 6. Chapter 7 deals with oxidative stress-induced apoptosis, the role of the tumor 
suppressor p53 and cell cycle effects in menadione-treated Caco-2 cells. Finally, Chapter 8 
contains the over-all discussion of the findings of the previous chapters.
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Chapter 2
Quinone Toxicity in Freshly Isolated Rat Intestinal Cells.
Jurgen M. Karczewski, Aloys L.A. Sesink, Rob J. Wegh, Janny G.P. Peters, and 
Jan Noordhoek
D epartm ent o f  Toxicology, University o f  Nijmegen, Nijmegen, The Netherlands.
Abstract - Three morphologically and biochemically different populations of enterocytes, i.e. villus, mid­
villus and crypt cells, were isolated from the rat small intestine. In these populations, the cytotoxic effects 
of 1,4-naphthoquinone (NQ), 2-methyl-1,4-naphthoquinone (menadione; MEN) and 2,3-dimethoxy-1,4- 
naphthoquinone (DIM) were determined. These naphthoquinone derivatives differ in their ability to 
arylate thiol groups and to redox cycle. The redoxcycling and arylating quinones NQ and MEN were 
more toxic than the redoxcycler DIM. Crypt cells were more vulnerable to MEN than villus and mid­
villus cells. An increasing gradient of DT-diaphorase activity was found along the villus-crypt axis (villus 
cells: 211 ± 102, mid-villus cells 217 ± 88 and crypt cells 284 ± 121 nmol NADPH oxidised /min/mg 
protein). The redoxcycler DIM was more toxic to villus and mid-villus cells than crypt cells which is in 
agreement with the activities of DT-diaphorase and cytochrome P450 reductase. NQ induced the highest 
levels of intracellular oxidised and protein associated glutathione, which may reflect the rapid inactivation 
of glutathione reductase. A constant release of reduced glutathione was observed with control cells, 
which was inhibited by the three quinones used in this study. The relevance of this inhibition is unknown 
and needs further investigation.
Introduction
There are many opportunities for damage to the small intestine on exposure to stress by 
xenobiotics, bacteria, drugs and heavy metals. A common mechanism may be the generation of 
reactive oxygen species. Reactive oxygen species are involved in some types of gastrointestinal 
injury as in Crohn's disease \ ulcerative colitis 2 and ischemia-reperfusion, 3,4 . Quinones occur 
as compounds of potential toxicological significance in food and environmental pollution 5 and 
were used as model compounds for the generation of reactive oxygen species.
Quinones exert their cytotoxic effects by arylation of cellular macromolecular nucleophiles 
and redoxcycling 5,6 The relative importance of these processes (arylation vs. redox cycling) 
depends on the quinone's substituted groups 7,s. Quinones are metabolised by one-electron 
reduction to the corresponding semiquinone radical; this reaction is catalysed primarily by 
microsomal enzymes NADPH-cytochrome P-450 reductase and NADH cytochrome b5 
reductase and mitochondrial NADH ubiquinone oxido-reductase. Quinones are also reduced to 
hydroquinones in a two-electron reduction catalysed by DT-diaphorase 5,s. The semi- and 
hydroquinone can enter into a redox cycle with oxygen, reforming the quinone and generating 
the superoxide anion radical. Continuous redoxcycling results in cellular oxidative stress by the 
formation of superoxide anion and other potentially damaging reactive oxygen species 9 The 
two-electron reduction pathway is believed to be a detoxification pathway 10,11. The 
hydroquinone is more stable than the semiquinone and does not react with thiols 11. 
Hydroquinones are more readily conjugated to glucuronides or sulphates and excreted from the 
cell. Dicoumarol, a specific inhibitor of DT-diaphorase, greatly enhanced MEN induced 
toxicity in isolated hepatocytes 12,13. Further, the colon carcinoma cell-line Caco-2 is DT-
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diaphorase deficient and the lack of this enzyme caused an increased sensitivity towards 
quinone toxicity in comparison with the DT-diaphorase expressing cell- line HT-29 (Chapter 
4).
Naphthoquinone-induced toxicity is well investigated in isolated hepatocytes. Exposure of 
isolated hepatocytes to NQ and MEN, but not DIM resulted in loss of cell viability 13. 
Concomitant with a dose- and time-dependent glutathione (GSH) depletion, a rise in oxidised 
glutathione (GSSG, intra- and extracellular) and protein-bound glutathione (RSSG) was 
observed 6,14 Furthermore, exposure of isolated hepatocytes to toxic concentrations of quinones 
leads to oxidation of pyridine nucleotides 14-16, loss of ATP 17,18 and changes in intracellular 
Ca2+ homeostasis 12,15,19 Interference with these cellular processes can lead to disruption of 
mitochondria and the cytoskeleton 20, blebbing of the cellular membrane and eventually 
resulting in necrosis 12
Little is known about the effects of quinones on isolated enterocytes. It was found that thiol 
homeostasis and viability in isolated enterocytes was affected by quinones 21 and that these 
effects could be prevented by exogenous GSH 22 However, there are some differences between 
hepatocytes and enterocytes that need to be considered. GSH content in liver is up to 4 times 
higher than in the small intestine, whereas GSH synthesis in the small intestine is approximately 
10% of that in liver 23. According to Redegeld et a l 24, ATP depletion preceded cell death in 
MEN-treated hepatocytes. The ATP production in enterocytes is somewhat different than in 
hepatocytes. Hepatocytes predominantly use fatty acids as a source for ATP, whereas oxidation 
of glutamine and ketone bodies provides a substantial part of the energy requirement of 
enterocytes 25. In contrast to hepatocytes, glycogen is present only in limited amounts in 
enterocytes 26 Glycogen depleted hepatocytes appeared to be more sensitive to oxidative 
damage during MEN metabolism than glycogen containing cells 14,27 Furthermore, Bellomo et 
a l 21 and Lash et a l 22 did not consider the ability of intestinal epithelial crypt cells to 
differentiate into absorptive villus cells. While these cells migrate along the villus/crypt axis, 
they develop different metabolic activities and therefore crypt cells differ from villus cells in 
their contents of various enzymes, e.g. GSH-related enzymes , and cytochrome P-450 , . 
Whether these differences along the villus/crypt axis lead to a different susceptibility towards 
quinone induced cytotoxicity is not known.
The functional enterocytes originate from germ cells in the crypts and migrate along the 
crypt-villus axis. The loss of germ cells or oxygen radical induced genetic alterations may have 
far-reaching consequences for the intestinal epithelium. Therefore, it is important to assess the 
differences in vulnerability of the progressive stages of differentiation of the enterocytes. We 
used MEN and two related quinones, NQ and DIM, to distinguish between the effects of 
redoxcycling and arylation in freshly isolated epithelial villus and crypt cells. We observed an 
effect of DIM on viability, thiol homeostasis and the ATP content of villus and mid-villus cells 
but not in crypt cells. The toxicity was enhanced when the quinones were able to arylate.
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Materials and Methods
Chemicals. 1,4-naphthoquinone and menadione were purchased from Aldrich (Milwaukee, USA). 
2,3 dimethoxy-1,4-naphthoquinone was prepared according to Gant et al 1. The identity was checked 
with mass spectrometry. Monobromobimane was from Calbiochem (La Jolla, USA). Other chemicals 
and enzymes were obtained were from Sigma (St. Louis, USA). All chemicals were of analytical grade.
Animals. Male random bred Wistar rats (Cpb:WU) (180 - 220 g) were used in all experiments. They 
had free access to food (RMH pellets, Hope Farms Woerden) and water.
Enterocytes isolation and incubation. Rat small intestinal cells were prepared according to the 
vibration/chelation method of Harrison and Webster 32 as modified by McNicholas et al 33. Three 
fractions were obtained in an ice-cold isolation buffer (30 mM EDTA, 112 mM NaCl, 5 mM KCl, 20 
mM Tris, 0.5 mM DTT, pH 7.1), by changing the medium at timed intervals (fraction 1, containing tip 
villus cells: 2 x 5 min, fraction 2, containing mid villus cells: 1 x 7 min, fraction 3, containing crypt cells:
1 x 10 min).
Cells (106/ml, 40 ml) were incubated in a Krebs-Henseleit buffer (KH, formulation in mM: 1.2 
MgSO4.7H2O, 2.5 CaCl2.2H2O, 4.7 KCl, 94 NaCl, 11.6 D-glucose, 25 NaHCO3, 1.2 KH2PO4 and 5 L- 
Glutamine, pH 7.4) under a continuous 95% O2/ 5% CO2 atmosphere in syliated 100 ml Erlenmeyer 
flasks in a stirring waterbath (37 °C). Substrates were added in dimethylsulfoxide (DMSO, 0.25% final 
volume) in final concentrations of 50 ^M NQ, 100 ^M MEN or 300 ^M DIM.
Alkaline phosphatase. Activity of cytosolic alkaline phosphatase was used as a marker for separation 
of the cell fractions, the highest activity being present in the villus cells 34. For this purpose, a 100 ^l 
sample was pipetted in triplo in a 96 wells plate and incubated in a Thermomax microplate reader 
(Molecular Devices, Menlo Park, California, USA) for 2 minutes. The reaction was started by adding the 
100 ^l 5.6 mM sodium p-Nitro-phenylphosphate to the wells and monitored during 5 minutes at 405 nm. 
p-nitro-phenylphosphate was diluted in 0.4M TRIS/NaCl , pH 8.5. Reaction rates were corrected for 
non-enzymatic dephosphorylation of the substrate. Activity was compared with alkaline phosphatase 
standards.
Viability. Cell viability was estimated by calculating the percentage leakage of lactate dehydrogenase 
(LDH) in the medium according to the method of Bergmeyer et al 35, adjusted for measurements in 
microtitre plates. Aliquots of 1 ml were taken from the cell incubates and cells were carefully removed 
by centrifugation (500 g, 2 min, 4 °C ). Supernatant (50 ^l) and 100 ^l 0.9 mM sodium pyruvate were 
pipetted in triplicate in a 96-wells microtitre plate and incubated for 2 minutes in the Thermomax 
microplate reader. The reaction was started by adding 50 ^l 2.5 mM NADH to the wells and monitored 
during 2 minutes at 340 nm. All reagents and samples were diluted in PBS. Reaction rates were 
corrected for non-enzymatic NADH-oxidation. Complete LDH release (100%) was achieved by 
freeze/thawing followed by 5 min centrifugation at 15.000 g.
GSH, GSSG, RSSG and extracellular GSH. Reduced glutathione: GSH was determined by HPLC 
after derivatization with monobromobimane (mBBr) as described by Cotgreave and Moldeus 36 and 
modified by Toxopeus et al 6. At timed intervals 1 ml cell suspension was gently centrifuged (500 g, 2 
min, 4 °C), supernatant was removed from the pellet and the pellet was resuspended in 300 ^l ice-cold 
buffer containing 20 mM Hepes, 0.12 M NaCl, 5.6 mM KCL, 4.2 mM NaHCO3, 1 mM MgSO4.7H2O 
and 1.3 mM CaCl2.2H2O (pH 7.45).
Reduced glutathione: GSH was derivatized by adding 100 ^l 2 mM mBBr (dissolved in 50 mM N- 
ethylmorpholine) to 100 ^l resuspended pellet and incubating this mixture for 5 min in the dark. Protein 
was denatured by inclusion of 25 ^l 40% TCA and removed by centrifugation (5 min, 10.000 g).
Protein-bound glutathione: Protein of a 200 ^l sample was denatured with 25^l 40% TCA and 
washed twice with 250 ^l 5% TCA and resuspended in 100 ^l PBS + 1% SDS, 5 ^l saturated NaHCO3 
and 5 ^l 5 mM DTT. After shaking for 60 minutes at room temperature, this mixture was derivatized 
with 100 ^l 5 mM mBBr, protein was removed by adding 25 ^l 40% TCA and removed by 
centrifugation (5 min, 10.000 g).
Total intracellular glutathione: The resuspended pellet (200 ^l) was deproteinized by adding 25 ^l 
40% TCA and centrifugation (2 min, 10000 g, the pellet being used for the determination of protein 
mixed disulphides). Supernatant (100 ^l) was neutralised with 8 ^l 2.5 M NaOH and 50 ^l 1 M 
potassium phosphate buffer (pH 6.0) and was incubated with 5 ^l 25 mM DTT. This mixture was left
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shaking for 30 minutes at room temperature. GSH was derivatized by adding 100 ^l 5 mM mBBr. 
GSSG was calculated with the formula: GSSG=TGSH-GSH-RSSG.
Extracellular glutathione: Supernatant (100 ^l) of the cell suspension was treated the same way as 
reduced glutathione.
The mBBr-derivatives were separated using a Spectra-Physics HPLC system consisting of a SP8800 
ternary pump, a SP8875 autosampler, a SP4600 integrator and a Merck 100 RP-18 column 
(LichroCART 125-4 Lichrospher). Samples (20 ^l) of glutathione derivatives were injected on the 
column at 40 °C and were separated with a flow rate of 1 ml/min. Buffer A was 128 ml methanol and 
2.5 ml acetic acid diluted to 1 l with aqua pure, adjusted to pH 3.9 with 5 N NaOH. Buffer B was 900 
ml methanol and 2.5 ml acetic acid, diluted to 1 l with aqua pure. A linear gradient from 0% B at 0 min, 
50% B at 8 min to 0% B at 17 min was used to elute the glutathione derivatives that were detected 
using a Shimadzu RF-530 fluorescence detector at 1ex=385 nm and 1em=480 nm. Glutathione content 
was expressed as nmoles/mg protein.
Cellular ATP content. ATP was separated by HPLC as described by Jones 37 as adapted by 
Redegeld et al 27. Cells were treated with 300 ^l 5% (v/v) perchloric acid and neutralised with 700 ^l
0.8 M potassium phosphate buffer. Insoluble material was removed by centrifugation (5 min, 13000 g) 
and the supernatant stored at -80 °C until use. ATP was separated using HPLC. Supernatant (20 ^l) was 
injected on the column (Merck 100 RP-18 column, LichroCART 125-4 Lichrospher) at 40 °C and were 
separated with flow of 1 ml/min. The elution buffer was a 0.1 M potassium phosphate buffer, pH 6.0 
that was filtered through a 0.45 mm filter before use. ATP was detected by a Kratos Spectroflow 773 
UV detector at 260 nm. ATP content was expressed as nmoles/mg protein.
DT-Diaphorase. After sonification of 1 ml cell suspension of each fraction, DT-diaphorase activity in 
the cytosolic fraction was determined according the method of Ernster 38, as modified by Benson et al 39. 
A 3 ml mixture assay contained 25 mM Tris-HCl (pH 7.4), 0.7 mg BSA, 0.08 vol% Triton X-100, 5 ^M 
FAD, 500 ^M NADPH, 34 ^M cytochrome c, 0 or 10 ^M dicoumarol (added as 10 ^l 3 mM 
dicoumarol in 0.5 M Na2CO3, pH 11) and an appropriate amount of enzyme (final sample protein 
content should be approximately 30 mg/3 ml). After 3 minutes pre-incubation at 25 °C, the reaction was 
started by adding 10 ^l menadione (dissolved in ethanol, final concentration was 40 ^M). The reduction 
of cytochrome c was measured at 550 nm. The dicoumarol sensitive part was taken as a measure of the 
DT-diaphorase activity.
Cellular Protein. Cellular protein was quantified with the Bradford method 40 using bovine serum 
albumin as a standard.
Statistical analysis. Results are expressed as means ± SD of three independent experiments. 
Statistical differences between groups were determined by means of a three-way analysis of variance 
(ANOVA), followed by Dunnett’s multiple-comparison test. A probability of P 0.05 was considered 
significant.
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Results
Enterocytes were isolated according to the vibration-chelation method of Harrison and 
Webster 32 Microscopical examination showed that the first and second fractions contained 
long, columnar cells, whereas the last isolated fraction consisted of small, round cells (not 
shown). Typical total cell yields per 60 cm intestine were: villus cells: 154 (± 35) *106 cells, 
mid villus cells: 128 (± 27) *106 and crypt cells: 144 (±44) *106 cells. Relative alkaline 
phosphatase activities, as a measure of separation of the fractions, were 100%, 62% (±18%) 
and 29% (± 11%) in villus, mid-villus and crypt cells, respectively.
villus mid-villus crypt
Time (min) Time (min) Time (min)
Figure 2.1. Effect o f quinones on the viability o f villus, mid-villus and crypt cells. Enterocytes were 
treated with solvent (0.25% DMS0)(O) or exposed to 50 NQ (•), 100 MEN (■) or 300 ^M 
DIM (A). The viability was measured as described in materials and methods. Shown are the means ± 
SD of three independent experiments (*: p<0.05, **: p<0.01 compared to control cells).
villus mid-villus crypt
Tine(min) Time (min) Time (min)
Figure 2.2. Effect o f quinones on the cellular reduced GSH content o f villus, mid-villus and crypt cells. 
Enterocytes were treated with solvent (0.25% DMS0)(O) or exposed to 50 ^M NQ (•), 100 ^M MEN 
(■) or 300 ^M DIM (A). GSH was determined as described in materials and methods. Shown are the 
means ± SD of three independent experiments (*: p<0.05, **: p<0.0l compared to control cells).
Viability of non-exposed cells decreased by 20% in 60 minutes, which may be seen as a 
normal response to isolation from their physiological environment (fig. 2.1). No differences in 
quinone induced toxicity were observed between the different cell populations except with 
MEN. The crypt fraction displayed a higher vulnerability for this compound than villus cells 
(p£ 0.01: ANOVA). After 60 minutes of exposure to MEN, the loss of viability was higher in 
the crypt fraction than with the mid-villus cells (p£ 0.05: ANOVA).
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Quinones are toxic to cells via their capability of arylation or redoxcycling. Reactive oxygen 
species or the quinone itself may interfere with the thiol status of exposed cells. In order to 
investigate the effect of quinones on the thiol pool of enterocytes, reduced glutathione, oxidised 
glutathione and protein associated disulphides were measured. The control cells were not able 
to retain their reduced glutathione content and the levels decreased to 25% of the initial content 
(fig. 2.2). The levels of reduced glutathione were somewhat higher in untreated crypt cell 
compared to villus cells (p< 0.05: ANOVA), but these differences did not persist during 
exposure to quinones. The arylating quinones NQ and MEN rapidly depleted the GSH pool. In 
all fractions nearly 60-70% of all GSH was depleted during the first 10 minutes of exposure. 
The pure redoxcycler DIM did not have this depleting effect and followed nearly the same 
curve as observed with the control cells. In case of NQ, the loss of GSH was followed by the 
appearance of GSSG (fig. 2.3). These levels did not differ between the three isolated cell 
populations. Although small amounts of GSSG were found with MEN, these levels were not 
significantly different from the controls. The concentration of RSSG was the highest with NQ, 
with a maximum at 10 minutes, followed by a slow decrease (fig. 2.4). Effects of MEN and 
DIM were similar to those of NQ, but were substantially smaller. A comparison between 
villus, mid-villus and crypt cells showed no differences in the levels of protein disulphides. 
The levels of extracellular reduced glutathione rose constantly during the 60 min of incubation 
in control experiments (fig. 2.5). The similar rate of excretion was observed with all cell 
fractions. With all three quinones, only small amounts of extracellular GSH were found after 
addition of the tested quinones.
The ATP levels of controls did not statistically differ between three fractions and showed in 
all cases a decrease of nearly 60% after 60 minutes of incubation (fig. 2.6). The levels of ATP 
were further decreased in all experiments with quinones except in DIM-treated crypt cells (p<
0.01: ANOVA). The ATP content of MEN and NQ treated crypt cells showed a faster initial 
depletion of the ATP content than villus and mid-villus cells (p< 0.05: ANOVA).
villus mid-villus crypt
Time (min) Time (min) Tims (min)
Figure 2.3. Formation o f oxidised glutathione during exposure o f quinones to villus, mid-villus and 
crypt cells. Enterocytes were treated with solvent (0.25% DMS0)(O) or exposed to 50 ^M NQ (•), 
100 ^M MEN (■) or 300 ^M DIM (A). GSSG was measured as described in materials and methods. 
Shown are the means ± SD of three (control, MEN) or two (NQ, DIM) independent experiments (*: 
p<0.05, **: p<0.01 compared to control cells).
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villus mid-villus crypt
Time (min) Time (min) Time (min)
Figure 2.4 Formation o f protein-associated disulphides during exposure o f quinones to villus, mid­
villus and crypt cells. Enterocytes were treated with solvent (0.25% DMS0)(O) or exposed to 50 ^M 
NQ (•), 100 ^M MEN (■) or 300 ^M DIM (A). RSSG was measured as described in materials and 
methods. Shown are the means ± SD of three or two (NQ) independent experiments (*: p<0.05, **: 
p<0.01 compared to control cells).
DT-diaphorase is generally considered to play a key position in the detoxification process of 
quinones. A two-electron reduction allows conjugation followed by excretion 5,12 We were 
interested whether differences in distribution of this enzyme may explain the differences in 
toxicity. The activity of DT-diaphorase was distributed along the villus crypt axis as follows 
(in nmol oxidised NADPH/min/mg protein; means ± SD): villus cells: 211 ± 102, mid-villus 
cells 217 ± 88 and crypt cells 284 ± 121. DT-diaphorase showed great interindividual 
variability, but the activity appeared to be consistently higher in the crypt cell fraction (p<0.05, 
ANOVA).
villus mid-villus crypt
Time (min) Time (min) Time (min)
Figure 2.5. Effect o f quinones on the release o f glutathione during incubation o f villus, mid-villus and 
crypt cells. Enterocytes were treated with solvent (0.25% DMS0)(O) or exposed to 50 NQ (•), 
100 ^M MEN (■) or 300 ^M DIM (A). Extracellular GSH was determined as described in materials 
and methods. Shown are the means ± SD of three or two (MEN) independent experiments (*: p£0.05, 
**: p<0.01 compared to control cells).
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villus mid-villus crypt
Time (min) Time (min) Time (min)
Figure 2.6. Effect o f quinones on the ATP levels o f  villus, mid-villus and crypt cells. Enterocytes were 
treated with solvent (0.25% DMS0)(O) or exposed to 50 NQ (•), 100 MEN (■) or 300 ^M 
DIM (S). ATP was measured as described in materials and methods. 100% represents 9.59 ± 1.19 
nmol/mg protein. Shown are the means ± SD of three independent experiments (*: p<0.05, **: p<0.01 
compared to control cells).
Discussion
In the present study, we exposed freshly isolated enterocytes to redoxcycling and arylating 
quinones. The isolation procedure provided three morphologically and biochemically different 
populations of enterocytes i.e. villus, mid-villus and crypt cells. These isolated enterocytes 
proved to be a rather vulnerable cell type and a relatively high loss of viability, GSH and ATP 
was observed with the control cells. The depletion of cellular GSH in control cells may be the 
result of active basolateral transport of GSH since considerable amounts of GSH were 
retrieved in the incubation medium and the percentage loss of cellular GSH exceeded the loss 
of viability (leakage of LDH). Oral administration of GSH to rats resulted in increased levels 
of GSH in the plasma. The increase of GSH was not related to catabolism and resynthesis of 
GSH, which indicated a role of transport of intact GSH by intestinal cells 41. Nevertheless, our 
experiments made it possible to obtain more insight into the cellular response of different 
enterocyte populations to oxidative stress and arylation.
Quinone exposure in isolated enterocytes resulted in relatively small levels of LDH leakage 
as compared with other cells systems, such as isolated hepatocytes 6,13 A possible explanation 
for the reduced vulnerability to membrane damage is the natural protection of intestinal cells to 
lipid peroxidation. Intestinal cells contain unusually high amounts of non-esterified fatty acids 
and these compounds inhibit lipid peroxidation through iron chelation 42 This iron fatty acid 
complex is incapable of inducing the formation of the hydroxyl radical from Ff>O2, and thus 
preventing lipid peroxidation. These findings were confirmed in experiments at our laboratory 
(data not shown). LDH leakage is the result of cell rupture after blebbing. Because of the 
natural protection, the phospholipid bilayer may keep its viscosity and does not rupture easily 
after blebbing.
A comparison between the different cell fractions showed that only the toxicity of MEN was 
higher in crypt cells than villus or mid-villus cells. For NQ and DIM, no differences were 
found between the cell fractions. This higher toxicity of MEN in crypt cells is probably the 
effect of arylation rather then redoxcycling. NADPH cytochrome P-450 reductase is the major 
reductase involved in one electron reduction of quinones in hepatocytes 12,13 and in redoxcycling 
of diquat in intestinal tissue slices 43. In crypt cells NADPH cytochrome P-450 reductase 
content is substantially lower than in villus cells 30,44 Besides a lower rate of activation, the
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detoxification in the crypt fraction may be faster than that in the villus cells. In the present study, 
we show that the concentration of DT-diaphorase enzyme is higher in the crypt fraction. DT- 
diaphorase converts quinones to hydroquinones via an obligatory two electron reduction and is 
considered to be an essential step in the detoxification of quinones since a hydroquinone cannot 
able conjugate to GSH or arylate to protein thiols 11. Superoxide dismutase prevents the 
hydroquinone from auto-oxidation and thus stabilises the hydroquinone 10,11,45. The hydroquinone 
is excreted from the cell after glucuronidation or sulphation reactions 46,47 Because of the higher 
levels of DT-diaphorase and the lower amounts of cytochrome P450 reductase, redox cycling 
might be less abundant in crypt cells. The thiol status of MEN-exposed cells does not support 
this assumption, since the rapid depletion with MEN is not accompanied by a rise in 
intracellular GSSG. Therefore, it must be concluded that the arylation of MEN to cellular thiols 
is of more relevance than redoxcycling and crypt cells are obviously more vulnerable to this 
effect. This effect is also illustrated by the depletion rate of ATP. The alkylating quinones MEN 
and NQ induced a more rapid depletion of ATP in crypt cells in comparison with villus or mid­
villus cells.
Exposure to NQ resulted in higher levels of intracellular GSSG and RSSG than MEN. 
Similar observations were made in isolated hepatocytes 6. NQ and MEN are both capable of 
arylation although MEN is a lesser arylator than NQ due to its methyl-substituent in the quinoid 
ring 48. MEN has been shown to directly inhibit glutathione reductase, probably by arylations of 
its essential thiol in the active site of the enzyme 49 So, it can be expected that NQ is more 
potent inhibitor of glutathione reductase, which inevitably results in higher levels of oxidised 
glutathione than in MEN-exposed cells. The translocation of GSSG in hepatocytes was found to 
be ATP dependent 50,51 and this transport could be blocked with the thiol-alkylating agent NEM, 
indicating that the translocator possesses sulfhydryl groups essential for its activity 52. So the 
observed lack of ATP and inhibition of the translocator may account for the increased levels of 
intracellular GSSG. Bellomo et a l 49 reported a linear relationship between the cellular 
GSSG/GSH ratio and the formation of mixed disulphides catalysed by thiol transferases. This 
may explain the higher levels of RSSG in NQ-treated enterocytes. It is not certain whether GSH
S-transferases do participate in the depletion of GSH observed with NQ and MEN treatment. 
The rat small intestine contains the isozyme classes a , m and p but all three are inhibited by 
oxidative stress 53.
DIM is a pure redoxcycler and the activation and detoxification pathway described above 
are applicable for this quinone. So it can be expected that less redoxcycling of DIM occurs in 
the crypt cells. DIM caused a marked decrease in viability of villus and mid-villus cells but not 
in crypt cells. DIM had no effect on the GSH and GSSG content but the levels of RSSG were 
increased in all fractions, demonstrating presence of oxidative stress. Further, DIM-exposure 
resulted in a moderate depletion of ATP in villus and mid-villus cells whereas no effect was 
found for the crypt fraction. This demonstrates that crypt cells are indeed less vulnerable to 
oxidative stress than the more differentiated villus cells.
The release of GSH was abrogated by the exposure to quinones. The mechanism of efflux is 
obviously sensitive to oxidation as DIM interfered with the release of GSH. This event is not 
caused by a lack of ATP or the progressive depletion of GSH since no significant ATP and 
GSH depletion occurred in DIM-treated crypt cells. The mechanism by which enterocytes 
export intact GSH is unknown. An a -adrenergic release mechanism has been described in 
hepatocytes 54. It would be interesting whether a similar mechanism is present in enterocytes 
and the role of this transporter.
Our results confirm that the arylation capacity is the determining factor in the cytotoxic 
potential of quinones 6. The redoxcycling and arylating quinones NQ and MEN were more toxic 
than the redoxcycler DIM. Crypt cells were more vulnerable to MEN than villus and mid-villus 
cells. This may indicate that crypt cells are more vulnerable to arylation than villus and mid­
57
Quinone Toxicity in Freshly Isolated Rat Intestinal Cells
villus cells. A gradient of DT-diaphorase activity was found along the villus-crypt axis with the 
highest activity present in the crypt cells. The redoxcycler DIM was more toxic to villus and 
mid-villus cells than crypt cells which is in agreement with the activity of DT-diaphorase and 
cytochrome P450 reductase. NQ induced the highest levels of intracellular GSSG and RSSG, 
which may reflect the rapid inactivation of glutathione reductase. A constant release of reduced 
GSH was observed with control cells which was inhibited by the three quinones used in this 
study. The relevance of this inhibition is unknown and needs further investigation.
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Chapter 3
Toxicity of Menadione in the Differentiating Human 
Coloncarcinoma Cell-line Caco-2.
Jurgen M. Karczewski and Jan Noordhoek.
D epartment o f  Toxicology, University o f  Nijmegen, Nijmegen, the Netherlands.
Abstract - The human colon adenocarcinoma cell line Caco-2 is susceptible to spontaneous enterocytic 
differentiation after reaching confluence and was used on day 7, 14 and 21 of culture to investigate the 
toxicity of the quinone menadione. Menadione was less toxic in day 7 cells compared to the older cell 
cultures. Enzymatic activation of menadione and glucose-6-phosphate dehydrogenase activity did not 
alter during differentiation. Based on these observation it was concluded that redoxcycling of menadione 
occurred at similar levels throughout differentiation. Further, day 7 cells proved to be more vulnerable 
for ATP depletion but had significantly higher levels of intracellular reduced glutathione than older cells. 
We conclude that these levels of cellular reduced GSH play a major role in the protection of crypt-like 
enterocytic cells.
Introduction
The functional enterocytes are continuously renewed by proliferation of stem cells located in 
crypts, migration of daughter cells onto villi, and finally extrusion of senescent cells into the 
intestinal lumen 1. During the migration along the crypt-villus axis, intestinal cells undergo an 
intensive process of morphological and biochemical differentiation. Beside the expression of 
designated enzymes and transport mechanisms for nutrients, enterocytes display distinctive 
patterns of detoxifying systems. For example, cytochrome P450IA1 mRNA was constitutively 
expressed in rat villus cells with no detectable mRNA present in crypts. NADPH cytochrome 
P450 reductase, a necessary component for the activity of all P450 enzymes, was expressed 
constitutively at low levels in only villus cells 2.
Reactive oxygen species are involved in some types of gastrointestinal injury like in Crohn's 
disease 3, ulcerative colitis 4, ischemia-reperfusion, 5,6 and the metabolism of some types of 
ingested chemicals like quinones 7 and peroxides 8. Activities of antioxidant enzymes like 
superoxide dismutase, glutathione peroxidase and glutathione reductase were found to increase 
during differentiation along the crypt-villus in the rat intestine 9,1°.
The dynamic nature of the epithelium may result in changes in susceptibility to oxygen 
radicals or in the capability to activate xenobiotics. In vivo studies with the enterocytes are 
complicated by interference of the blood stream and surrounding tissue like the submucosa. 
Isolation of enterocytes is an alternative option but may be complicated by apoptotic cell death 
induced by dissociation of the cell from the extracellular matrix 11,12 The demonstration that the 
human colon adenocarcinoma cell-line Caco-2 is susceptible to spontaneous enterocytic 
differentiation has designed this cell-line as the most relevant in vitro model for studies related 
to both differentiation and regulation of intestinal absorbo-digestive functions 13-15. Confluent 
monolayers were first reported to exhibit morphological, immunocytochemical and biochemical 
differentiation patterns characteristic of mature enterocytes 13. The Caco-2 cell-line has made 
an entry in the field of toxicological research as a model for assessment of intestinal toxicants. 
The presence of cytochrome P450 and glutathione-S-transferase activity has been demonstrated
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in this cell-line 16-18. Caco-2 cells also express antioxidant enzymes like superoxide dismutase, 
glutathione reductase, glutathione peroxidase, catalase in similar patterns as in the mammalian 
epithelium and may therefore be a suitable model for the investigation of the role of oxidative 
stress on differentiating epithelial cells 19
MEN exert its toxic effects by redoxcycling and arylation. Redoxcycling involves one- 
electron reduction pathways catalysed by microsomal NADPH cytochrome P450 reductase, 
microsomal NADH cytochrome b5 reductase, mitochondrial NADH ubiquinone oxido-reductase 
and gives rise to a semiquinone. Cytosolic DT-diaphorase reduces the quinone to a 
hydroquinone via a two-electron reduction. Superoxide anion radical and singlet oxygen are 
formed during the oxidation process of the hydroquinone and semiquinone 7. The hydroquinone 
of MEN is more stable than the semiquinone and is a target for detoxification reactions like 
glucuronidation or sulphatation 20-22. The arylation reaction between quinones and nucleophiles 
like GSH is a 1,4-reductive addition of the Michael type, which reduces the quinone to its 
corresponding glutathionyl hydroquinone 23. MEN induced cell death in rat hepatocytes is
2+ 22 25 26
associated with an altered thiol and Ca homeostasis , , . The semiquinone of MEN and the 
reactive oxygen species generated by MEN were found to interact with DNA of hepatocytes 27­
29 Further, quinones interfere with the energy production of the cell. Redegeld et a l 30 showed a 
loss of ATP preceding cell death in MEN-treated hepatocytes.
In this study, the susceptibility to MEN toxicity was assessed in differentiating Caco-2 cells. 
The susceptibility to MEN results from the cell’s capability to detoxify MEN and MEN-derived 
oxygen species and its ability to support redoxcycling. The levels of glutathione, being the most 
important protective thiol, and glutathione reductase were assessed to compare the antioxidant 
capabilities during differentiation. Further, the activity of the glucose-6-phosphate 
dehydrogenase was measured since this enzyme plays a key role in the energy supply for the 
reduction of oxidised GSH and redoxcycling. The differentiating monolayers were determined 
for their capacity to support redoxcycling with a cytochrome c reduction assay
Materials and Methods
Chemicals and Materials. Menadione was purchased from Aldrich (Milwaukee, USA). 
Monobromobimane was from Calbiochem (La Jolla, USA). Other chemicals and enzymes were obtained 
from Sigma (St. Louis, USA). All chemicals were of analytical grade. All cell culture materials were 
purchased from ICN (Costa Mesa, USA), except for flasks and tissue culture plates that were from 
Greiner (Alphen a/d Rijn, NL) and gentamycine (Centrafarm, Etten-Leur, NL).
Cell culture and incubation. Caco-2 cells were maintained at 37 °C in DMEM, containing 10% (v/v) 
fetal bovine serum, 10 mM HEPES, 1% nonessential amino acids, 5 mM L-glutamine, 5 ^g/ml 
gentamycine in an atmosphere containing 5% CO2. 1x105 cells were seeded in 24-wells culture plates and 
became confluent after 4 days. Cell cultures were supplied with medium every second day and used on 
day 7, 14 and 21. Incubations with MEN were performed in 24 wells tissue plates in an atmosphere as 
described as above. Cells were washed with Krebs-Henseleit buffer (KH, formulation in mM: 1.2 
MgSO4.7H2O, 2.5 CaCl2.2H2O, 4.7 KCl, 94 NaCl, 11.6 D-glucose, 25 NaHCO3, 1.2 KH2PO4 and 5 L- 
glutamine, pH 7.4) and supplied with 0.5 ml KH. MEN was added in dimethylsulfoxide (0.3% of final 
volume).
Neutral Red Uptake Assay. Viability was determined according Borenfreund and Puerner 31. Briefly, 
after incubation the monolayer was washed with KH. Fresh complete DMEM with 50 ^g/ml neutral red 
was added to the wells. After 30 min of incubation at 37 °C cells were washed rapidly with 40% 
formaldehyde-10% CaCl2, to remove extraneously adhering, unincorporated dye. Neutral red was 
extracted with 500 ^l 1% acetic acid-50% ethanol and 150 ^l were transferred to a 96 wells titreplate. 
The plate was measured on a Thermomax microplate reader (Molecular Devices, Menlo Park, 
California, USA) equipped with a 550 nm filter. The readings were expressed as percentages of the non­
exposed cells.
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Cellular ATP and NAD+ content. Cells were treated with 300 ^l 5% (v/v) perchloric acid and 
neutralised with 700 ^l 0.8 M potassium phosphate buffer. Insoluble material was removed by 
centrifugation (5 min, 13000 g) and the supernatant was stored at -80 °C until use. ATP and NAD+ were 
separated using a Spectra-Physics HPLC system consisting of a SP8800 ternary pump, a SP8875 
autosampler, a SP4600 integrator and a Merck 100 RP-18 column (LichroCART 125-4 Lichrospher). 20 
^l supernatant was injected on the column at 40 °C and were separated with flow of 1 ml/min. The 
elution buffer was a 0.1 M potassium phosphate buffer, pH 6.0 that was filtered through a 0.45 mm 
filter before use. ATP and NAD+ were detected by a Kratos Spectroflow 773 UV detector at 260 nm. 
ATP and NAD+ content was expressed as nmole/mg protein. The energy charge was calculated with the 
equation: (ATP+0.5*ADP)/(ATP+ADP+AMP).
GSH and extracellular (GSH+ GSSG). Reduced GSH was determined by HPLC after derivatization 
with monobromobimane (mBBr) as described by Cotgreave and Moldeus 32. After incubation cells were 
washed with KH and 100 ^l aqua pure was added to the well. GSH was derivatized by adding 100 ^l 2 
mBBr dissolved in 50 mM N-ethylmorpholine and incubating this mixture for 5 min in the dark. Protein 
was denatured by inclusion of 25 ^l 40% trichloric acid (TCA) en removed by centrifugation (5 min, 
13.000 g).
For the determination of extracellular and total extracellular glutathione (GSH+GSSG), 250 ^l aliquots 
of KH buffer were taken at the appropriate time from the culture plate. For the estimation of total 
extracellular GSH, 100 ^l KH was reduced with 10 ^l 25 mM DTT in 45 minutes at room temperature. 
The mixture was labelled with 100 ^l 5 mM mBBr and deproteinized with 10 ^l 40% TCA.
20 ^l glutathione derivatives were separated by HPLC using a Merck 100 RP-18 column at 40 °C 
and a flow rate of 1 ml/min. Buffer A was 128 ml methanol and 2.5 ml acetic acid diluted to 1 l with 
aqua pure, adjusted to pH 3.9 with 5 N NaOH. Buffer B was 900 ml methanol and 2.5 ml acetic acid, 
diluted to 1 l with aqua pure. A linear gradient from 0% B at 0 min, 50% B at 8 min to 0% B at 17 min 
was used to elute the glutathione derivatives that were detected using a Shimadzu RF-530 fluorescence 
detector at 1ex=385 nm and 1em=480 nm. GSH content was expressed as nmol/mg protein.
Enzyme assays. Caco-2 cells were grown for 7, 14 and 21 days in 24 wells culture plates. For enzyme 
determination, cells were washed with ice-cold isotonic phosphate buffered saline (PBS), scraped with a 
rubber policeman and resuspended in 1 ml PBS. Homogenisation was performed at 4 °C using a 
ultrasonic desintegrator (MSE, Beun and de Ronde, Amsterdam, NL). Homogenates were immediately 
frozen in liquid nitrogen and stored at -80 °C until use.
Activity of alkaline phosphatase was determined according to Weiser 33. This method was adapted for 
use in microtitre plates and used as a marker for differentiation of the Caco-2 cell culture. 100 ^l sample 
was pipetted in a 96 wells plate and incubated in a titreplate reader for 2 minutes. The reaction was 
started by adding the 100 ^l 0.4 M TrisHCl/0.4 M NaCl buffer pH 8.5 containing 5.6 mM p- 
nitrophenylphosphate to the wells and monitored during 5 minutes at 405 nm at 37 °C. Reaction rates 
were corrected for non-enzymatic dephosphorylation of the substrate. Activity was compared with 
alkaline phosphatase standards.
Glutathione reductase was determined as described by Beutler 34. Briefly, 100 ^l sample was added 
to 900 ^l 55 mM Tris-HCl buffer (pH 8.0) containing 0.25 mM Na2EDTA.2H2O, 3.3 mM GSSG and
0.1 mM NADPH. The decrease of NADPH was followed for 2 min at 340 nm at 37 °C in a Perkin 
Elmer Lambda 15 UV/VIS spectrophotometer (Perkin Elmer, Norwalk, USA).
Glucose-6P-dehydrogenase was adapted from Beutler 34. The rate of NADPH formation was 
followed spectrophotometrically at 340 nm. 100 ^l sample was added to 800 ^l 0.1 M Tris-HCl buffer 
(pH 8.0) containing 0.5mM Na2EDTA.2H2O, 10 mM MgCl2.6H2O and 0.2 mM NADP+ and incubated 
at 37 °C for 5 min. The reaction was started by adding 100 ^l glucose-6-phosphate (0.6 mM final 
concentration).
Cytochrome c reduction was determined according the method of Benson et al 35. A 3 ml mixture 
contained 25 mM Tris-HCl (pH 7.4), 0.7 mg BSA, 0.08% (v/v)Triton X-100, 500 mM NADPH, 34 
mM cytochrome c and a appropriate amount of enzyme. After 3 minutes pre-incubation at 25 °C, the 
reaction was started by adding 10 ^l MEN (dissolved in ethanol, final concentration was 40 mM). The 
reduction of cytochrome c was measured at 550 nm.
Cellular Protein. Cellular protein was quantified with the Bradford method 36 using bovine serum 
albumine as a standard.
63
Toxicity o f MEN in the Differentiating Human Coloncarcinoma Cell-line Caco-2
Statistical analyses. Results are presented as means ± SD unless otherwise indicated. Data were 
analysed with One Way Analysis of Variance (ANOVA) and adjusted t-tests with p values corrected by 
the Bonferroni method.
Results
Caco-2 cells differentiate after reaching a confluent monolayer. Microscopical examination 
showed a nearly confluent monolayer on day 7 of culture with cell contours still visible. As 
differentiation proceeded, cell contours of the day 14 cultures were veiled by the developing 
brushborder on the apical side of the cell. The development of a brushborder was characterised 
by the expression of a typical brushborder enzyme alkaline phosphatase. Figure 3.1 shows the 
significantly increased expression of alkaline phosphatase in the 14 day-old Caco-2 monolayer 
compared to the 7 days culture. The activity of alkaline phosphatase did not significantly 
increase further after 14 days of culture.
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Figure 3.1. Alkaline phosphatase as a marker o f cellular differentiation o f Caco-2 cells. Alkaline 
phosphatase was assessed as described in material and methods. Shown are the means ± SD of six 
independent experiments (**: p<0.01 compared to 14 and 21 days-old Caco-2 monolayer).
In order to investigate the vulnerability throughout the differentiation of the Caco-2 cell-line,
7, 14 and 21 days cultures were exposed to 100 |iM MEN for 2 and 4 hours. Incubation with 
DMSO alone had no effect on cells compared with control cells (data not shown). Figure 3.2 
demonstrates that 7 days-old cells had slightly higher viability after 2 hours exposure to 100 
|iM MEN compared to the 14 and 21 days cultures. The viability was decreased further after 4 
hours of exposure to MEN but no differences in viability were observed between the different 
cultures.
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Figure 3.2. Effect o f MEN treatment on viability o f Caco-2 cells. 100 MEN was applied to 7, 14 
and 21 days-old Caco-2 cells. Depicted are control (I I ), 2 hours (□ ) and 4 hours (I I) MEN 
treatment. Shown are the means ± SD of six independent experiments (*: p<0.05 compared to 14 and 21 
days-old Caco-2 monolayer).
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To determine if changes in ATP and related adenonucleotides could explain the differences 
in loss of viability, cellular levels of ATP, ADP, AMP and NAD+ were assessed. The data 
presented in figure 3.3a and 3.3b show a rapid depletion of cellular ATP and NAD+ content by 
MEN. After exposure to MEN, the cellular ATP and NAD+ levels of 7 days-old monolayer 
were lower than in the older Caco-2 cultures. The energy charge was calculated as described in 
material and methods and was significantly lower in the 7 days-old monolayer compared to the 
older cell cultures (fig. 3.4).
Table 3.1. Comparison o f glutathione reductase, glucose-6P-dehydrogenase and cytochrome c
reduction between 7, 14 and 21 days Caco-2 cell monolayers.
Enzyme 7
Days in culture 
14 21
Glutathione reductase1 14.14 ± 4.89
*
25.14 ± 7.94 29.56 ± 3.87**
Glucose-6P-dehydrogenase2 23.90 ± 1.35 22.34 ± 4.96 21.71 ± 1.89
Cytochrome c reduction3 93.03 ± 8.83 85.44 ± 16.42 82.32 ± 3.17
1 Glutathione reductase activity was expressed in nmol GSSG reduced per min per mg protein., n=4 (*: p<0.05, 
**: p<0.01 compared to 7 days culture).
2 Glucose-6P-dehydrogenase activity was expressed in nmol.min-1.mg protein-1, n=6.
3 Cytochrome c reduction was expressed in nmol cytochrome c.min-1.mg protein-1, n=6.
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Figure 3.3. Effect o f MEN on the ATP (a) and NAD+ (b) content o f  Caco-2 cells. 100 |iM MEN was 
applied to 7, 14 and 21 days-old Caco-2 cells. Depicted are control (I I ), 2 hours (□ ) and 4 hours 
MEN treatment (I I). Shown are the means ± SD of six independent experiments (**: p<0.01 
compared to 14 and 21 days-old Caco-2 monolayer).
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Figure 3.4. Effect o f  MEN treatment on energy charge in Caco-2 cells. 100 ^M MEN was applied to 7, 
14 and 21 days-old Caco-2 cells. Depicted are control (I I ), 2 hours (□ ) and 4 hours MEN 
treatment (I I). Shown are the means ± SD of six independent experiments (**: p<0.01 compared to 
14 and 21 days-old Caco-2 monolayer, ##: p<0.01 compared to the 21 days-old Caco-2 monolayer).
##
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MEN is toxic to cells via redoxcycling and arylation. Both mechanisms may affect the thiol 
pool including GSH. Determination of reduced GSH in control cells shows that 7 days-old 
Caco-2 cells contained considerably more GSH than the older cell cultures (Fig. 3.5). The GSH 
content was not affected by incubation with KH and DMSO alone (data not shown). Further, 
MEN depleted GSH in all cell cultures but less reduced GSH was left in the 14 and 21 days- 
old monolayer. Due to the massive formation of intracellular oxidised glutathione by the 
redoxcycling of MEN, excess of oxidised glutathione will be excreted out of the cell. Due to 
experimental conditions no discrimination can be made between reduced and oxidised 
extracellular glutathione. Figure 3.6 shows the presence of total extracellular glutathione of 
control and MEN-treated cells. In the buffer of control cells, a small amount of glutathione was 
found in all incubations. The level of extracellular glutathione increased as a result of the 
treatment with MEN in all monolayers. In case of the 7 days-old Caco-2 cells, significantly 
more extracellular glutathione was found than with the older cell cultures.
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Figure 3.5. Effect o f MEN treatment on intracellular reduced GSH in Caco-2 cells. 100 MEN was 
applied to 7, 14 and 21 days-old Caco-2 cells. Depicted are control (I I), 2 hours (I I) and 4 hours 
MEN treatment (I I). Shown are the means ± SD of six independent experiments (**: p<0.01 
compared to 14 and 21 days-old Caco-2 monolayer).
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Figure 3.6. Effect o f MEN treatment on total extracellular glutathione in Caco-2 cell culture 
incubates. 100 |iM MEN was applied to 7, 14 and 21 days-old Caco-2 cells. Depicted are control (I I 
), 2 hours (I I) and 4 hours MEN treatment (I I). Shown are the means ± SD of six independent 
experiments (**: p<0.01 compared to 14 and 21 days-old Caco-2 monolayer).
In order to explain the differences in GSH between the three cell cultures, the enzymes that 
are directly involved in the maintenance of reduced GSH levels were assessed. Glucose-6- 
phosphate dehydrogenase, the key-enzyme of the hexose monophosphate shunt was present in 
equal amounts in the cell of different ages (table 3.1). However, the level of glutathione 
reductase was significantly higher in the 1 4  and 2 1  day-old culture.
Beside the antioxidant status of cells, the MEN reducing capacity of Caco-2 cell-line may 
alter during differentiation. Homogenates of Caco-2 cells were tested for their ability to reduce 
cytochrome c using MEN as electron transferring intermediate. Table 3.1 shows that no 
differences in cytochrome c reduction were found between the different ages of the cells.
Discussion
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Reactive oxygen species are involved in some types of gastrointestinal injury like in Crohn's 
disease 3, ulcerative colitis 4 and ischemia-reperfusion 5,6 The functional enterocytes originate 
from germ cells in the crypts and migrate along the crypt-villus axis. The loss of germ cells or 
oxygen radical induced genetic alterations may have far-reaching consequences for the 
intestinal epithelium. Therefore, it is important to assess the vulnerability of enterocytes for 
oxidative stress in the progressive stages of differentiation.
Differentiation of Caco-2 cells was followed by the expression of the brushborder enzyme 
alkaline phosphatase. In our experiments we observed an increase of alkaline phosphatase 
activity from day 7  to day 14  and after this period no further elevation of this enzyme was 
measured. The levels of NAD+ in control cells showed a similar increase during the first period 
of differentiation and remained constant after day 14 of culture. The concentration of ATP was 
constant during differentiation while the GSH levels decreased during the first period of 
differentiation. The levels of GSH, ATP, alkaline phosphatase at day 14 day did not 
significantly differ when compared with the cultures of day 2 1 .
Oxidative stress was induced by MEN, a redoxcycling compound that is capable of 
generating superoxide anion radical and singlet oxygen 7. The viability of 7 days cells after 2 
hours exposure to MEN was higher than with the older cultures, but no differences were 
observed between the 14 and 21 days cells. After 4 hours of exposure, no differences in 
viability were observed between the cultures. This is probably the result of the progressed 
toxicity of MEN which exceeds the differences between the cultures observed after 2 hours of 
exposure.
The differences in susceptibility to MEN may be the result of differences in activating MEN 
and antioxidant levels. The capability of cells to support redoxcycling of MEN was assessed by 
the NADPH supported cytochrome c reduction. From these results, it was concluded that the 
capability of cells to reduce MEN via cytochrome P450 reductase and DT-diaphorase did not 
change during differentiation. It is possible that the NADH-dependent reduction of MEN is less 
abundant in the day 7 cells since the levels of NAD+ in these cells were significantly lower. 
Redoxcycling requires a constant supply of NADPH. The generation of NADPH is 
predominantly determined by glucose flux through the pentose phosphate pathway and is 
regulated at the level of glucose 6 -phosphate dehydrogenase 37. The activity of this enzyme did 
also not alter during differentiation in our experiments. This in contrast with the group of 
Cepinskas et a l 38 who reported a two-fold increase of glucose 6-phosphate dehydrogenase 
activity between one and seven day postconfluent Caco-2 cells. Our cells reached confluence 
after 4-5 days after seeding and were thus 2-3 days postconfluent. It is conceivable that the 
increase of glucose 6-phosphate dehydrogenase activity may have taken place in this period. 
MEN was reported to induce a dose-dependent increase in pentose phosphate pathway activity 
in 14 to16 day-confluent Caco-2 cells 39 Although the key-enzymes involved in redoxcycling of 
MEN showed similar activities during differentiation, it may still be possible that the cellular 
regulation was underestimated by our in vitro approach. Enzymes of the pentose phosphate 
pathway and especially glucose 6-phosphate dehydrogenase are upregulated upon binding of 
thiols like GSH 40,41.
The increased susceptibility to MEN during differentiation of Caco-2 cells may be 
connected to changes of antioxidant GSH. Interestingly, the less differentiated Caco-2 cells 
appeared to have higher levels of reduced GSH, this in contrast to the study of Zucco et a l 42 
who reported no changes in the GSH content during differentiation. Our results resemble the 
observations made in the intestinal tract of the rat. Several groups reported higher levels of 
reduced GSH in undifferentiated crypt cells 9,43,44. Compared to villus cells, rat crypt cells have 
higher levels of GSH synthesising enzymes 43 and lower amounts of GSH utilising enzymes like 
glutathione transferases 9,10,44 and T-glutamyltranspeptidase 43. The combination of these factors
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may explain the higher levels of GSH in day 7 cells compared to the older monolayers. Because 
of the higher levels of GSH, the crypt-like Caco-2 cells may be better protected against MEN 
than the more differentiated cells. The levels of reduced GSH in cells suffering from oxidative 
stress are primarily maintained by glutathione reductase and excessive formation of oxidised 
glutathione will result in the excretion of this oxidised peptide. The day 7 cultures have 
considerably lower amounts of glutathione reductase compared to the older cultures. As a 
consequence, higher levels of extracellular glutathione were retrieved in the medium of these 
MEN treated cells.
Although, during differentiation Caco-2 cells seem to become more vulnerable for the 
toxicity of MEN, the energy homeostasis of less differentiated cells was more affected by MEN 
than with the older cells. Baker et a l 45 showed that the ATP-levels of Caco-2 cells are 
particularly vulnerable to MEN compared to t-butyl hydroperoxide and other free oxygen 
radical generating systems like xanthine oxidase. Several enzymes involved in the energy 
producing systems are particularly vulnerable to thiol reactive agents. Glyceraldehyde-3- 
phosphate dehydrogenase is inhibitable by the alkylator iodoacetic acid 46, hydrogen peroxide 47 
and MEN 30. The co-factor NAD+ was lower in control cells of the 7 days-old cultures in 
comparison with older cells and was more rapidly depleted during MEN treatment. The 
depletion of NAD+ may be the result of DNA strand breaks causing an activation of poly(ADP- 
ribose)polymerase 48 or an interconversion of NAD+ to NADP+ 49. The lower levels of ATP in 
7 days-old culture may be the result of the lower levels of NAD+ .
Although the Caco-2 cell-line resembles normal human enterocytes in many aspects, some 
caution should be taken in account when comparing this coloncarcinoma cell-line with normal 
intestinal tissue. A comparative study between colonic enterocytes and Caco-2 cells showed 
that the Caco-2 cell contained significantly lower levels of superoxide dismutase and catalase
50. Further, the conditions under which a cell-line is cultured may be responsible for the 
variation found between different investigations or tissue comparative studies. For instance, the 
inclusion of L-glutamine in culture medium has a distinct effect on the proliferation and 
differentiation of the Caco-2 cell-line. Glutamine decreased the doubling time, partly inhibited 
the expression of marker enzymes like alkaline phosphatase and diminished both adhesion and 
integrin surface expression in a dose-dependent manner 51. Nevertheless, the Caco-2 cell-line 
offers many perspectives to study the actions of toxicants like MEN on the cellular physiology 
of the enterocyte.
In summary, we have demonstrated that MEN caused a loss of viability in the differentiating 
cell-line Caco-2. Differentiation of cells appeared to be associated with an increased 
vulnerability to the quinone. This effect did not correlate with the MEN-induced changes in the 
ATP content or the energy charge but was probably dependent on the differences in the GSH- 
levels. Although the activity of glutathione reductase was lower in Caco-2 cells of 7 days 
cultures, the level of reduced GSH was significantly higher in these cells compared with further 
differentiated cells. So, we conclude that lower levels of intracellular GSH cause the increased 
vulnerability for MEN during differentiation.
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Chapter 4
Quinone Toxicity in DT-diaphorase Efficient and Deficient 
Coloncarcinoma Cell-lines.
Jurgen M. Karczewski, Janny G.P. Peters, and Jan Noordhoek.
D epartment o f  Toxicology, University o f  Nijmegen, the Netherlands.
Abstract - The human coloncarcinoma cell-lines Caco-2 and HT-29 were exposed to three structurally 
related naphthoquinones. Menadione (MEN), 1,4-naphthoquinone (NQ) and 2,3-dimethoxy-1,4- 
naphthoquinone (DIM) redoxcycle at similar rates, NQ is a stronger arylator than MEN and DIM does 
not arylate thiols. The Caco-2 cell line was particularly vulnerable to NQ and MEN and displayed 
moderate toxic effects of DIM. The HT-29 cell-line was only vulnerable to NQ and MEN after inhibition 
of DT-diaphorase (DTD) with dicoumarol, whereas dicoumarol did not affect the toxicity of quinones to 
Caco-2 cells. DTD activity, as estimated by the dicoumarol-sensitive reduction of 2,6- 
dichlorophenolindophenol, in the HT-29 and Caco-2 cell-line were 393.7 ± 46.9 and 6.4 ± 2.2 nmol 
NADPH.min'Vmg protein-1, respectively. MEN depleted glutathione to a small extent in the HT-29 cell- 
line but a rapid depletion similar to Caco-2 cells was achieved when dicoumarol was added. The data 
demonstrates that the DTD-deficient Caco-2 cell-line is more vulnerable to arylating or redoxcycling 
quinones than DTD-expressing cell-lines.
Exposure of the Caco-2 cell-line to quinones gave a rapid rise in protein disulphides and oxidised 
glutathione. In contrast to NQ and DIM, no intracellular oxidised glutathione (GSSG) was observed with 
MEN. The relatively higher levels of ATP in MEN-exposed cells may account for efficient extrusion of 
intracellular GSSG. The reductive potential of the cell as measured by MTT-reduction was only 
increased by MEN and not with NQ and DIM. We conclude that arylation is major a contributing factor 
in the toxicity of quinones. For this reason, NQ was the most toxic quinone, followed by MEN and the 
pure redoxcycler DIM elicited modest toxicity in Caco-2 cells.
Introduction
Quinones like streptonigrin, mitomycine and diaziquone are widely used in the treatment of 
gastrointestinal malignancies. Drug resistance, either intrinsic or acquired, severely limits the 
effectiveness of chemotherapy. Research has been focused on increased detoxification by 
glutathione and glutathione-dependent enzymes like glutathione-S-transferases 1-3 and the 
expression of mdr-1/P-glycoprotein 4 Antitumor quinones require enzymatic reduction prior to 
eliciting their antitumor activity. One of the major reducing enzymes is DTD and the level of 
this enzyme varies between different tumor tissues 5,6 The majority of DTD activity in human 
tissues is the product of the dioxine-inducible gene NQO¡ 7 DTD catalyses exclusively the 2- 
electron reduction of quinones which is necessary for the activation of streptonigrin, 
mitomycine and more novel drug EO9 5,8,9 After possible rearrangement reactions, the 
hydroquinone may become a reactive alkylating agent or autooxidise, leading to reactive oxygen 
species and toxicity.
Menadione or 2-methyl-1,4-naphthoquinone (MEN) is a vitamin K3 analogue and has been 
used in antitumour therapy 8. MEN and other naphthoquinones can undergo a one- and two- 
electron reduction which give rise to the semiquinone and the hydroquinone, respectively. Both
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can reduce molecular oxygen to the superoxide anion radical, thereby regenerating the parent
quinone 10.
Besides redoxcycling, quinones can arylate to nucleophilic moieties of the cell but this process 
depends on the substituents of the molecule 11,12 In this study, we used the related quinones 1,4- 
naphthoquinone (NQ), MEN and 2,3-dimethoxy-1,4-naphthoquinone (DIM) which were all able 
to redox cycle and cause oxidative stress and thiol oxidation in hepatocytes 11-13. However, the 
quinones differ in their ability to arylate. NQ is a strong arylator compared to MEN and DIM is 
not capable of arylation due to its substituents at the C2 and C3. In contrast to streptonigrin, 
mitomycine and EO9, the hydroquinone of naphthoquinones is more stable than the semiquinone 
and is a target for detoxification reactions like glucuronidation or sulphatation 10,14,15. For these 
reasons, the DTD mediated two-electron reduction is generally considered to be a 
detoxification reaction.
MEN has a wide range of effects on cells. Exposure of hepatocytes to MEN perturbs the 
cytoskeleton of the cell, which can be recognised as membrane blebbing 10 The blebformation 
is associated with an altered thiol and Ca2+ homeostasis 10,16-20 The semiquinone of MEN and 
the reactive oxygen species generated by MEN were found to interact to interact with DNA of
20-23 24 25hepatocytes 20-23, CHO cells 24 and leukemic K562 cells 25. Further, quinones interfere with the
energy production of the cell. Redegeld et al. 26 showed a loss of ATP preceding cell death in
MEN-treated hepatocytes.
Most studies on naphthoquinone toxicity were performed in rat hepatocytes and nothing is 
known about the toxic response of human intestinal tissue. In this report, we show that two 
human colon carcinoma cell lines differ in sensitivity to naphthoquinones due to differences in 
expression of DTD. The DTD deficient Caco-2 cell-line proved to be vulnerable to all 
quinones in contrast to the DTD efficient HT-29 cell-line in which toxicity and glutathione 
depletion only occurred after inhibition of DTD with dicoumarol. A comparison between 
glutathione status, ATP, protein thiol and MTT reduction in Caco-2 cells was made to study the 
behaviour of arylation and/or redox cycling quinones. We conclude that arylation is a major 
contributing factor in the toxicity of these quinones. For this reason, NQ was the most toxic 
quinone, followed by MEN and the pure redoxcycler DIM was only modest toxic to Caco-2 
cells.
Materials and Methods
Chemicals. 1,4-naphthoquinone and menadione were purchased from Aldrich (Milwaukee, USA).
2,3- dimethoxy-1,4-naphthoquinone was prepared according 13. The identity was checked with mass 
spectrometry. Monobromobimane was from Calbiochem (La Jolla, USA). Other chemicals and enzymes 
were obtained from Sigma (St. Louis, USA). All chemicals were of analytical grade. All cell culture 
materials were purchased from ICN (Costa Mesa, USA), except for flasks and tissue culture plates that 
were from Greiner (Alphen a/d Rijn, NL) and gentamicine (Centrafarm, Etten-Leur, NL)
Cell culture and incubation. The Caco-2 and HT-29 cell-lines were kindly provided by Dr. W. 
Peters (Dept. of Gastroenterology, University Hospital Nijmegen, Nijmegen, the Netherlands). Caco-2 
and HT-29 cells were maintained at 37 °C in DMEM, containing 10% (v/v) fetal bovine serum, 10 mM 
HEPES, 1% nonessential amino acids, 5 mM L-glutamine, 5 ^g/ml gentamicine in an atmosphere 
containing 5% CO2. 1x105 cells were seeded in 24-wells culture plates and became confluent after 4 
days. Cell cultures were supplied with medium every second day and used on day 7 of culture. 
Incubations with menadione were performed in 24 wells tissue plates in an atmosphere as described as 
above. Cells were washed with Krebs-Henseleit buffer (KH, formulation in mM: 1.2 MgSO4.7H2O, 2.5 
CaCl2.2H2O, 4.7 KCl, 94 NaCl, 11.6 D-glucose, 25 NaHCOs, 1.2 KH2PO4 and 5 L-glutamine, pH 7.4) 
and supplied with 0.5 ml KH. MEN, NQ and DIM were dissolved in dimethylsulfoxide and control cells 
were treated with equal volumes of the solvent (0.3% of final volume).
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Neutral Red Uptake Assay. Viability was determined according 27. Briefly, after incubation the 
monolayer was washed with KH. Fresh complete DMEM with 50 ^g/ml neutral red was added to the 
wells. After 30 min of incubation at 37 °C cells were washed rapidly with 40% formaldehyde-10% 
CaCl2, to remove extraneously adhering, unincorporated dye. Neutral red was extracted with 500 ^l 1% 
acetic acid-50% ethanol and 150 ^l were transferred to a 96 wells titreplate. The plate was measured on 
a Thermomax microplate reader (Molecular Devices, Menlo Park, California, USA) equipped with a 550 
nm filter. The readings were expressed as percentages of the non-exposed cells.
DTD activity. Activity of DTD was determined according to Fisher and Gutierrez 28. Briefly, 100 ^l 
cell homogenate was added to 800 ^l phosphate buffered saline pH 7.4 containing 50 ^M 2,6- 
dichlorophenolindophenol, 0.23 mg BSA/ml and 0.01% Tween 20. The reaction was started by adding 
100 ^l 2mM NADPH. The reaction rate was monitored for 2 min at 37 °C in a Perkin Elmer Lambda 15 
UV/VIS spectrophotometer (Perkin Elmer, Norwalk, USA) by measuring the decrease in absorbance at 
600 nm due to reduction of the substrate and the of NADPH at 340 nm. DTD activity was determined 
in the absence and presence of 50 ^M dicoumarol, a highly potent inhibitor of DTD. The cell 
homogenates were incubated with dicoumarol for 2 min prior to enzyme assay.
Cellular ATP content. Cells were treated with 300 ^l 5% (v/v) perchloric acid and neutralised with 
700 ^l 0.8 M potassium phosphate buffer. Insoluble material was removed by centrifugation (5 min, 
13000 g) and stored at -80 °C until use. ATP was separated using a Spectra-Physics HPLC system 
consisting of a SP8800 ternary pump, a SP8875 autosampler, a SP4600 integrator and a Merck 100 RP- 
18 column (LichroCART 125-4 Lichrospher). 20 ^l supernatant was injected on the column at 40 °C 
and were separated with flow of 1 ml/min. The elution buffer was a 0.1 M potassium phosphate buffer, 
pH 6.0 that was filtered through a 0.45 mm filter before use. ATP was detected by a Kratos Spectroflow 
773 UV detector at 260 nm. ATP content was expressed as nmol/mg protein.
GSH and extracellular (GSH+GSSG). Reduced glutathione was determined by HPLC after 
derivatization with monobromobimane (mBBr) as described by Cotgreave and Moldeus 29. After 
incubation, cells were washed with KH and 100 ^l aqua pure was added to the well. GSH was 
derivatized by adding 100 ^l 2 mBBr dissolved in 50 mM N-ethylmorpholine and incubating this mixture 
for 5 min in the dark. Protein was denatured by inclusion of 25 ^l 40% trichloric acid (TCA) and 
removed by centrifugation (5 min, 13.000 g). For determination of RSSG, 500 ^l of cell material was 
precipitated with 25 ^l 40% TCA and separated by centrifugation. The pellet was washed 3 times with 
500 ^l 5% TCA and resuspended in 100 ^l 1% SDS in PBS. After neutralisation with 10 ^l saturated 
NaHCO3, mixed disulphides were reduced with 5 ^l 25 mM dithiothreitol (DTT). After 45 min 
incubation, GSH was labelled with 100 ^l 5 mM mBBr and measured as described. In order to measure 
total GSH (GSH+GSSG+RSSG), 100 ^l cell material was treated with 10 ^l 20% TCA to inactivate 
GSH metabolising enzymes. After buffering with 100 ^l 1 M phosphate, 100 ^l sample was reduced 
with 10 ^l 25 mM DTT and labelled with 100 ^l 10 mM mBBr. GSSG calculated with the formula: 
GSSG=TGSH-GSH-RSSG. For the determination of extracellular and total extracellular glutathione 
(GSH+GSSG), 250 ^l aliquots of KH buffer were taken at the appropriate time from the culture plate. 
For the estimation of total extracellular GSH, 100 ^l KH was reduced with 10 ^l 25 mM DTT in 45 
minutes at room temperature. The mixture was labelled with 100 ^l 5 mM mBBr and deproteinized with 
10 ^l 40% TCA.
20 ^l samples of glutathione derivatives were separated by HPLC using a Merck 100 RP-18 column at 
40 °C and a flow rate of 1 ml/min. Buffer A was 128 ml methanol and 2.5 ml acetic acid diluted to 1 l 
with aqua pure, adjusted to pH 3.9 with 5 N NaOH. Buffer B was 900 ml methanol and 2.5 ml acetic 
acid, diluted to 1 l with aqua pure. A linear gradient from 0% B at 0 min, 50% B at 8 min to 0% B at 17 
min was used to elute the glutathione derivatives that were detected using a Shimadzu RF-530 
fluorescence detector at 1ex=385 nm and 1em=480 nm. Glutathione content was expressed as nmole/mg 
protein.
Protein thiols. Protein thiols were determined using Ellman's reagent 30 according to Sedlak and Lindsay 
31 and modified by Toxopeus et al 32. Briefy, 500 ^l cell lysate was precipitated with 100 ^l 3.5% 
HClO4 and pelleted (5 min, 500 g). The pellet was washed twice with 500 ^l 5% TCA and resuspended 
in 1 ml PBS/EDTA(5 mM)/SDS (0.5% w/v). 10 ^l 1 N NaOH was added to clarify the mixture. 150 ^l 
sample or glutathione standard incubated with 20 ^l Ellman's reagent for 30 min at 37 °C and the optical 
density of the mixture was measured at 405 nm. A correction for the background was performed by 
inclusion 30 ^l 100 nM NEM. The data was expressed as nmol SH/mg protein.
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MTT reduction assay. After incubations with quinones, cells were washed twice with KH and 500 ^l 
phosphate buffered saline containing 1 mg/ml MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide) was added to each well. After 1h incubation at 37 °C and 5% CO2, cells were 
washed again with KH and the formed formazan was extracted from the cells with 500 ^l isopropanol. 
The optical density of the extract was determined in a microtitre plate at 550 nm. The data was 
expressed as percentages of the values of the controls at t=0h.
Cellular Protein. Cellular protein was quantified with the Bradford method 33 using BSA as a 
standard.
Statistical analysis. Results are expressed as means ± SD of three to six independent experiments. 
Statistical significance between two groups was determined by means of an unpaired Student’s-t-test. 
Statistical differences between groups were determined by means of a one-way analysis of variance 
(ANOVA), followed by Dunnett’s multiple-comparison test. A probability of P 0.05 was considered 
significant.
Results
Caco-2 and HT-29 coloncarcinoma cells reached confluence after 5-6 days and were used 
on day 7 and 8  of culture. No significant differences in neutral red uptake, intracellular ATP 
and glutathione levels, MTT reduction and DTD activity were observed between cells of day 7 
and day 8 of culture. Caco-2 and HT-29 cells were exposed to 50 |iM NQ, 100 |iM MEN and 
300 |iM DIM for 2 and 4 hours with or without 100 |iM dicoumarol, a potent inhibitor of DTD. 
Dicoumarol alone, had no effect on Caco-2 cells but the HT-29 cell-line displayed an higher 
neutral red uptake compared to the control cells (fig. 4.1). NQ caused an sharp drop in viability 
of Caco-2 cells while this effect was not observed with HT-29 cells. Dicoumarol had no effect 
on the viability of NQ-exposed Caco-2 cells but had an deteriorating effect on the viability of 
NQ-treated HT-29 cells. Menadione displayed an similar effect on the viability of both cell- 
lines. The effect of the inhibitor dicoumarol was in accordance with the effect observed with 
NQ. DIM which is unable to arylate due to the substituents at the 3’ and 4’ position was not 
toxic to HT-29 cells and moderately toxic to Caco-2 cells. Again, no effect of dicoumarol was 
observed in combination with DIM in the Caco-2 cell-line. Dicoumarol combined with DIM 
resulted in increased neutral red uptake compared to DIM exposed HT-29 cells. Exposure to 
dicoumarol alone did not have an effect on the viability of cells (data not shown).
Since dicoumarol had no effect on the toxic action of NQ or MEN in Caco-2 cells, the 
activity of DTD was examined in both cell-lines using 2,6-dichlorophenolindophenol as 
substrate. The HT-29 cell-line was reported to contain a functional gene and normal expression 
of DTD 5,6 Table 4.1 shows that the greater part of NADPH oxidising activity in the HT-29 
cell-line is dicoumarol-sensitive. This in contrast to the Caco-2 cell-line, where very low 
levels 2,6-dichlorophenolindophenol reducing activity were observed. The reducing activity in 
the Caco-2 cell-line was for greater part not inhibited by dicoumarol, which is a strong 
indication that DTD is not functional in the Caco-2 cell-line.
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Figure. 4.1. Effect o f  quinones on the viability o f coloncarcinoma cells. Caco-2 cells and HT-29 cells 
were untreated (A), or exposed to 50|iM NQ (B), 100 (iM MEN(C) or 300 (iM DIM (D) without
(1....1) or with 100 |iM dicoumarol (I I). Shown are the means ± SD of three independent experiments
(*: p<0.05, **: p<0.01 effect of dicoumarol on quinone-exposed cells compared to treatment with 
quinone only; #: p<0.05, ##: p<0.01 effect of quinone on cells compared untreated cells).
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Table 1. Comparison o f  DTD1 activity between coloncarcinoma cell-lines.
Cell-line without dicoumarol with dicoumarol dicoumarol
inhibitable activity
HT-292 445.7 ±41.7 52.0 ± 5.8 393.7 ±46.9
Caco-22 29.9 ± 1.1 23.5 ± 1.9 6.4 ± 2.2
1 DTD activity was expressed in the oxidation of nmol NADPH.min-1.mg protein-1.
2 Experiments were performed in fourfold.
**: p<0.01 when the Caco-2 cell-line was compared the HT-29 cell-line.
Since the cell-lines differ in dicoumarol-sensitive DTD activity, the effect of dicoumarol on 
menadione induced glutathione depletion was determined in the Caco-2 and HT-29 cell-line. 
Figure 4.2A shows a gradual decline of levels of reduced GSH in the HT-29 cell-line probably 
due to intracellular consuming processes. Some of these processes seemed to be dicoumarol 
sensitive since dicoumarol-treated cells contained more reduced GSH than control cells. 
Although MEN was not able to induce an decrease in viability, the quinone clearly decreased 
the intracellular levels of glutathione. This decrease was strongly enhanced in the presence of 
dicoumarol. Figure 4.2B shows that MEN rapidly depleted the levels of reduced GSH in the
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Caco-2 cell-line. Dicoumarol did not increase this depletion nor affected the levels of GSH in 
control cells.
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Figure 4.2. Effect o f menadione and dicoumarol on the glutathione content o f HT-29 (A) and Caco-2 
cells (B). HT-29 and Caco-2 cells were untreated (□) or exposed to 100 dicoumarol (O) 100 
MEN (■) or to a combination of MEN and dicoumarol (•). Glutathione was extracted and measured as 
described in materials and methods. Shown are the means ± SD of three independent experiments(*: 
p<0.05, **: p<0.01 compared to untreated cells; ##: p£0.01: compared to menadione exposed cells).
B
HT-29 cells seem to metabolise quinones primarily via two-electron reduction pathways 
and are not really affected. In the Caco-2 cell-line, quinones enter redoxcycling for a greater 
part via one-electron reduction. Based on the results achieved with the Caco-2 cell-line, it was 
concluded that quinones elicit toxicity via the parent quinone and its corresponding 
semiquinone. In order to investigate whether quinones are toxic to cells via arylation or 
redoxcycling, the distribution of glutathione was determined in NQ, MEN and DIM treated 
Caco-2 cells.
Control Caco-2 cells display high levels of reduced glutathione and small amounts of 
intracellular oxidised free glutathione (fig. 4.3a). All quinones affected the distribution of 
glutathione, but in different manners (fig. 4.3b,c,d). Exposure to NQ and MEN rapidly depleted 
cells of reduced glutathione, while DIM caused a more gradual slow decline. Formation of 
mixed disulphides in Caco-2 cells occurred with all three quinones. All quinones in this study 
induced the formation of free oxidised glutathione. With MEN, only a small amount of free 
oxidised glutathione was found within the cell at t=1 hrs and the larger part of GSSG was 
retrieved in the incubation buffer. In contrast to MEN, free intracellular GSSG was found in 
cells exposed to NQ and DIM. No extracellular glutathione was found with DIM but large 
amounts of extracellular GSSG were observed in incubations with NQ and MEN. In these 
experiments, only oxidised glutathione was found in the incubation buffer of quinone-treated 
cells. GSSG appeared at t=1hr in the incubation buffer with MEN and somewhat later with NQ. 
Both NQ and MEN caused an initial decrease of the total amount of glutathione.
Excessive formation of intracellular GSSG is accompanied by formation of protein associated 
disulphides using all three quinones (fig. 4.3). Further, arylating quinones like NQ and MEN 
can bind directly to cellular protein thiols. Both mechanisms lead to depletion of cellular thiols 
and may have deteriorating effects on the viability of cells. Figure 4.4A shows that both NQ and 
MEN rapidly depleted cellular protein thiols and DIM had only a significant effect on protein 
thiols after 4 hours of exposure. Figure 4.4B shows that protein thiols were arylated at a similar 
rate by the NQ and MEN.
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Figure 4.3. Effect o f quinones on the distribution o f glutathione in the Caco-2 cell-line. Caco-2 cells 
were exposed to KH buffer alone or exposed to KH containing 50|iM NQ (B), 100 |iM MEN(C) or 300
|iM DIM (D). Depicted are reduced glutathione ( I I), protein-bound glutathione (I I ), oxidised 
glutathione (I I) and extracellular oxidised glutathione (EMI) Shown are the means ± SD of four 
independent experiments (*: p£0.05, **: p£0.01 effect of exposure to quinones on cells compared to 
control cells; #: p<0.05, ##: p<0.01 effect of incubation on control cells).
The viability of cells is closely related to the cellular content of energy-rich components like 
ATP. Enzymes of energy producing pathways like the glycolysis and the TCA cycle contain 
crucial thiols and are particularly vulnerable for the actions of quinones 26,34 In order to 
investigate the involvement of ATP in the toxicity of the three quinones, ATP was measured 
throughout the incubation. Figure 4.5 shows that NQ caused a fast drop of cellular ATP and as 
much as 16% is left after 4h. MEN showed a more gradual loss of ATP and the depletion after 
4h is comparable with NQ. The moderately toxic quinone DIM showed a small depletion of 
ATP after 4hrs of incubation.
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Figure 4.4. Effect o f  quinones on protein thiols o f Caco-2 cells. Caco-2 cells were untreated (□) or 
exposed to 50 NQ (■), 100 MEN (•) or 300 ^M DIM (A). Graph A shows the actual cellular 
protein thiols that were determined as described in materials and methods. Shown are the means ± SD of 
three independent experiments (*: p<0.05, **: p<0.01 compared to untreated cells). The percentage 
alkylated thiols presented in graph B were calculated by subtracting the nmoles protein associated 
glutathione (fig. 4.3) from the data in graph A.
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Figure 4.5. Effect o f quinones on intracellular ATP content o f  Caco-2 cells. Caco-2 cells were 
untreated (□) or exposed to 50 ^M NQ (■), 100 ^M MEN (•) or 300 ^M DIM (A). ATP was 
extracted and measured as described in materials and methods. Shown are the means ± SD of four 
independent experiments (*: p<0.05,**: p<0.01 compared to untreated cells).
Although MEN showed a similar depletion of protein thiol as NQ (fig. 4.4), MEN-treated 
cells contained more ATP than the NQ-exposed cells (fig 4.5). The MTT assay is associated 
with the activity of mitochondrial enzyme succinate dehydrogenase and was used to estimate to 
activity of mitochondria during exposure to quinones. As expected, control cells displayed a 
unaltered reduction of MTT during incubation (fig 4.6). Exposure to DIM had no effect on the 
cellular reduction of MTT when compared to controls. NQ however, caused a sharp drop in 
MTT reduction after 2h of incubation. Interestingly, incubation with MEN resulted in a initial 
rise of MTT reduction and then a decline to 50% of the controls.
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Figure. 4.6. Effect o f quinones on cellular MTT reduction o f Caco-2 cells. Caco-2 cells were untreated 
(□) or exposed to 50 NQ (■), 100 MEN (•) or 300 ^M DIM (A). Shown are the means ± SD 
of three independent experiments (*: p<0.05,**: p<0.01 compared to untreated cells).
Discussion
The behaviour of quinones with regard to their toxicity is strongly related to the biochemical 
constitution of the exposed cell and chemical structure of the quinone. Naphthoquinones like
10 26 32
MEN are well studied for their ability to induce oxidative stress in hepatocytes ’ ’ , 
cardiomyocytes 35 and isolated intestinal cells 36. Quinones exert their toxic effect by 
redoxcycling and arylation. Redoxcycling involves one-electron reduction pathways catalysed 
by microsomal NADPH cytochrome P450 reductase, microsomal NADH cytochrome b5 
reductase, mitochondrial NADH ubiquinone oxido-reductase and gives rise to a semiquinone. 
Cytosolic DTD reduces the quinone to a hydroquinone via a two-electron reduction. Superoxide 
anion radical and singlet oxygen are formed during the oxidation process of the hydroquinone 
and semiquinone 8. The arylation reaction between quinones and nucleophiles like GSH is a
1,4-reductive addition of the Michael type, which reduces the quinone to its corresponding 
glutathionyl hydroquinone 37
The quinones MEN, NQ and DIM were used in this study because of their differences in 
eliciting toxicity. NQ and MEN are both capable of arylation although MEN is a lesser arylator 
than NQ due to its methyl-substituent in the quinoid ring 38. Because of this methyl-substituent, 
MEN (E(Q/Q-= -203 mV) has a lower redoxpotential than NQ (E(Q/Q-= -140 mV) and is for 
this reason a better redoxcycler 8. The one electron reduction potential of DIM was estimated at 
-183 mV 39 and it has similar redoxcycling capabilities as menadione, which was confirmed in 
studies using hepatocytes 13.
Two human coloncarcinoma cell-lines were used in this comparative study in which the 
three quinones caused different effects on the viability. None of the quinones had any effect on 
the viability of HT-29 cells whereas especially NQ and MEN caused a rapid decrease in 
viability with the Caco-2 cell-line. In the HT-29 cell-line, the two quinones were only toxic 
when DTD was inhibited by dicoumarol, which indicates a difference in DTD activity between 
the two cell-lines. Naphthoquinones are a substrate for human DTD. A comparative study 
between human and rat hepatoma cells showed no difference in activity between species 40. An 
other study compared the MEN reducing activity of purified rat and human DTD. The DTD was 
purified from rat liver cytosol and from E-coli in which rat and human lung tumor diaphorase 
complementary DNA was expressed. The enzyme kinetics of reduction of MEN were similar 
for the three enzyme preparations 41. Measurement of DTD confirmed a very low activity in
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Caco-2 cells in comparison with HT-29 cells. Loss of DTD activity is documented in several 
studies with tumor material. A study with 10 human coloncarcinoma cell-lines shows that seven 
lines expressed lower or no DTD activity compared to the HT-29 cell-line 6 HT-29 cells seem 
to metabolise quinones primarily via two-electron reduction pathways which converts quinones 
to hydroquinones. Superoxide dismutase prevents the hydroquinone from autooxidation and thus 
stabilises the hydroquinone 39,42-44 The manganese containing form of superoxide dismutase was 
detected in HT-29 cells 45 while CuZn superoxide dismutase was demonstrated in the Caco-2 
cell-line 46 The hydroquinone is excreted from the cell after glucuronidation or sulphation 
reactions 14,15. Caco-2 cells appeared to be deprived of DTD activity and quinones redoxcycle 
only via one-electron reduction. The absence or inhibition of DTD activity had a detrimental 
effect on the cellular GSH content of quinone-exposed cells. MEN caused a moderate depletion 
of glutathione in the absence of dicoumarol but induced an intensive exhaustion in combination 
with dicoumarol in HT-29 cells. Since a hydroquinone does not conjugate to GSH or arylate to 
protein thiols 44, a large amount of MEN is not able to form conjugates with GSH in HT-29 
cells. The inactivation of DTD allows MEN to enter the one-electron reduction pathways with 
consequent consumption of GSH by both arylation and redoxcycling as occurred in Caco-2 
cells. A little is known about the one-electron reduction pathways capabilities of both cell 
lines. The HT-29 cell line has a cytochrome P450 reductase activity of 3 nmol/min/mg 5,47 
Schiemdlin-Ren et a l 48 demonstrated the presence of cytochrome P450 reductase with 
immunoblots of Caco-2 homogenates. Rossi et a l 49 found a cytochrome P450 reductase activity 
of 5.01±0.61 nmol/min/106 cells in the Caco-2 cell line. Based on our protein measurements 
(1.86±0.05 mg/106 Caco-2 cells), the cell-lines are expected to have similar cytochrome P450 
reductase activities. Some notion must be taken in account with the use of dicoumarol since this 
inhibitor was found to inhibit several other enzymes like glutathione transferase and has a 
disturbing effect on the mitochondrial oxidative phosphorylation 40. The Caco-2 cell line was 
reported to have an transferase activity of 0.6-5.4 |imol/min/mg 50 The transferase activity of 
HT-29 cells is 0.3 nmol/min/mg 47, 100 nmol/min/mg 5,51 and 200 nmol/min/mg 52-54 The 
glutathione levels in dicoumarol treated HT-29 cells were higher than in control cells and this 
may indicate the inhibitory effect of dicoumarol on the glutathione transferases, although this 
effect was not visible in the Caco-2 cell line. The dicoumarol-induced increased depletion of 
GSH in MEN-treated HT-29 cells can not be explained by this inhibiting effect since 
dicoumarol did not affect the rate of MEN-induced GSH depletion in Caco-2 cells.
The toxicity of the different arylation and redoxcycling quinones was studied in more details 
with the Caco-2 cell-line. Formation of mixed disulphides and intra- and extracellular GSSG is 
an indication for oxidative stress. Exposure to the three quinones resulted in different patterns 
of glutathione distribution. NQ and MEN rapidly depleted the reduced GSH pool, while DIM 
showed a more gradual decrease indicating that arylation is a major factor of the quinone 
mediated decrease of GSH. During the first period of exposure, a decrease of the total amount 
of glutathione with a subsequent restoration to its initial levels occurred only with the arylating 
quinones. Since the conjugation of GSH to quinones is irreversible, the supplement of total 
GSH must be the result of de novo synthesis of GSH. In all cases, protein-associated 
glutathione appeared within 30 minutes of exposure. Similar observations were made with 
menadione- and t-butyl hydroperoxide-treated hepatocytes 55,56. Birge et a l 57 suggested that 
thiolation of protein thiols is a protective mechanism since the same proteins arylated by 
paracetamol are thiolated by glutathione during oxidative stress caused by paracetamol. 
However, it is more likely that the thiolation of proteins occurred as the result of increased 
GSSG formation since with the non-arylating quinone DIM similar high levels of protein 
disulphides were observed. Extracellular GSSG was found after 1 hour of MEN exposure but 
no intracellular GSSG was observed in contrast to NQ where relatively high levels of 
intracellular GSSG were found. The translocation of GSSG in hepatocytes was found to be
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ATP dependent 58,59 and this transport could be blocked with the thiol-alkylating agent NEM, 
indicating that the translocator possesses thiol groups essential for its activity 60 NQ did not 
irreversibly block GSSG export but only delayed the process. NQ induced a more rapid 
depletion of cellular ATP than MEN and the lack of ATP after NQ-treatment may contribute to 
the stronger accumulation of intracellular GSSG. An other explanation is the finding that 
glutathione-S-conjugates are responsible for the accumulation of GSSG by inhibiting GSSG 
reductase 15,61. Further, MEN has been shown to directly inhibit glutathione reductase 55. Since 
NQ is stronger arylator than MEN, it is conceivable that direct and indirect inhibition of 
glutathione reductase occurred earlier with NQ. Although MEN and DIM have similar 
redoxcycling capabilities, the higher rate of GSSG formation and stronger toxicity observed 
with MEN may be ascribed to the MEN-induced inhibition of glutathione reductase.
NQ and MEN rapidly depleted the cellular ATP content of Caco-2 cells. Quinones and 
activated oxygen species are able to interfere with cellular energy producing enzymes. Hyslop 
e t a l 34 showed that hydrogen peroxide inactivates both glycolytic and mitochondrial pathway 
by interfering with glyceraldhyde-3-phosphate dehydrogenase (GAPDH) and ATP-ases 
respectively. Redegeld et a l 26 have shown that GAPDH was 80% inhibited by menadione 
(150-200 |iM). The difference between ATP depletion by NQ and MEN is not simply 
attributable to the differences in arylation of protein thiols. The percentage arylated protein 
thiols did not differ during exposure to NQ and MEN. The higher levels of ATP in MEN- 
treated cells corresponded with an initial increase of MTT reduction. Although the mechanism 
of MTT reduction is still unclear, several cellular reductive pathways are involved. Earlier 
work shows the role of mitochondrial succinate dehydrogenase 62 and in HeLa cells, MTT was 
reduced by superoxide anion radicals derived from mitochondria or xanthine oxidase 63. The 
initial rise of MTT reduction in the presence of menadione may reflect the ability of menadione 
to interfere with the electron current in the electron transport chain in mitochondria 64. Berridge 
and Tan 65 showed that most cellular MTT reduction occurs outside the mitochondrial inner 
membrane and involves NADH and NADPH-dependent mechanisms. A further alternative 
explanation may be an increased production of NADPH as the result of the activation glucose-
6 -phosphate dehydrogenase. Enzymes, which involved in the hexose monophoshate shunt 
(HMPS) like glucose-6-phosphate dehydrogenase are upregulated upon S-thiolation 66,67 This 
can explain the 600% rise of HMPS activity in 50 |iM MEN-exposed Caco-2 cells in the 
experiments of Baker and Baker 68. This increased reductive potential may have beneficial 
effects on the elimination of GSSG and semiquinones.
Our results confirm that the arylation capacity is determining factor in the cytotoxic potential 
of quinones 12 The redoxcycling and arylating quinones NQ and MEN were more toxic than the 
redoxcycler DIM. Whether a quinone can elicit toxicity is dependent on the presence of 
reducing enzymes like DTD. The Caco-2 cell-line displays a very low activity of DTD and was 
therefore more susceptible to quinone toxicity than the HT-29 cell-line. The presence of DTD is 
of interest for cancer therapy. The cytotoxicity and DNA crosslinking ability of mitomycin C 
and diaziquone are dependent on a two-electron reduction by DTD and the HT-29 cell-line was 
found to be more sensitive than the DTD deficient or low level expressing colon carcinoma 
cell-line BE 5,e. On the other hand, this paper shows that redoxcycling and arylating 
naphthoquinones were toxic to cells when DTD-activity was inhibited or missing. The 
determination of enzymatic capabilities of a tumor may give an indication for the choice of an 
anti-cancer drug.
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Chapter 5
Prevention of Oxidant-induced Cell-death in Caco-2 
Coloncarcinoma Cells after Inhibition of Poly(ADP-ribose) 
polymerase and Ca2+ Chelation: Involvement of a Common 
Mechanism.
Jurgen M. Karczewski, Janny G.P. Peters, and Jan Noordhoek.
D epartment o f  Toxicology, University o f  Nijmegen, Nijmegen, the Netherlands.
Abstract - The human coloncarcinoma cell-line Caco-2 was exposed to the oxidative stress inducing 
agents menadione (MEN), 2,3-dimethoxy-1,4-naphthoquinone, and hydrogen peroxide. All three agents 
caused DNA damage, which was assessed with alkaline unwinding. Further, all three agents induced 
intensive NAD+ depletion, followed by a decrease of intracellular ATP and viability. Inhibition of 
poly(ADP-ribose) polymerase (PARP, EC 2.4.2.30) by 3-aminobenzamide prevented the depletion of 
NAD+. These cells had a higher viability and ATP-content. The most pronounced effect was observed 
with 25 ^M MEN, while at higher levels a partial preservation of NAD+ was observed but no effect on 
ATP or viability. The chelation of intracellular calcium by BAPTA-AM also prevented the dramatic loss 
of NAD+ demonstrating that Ca2+ is an activating factor in PARP mediated cell killing.
Introduction
Activated oxygen species are well-documented mediators of cell injury under a variety of 
pathological and physiological conditions 1. Oxygen radicals are involved in some types of 
gastrointestinal injury like in Crohn's disease 2, ulcerative colitis 3 and ischemia-reperfusion, 4,5 
Oxidative injury was reported to develop according to a fairly general pattern occurring in 
different cells and involved basically: free-thiol oxidation and appearance of protein- 
disulfides, depletion of the ATP-pool, elevation of free cytosolic calcium, disassembly of 
cytoskeleton, increased plasma membrane peroxidation and permeability, release of cytosolic 
components, and induction of DNA strand breaks. MEN, a well-studied source of radicals in 
hepatocytes, has a wide range of effects on cells. Exposure of hepatocytes to MEN perturbs the 
cytoskeleton of the cell, which can be recognized as membrane blebbing 6 The blebformation is 
associated with altered thiol and Ca2+ homeostasis 6-11. The semiquinone of MEN and the 
reactive oxygen species generated by MEN were found to interact with DNA of hepatocytes 12­
14, CHO cells 15 and leukemic K562 cells 16
DNA-damaging agents, including alkylating agents, ionizing radiation 17 and reactive oxygen 
species like H2O2 activate PARP 18-20 The poly(ADP-ribosylation) is a post-translational 
modification of nuclear protein and enzymes, induced by DNA damage. ADP-ribosylation of 
histones causes a release of DNA from the nucleosomal structure. This process is known as 
histone shuttling and facilitates the access of repair enzymes to the damaged DNA 21. The rapid 
depletion of NAD+ following excessive DNA damage may disturb the cellular ATP production 
and eventuate in necrotic cell death 22 This suicide response to unrepairable intracellular stress 
assures that unwanted mutations do not arise but excessive activation of the same mechanism 
may also be responsible for aggravation of inflammatory diseases. Due to partial collapse of 
the antioxidant system and the subsequent cytokine-mediated hyperreactivity of mononuclear
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and poly-morphonuclear leukocytes, patients suffering from inflammatory and autoimmune 
rheumatic diseases produce up to 30-fold levels of reactive oxygen species 23. Recently, 
inhibition of PARP activity was found to partly suppress potassium peroxochromate-induced 
arthritis in mice and inhibited the phagocytic generation of reactive oxygen species 24
We used a spontaneously differentiating coloncarcinoma cell-line Caco-2 as a model for 
studying the role of PARP in oxidative stress in the gastro-intestinal epithelium. This cell-line 
retains many of the morphological features and enzyme levels characteristics of normal human 
enterocytes 25. The present study describes the effect of induced oxidative stress on the DNA of 
Caco-2 cells and the subsequent depletion of NAD+ and ATP. We show the involvement in of 
PARP in the cytotoxicity of quinones and H2O2 in this cell type. Further, the role of calcium was 
studied with respect to depletion of cellular NAD+ pool.
Material and Methods
Chemicals. MEN was purchased from Aldrich (Milwaukee, USA). 2,3 dimethoxy-1,4- 
naphthoquinone was prepared according Gant et al 26. The identity was checked with mass 
spectrometry. Monobromobimane was from Calbiochem (La Jolla, USA). Other chemicals and enzymes 
were obtained from Sigma (St. Louis, USA). All chemicals were of analytical grade. All cell culture 
materials were purchased from ICN (Costa Mesa, USA), except for flasks and tissue culture plates that 
were from Greiner (Alphen a/d Rijn, NL) and gentamicine (Centrafarm, Etten-Leur, NL).
Cell culture and incubation. Caco-2 were maintained at 37 °C in DMEM, containing 10% (v/v) fetal 
bovine serum, 10 mM HEPES, 1% nonessential amino acids, 5 mM L-glutamine, 5 ^g/ml gentamicine in 
an atmosphere containing 5% CO2. 1x105 cells were seeded in 24-wells culture plates and became 
confluent after 4 days. Cell cultures were supplied with medium every second day and used on day 7 of 
culture.
Incubations with MEN were performed in 24 wells tissue plates in an atmosphere as described above. 
Cells were washed with Krebs-Henseleit buffer (KH, formulation in mM: 1.2 MgSO4.7H2O, 2.5 
CaCl2.2H2O, 4.7 KCl, 94 NaCl, 11.6 D-glucose, 25 NaHCOs, 1.2 KH2PO4 and 5 L-glutamine, pH 7.4) 
and supplied with 0.5 ml KH. MEN and DIM were dissolved in dimethylsulfoxide and control cells were 
treated with equal volumes of the solvent (0.3% of final volume).
Neutral Red Uptake Assay. Viability was determined according Borenfreund and Puerner 27. Briefly, 
after incubation the monolayer was washed with KH. Fresh complete DMEM with 50 ^g/ml neutral red 
was added to the wells. After 30 min of incubation at 37 °C cells were washed rapidly with 40% 
formaldehyde-10% CaCl2, to remove extraneously adhering, unincorporated dye. Neutral red was 
extracted with 500 ml 1% acetic acid-50% ethanol and 150 ^l were transferred to a 96 wells titreplate. 
The plate was measured on a Thermomax microplate reader (Molecular Devices, Menlo Park, 
California, USA) equipped with a 550 nm filter. The readings were expressed as percentages of the non­
exposed cells.
Cellular ATP and NAD+ content. Cells were treated with 300 ^l 5% (v/v) perchloric acid and 
neutralised with 700 ^l 0.8 M potassium phosphate buffer. Insoluble material was removed by 
centrifugation (5 min, 13000 g) and stored at -80 °C until use. ATP and NAD+ were separated using a 
Spectra-Physics HPLC system consisting of a SP8800 ternary pump, a SP8875 autosampler, a SP4600 
integrator and a Merck 100 RP-18 column (LichroCART 125-4 Lichrospher). 20 ^l supernatant was 
injected on the column at 40 °C and were separated with a flow of 1 ml/min. The elution buffer was a
0.1 M potassium phosphate buffer, pH 6.0 that was filtered through a 0.45 mm filter before use. ATP 
and NAD+ were detected by a Kratos Spectroflow 773 UV detector at 260 nm. ATP and NAD+ contents 
were expressed as percentages of the control cells.
Cellular GSH content. Reduced glutathione was determined by HPLC after derivatization with 
monobromobimane (mBBr) as described by Cotgreave and Moldeus 28. After incubation cells were 
washed with KH and 100 ^l aqua pure was added to the well. GSH was derivatized by adding 100 ^l 2 
mBBr dissolved in 50 mM N-ethylmorpholine and incubating this mixture for 5 min in the dark. Protein 
was denatured by inclusion of 25 ^l 40% trichloric acid and removed by centrifugation (5 min, 13.000
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g). 20 ^l GSH derivatives were separated by HPLC using a Merck 100 RP-18 column at 40 °C and a 
flow rate of 1 ml/min. Buffer A was 128 ml methanol and 2.5 ml acetic acid diluted to 1 l with aqua 
pure, adjusted to pH 3.9 with 5 N NaOH. Buffer B was 900 ml methanol and 2.5 ml acetic acid, diluted 
to 1 l with aqua pure. A linear gradient from 0% B at 0 min, 50 % B at 8 min to 0 % B at 17 min was 
used to elute the GSH derivatives that were detected using a Shimadzu RF-530 fluorescence detector at 
1ex=385 nm and 1em=480 nm. Glutathione content was expressed as percentages of the control cells.
Determination o f DNA single-strand breaks (SSB). The formation of SSB in DNA was measured by 
alkaline unwinding and determination of ethidium bromide fluorescence on a LS50 spectrofluorometer 
(Perkin Elmer, Norwalk, USA) with excitation at 520 nm and emission at 590 nm according to the 
method of Birnboim and Jevcak 29. After incubation with DNA damaging agents, cells were washed once 
with KH. Cells were detached from the culture plates with 200 ^l trypsin/EDTA in 12 min at 37 °C after 
which 200 ^l culture medium was added to inactivate the trypsin. Cells were separated from the solution 
and were resuspended in 100 ^l 250 mM meso-inositol containing 10 mM Na3PO4.12H2O and 1 mM 
MgCl2.6H2O, pH7.2 and 100 ^l 9 M urea containing 10 mM NaOH, 2.5 mM EDTA.2H2O, 0.1 % SDS 
were added. Cells were lysed during an incubation period of 30 min on ice. The alkaline lysates were 
incubated for 10 min on ice followed by 10 min at 15 °C. DNA unwinding was stopped by adding 200 ^l 
14 mM B-mercaptoethanol/1 M glucose. The lysates were sonicated briefly and 750 ^l Ethidium- 
bromide 13.4 mg/ml 13.3 mM NaOH was added.
DNA unwinding was calculated using the formula: (F-Fmin)/(Fmax-Fmin)*100, where F is the fluorescence 
of the sample, Fmin is the background fluorescence of a sample that was damaged by passing 3 times 
through a 12x0.4mm injection needle. Fmax is the fluorescence of samples kept at pH 11.0, which is 
below the pH needed to induce unwinding of single stranded DNA.
DNA SSB were expressed as percentages of the control values in order to normalise the variation in 
DNA unwinding of the control cells at the start of the experiment.
Statistics. Results are expressed as means ± SD of three to six independent experiments. Statistical 
significance between two groups was determined by means of an unpaired Student’s-t-test. Statistical 
differences between groups were determined by means of a one-way analysis of variance (ANOVA), 
followed by Dunnett’s multiple-comparison test. A probability of P 0.05 was considered significant.
Results
As expected, MEN induced concentration dependent toxicity and depletion of ATP in the human 
coloncarcinoma cell line Caco-2 (fig.5.1). The depletion of NAD+ however occurred at the 
same rate with all concentrations of MEN (ANOVA, p  0.01) indicating a process that was 
already maximally activated with an exposure of 25 |iM MEN. MEN was able to induce DNA 
damage as depicted in fig. 5.2. Hydrogen peroxide was used as a control since this agent is 
capable of inducing DNA damage in several cell-lines. DIM is in contrast to MEN not able to 
arylate and is therefore a pure redoxcycler. DIM was used to assess whether oxygen species 
solely derived from redoxcycling can induce DNA damage in this cell-line. Both hydrogen 
peroxide and DIM caused considerable amounts of single strand breaks and MEN also 
generated SSB.
DNA damage is a trigger for the activation of PARP in all types of mammalian cells. In 
order to estimate the contribution of PARP in the toxicity of MEN in intestinal cells, the effect 
of the relatively specific inhibitor 3-aminobenzamide (3-ABA) was studied. Caco-2 cells were 
exposed to 25, 50 and 100 |iM MEN in combination with 3-ABA and the effect on viability, 
cellular NAD+ and ATP was assessed (fig.5.1). Incubation of the cells with 3-ABA alone 
resulted in a slight increase of NAD+ but the inhibitor had no effect on the viability or ATP 
content. 3-ABA clearly prevented the drop in NAD+ in cells that were treated with 25 |iM 
MEN and the protecting effect was also present with higher concentration of MEN. The ATP- 
depletion observed with 25 |iM was partly reversed by 3-ABA however at higher 
concentration of MEN the inhibitor was not able to prevent the depletion of ATP.
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Figure 5.1. Effect o f 3-ABA on MEN treated Caco-2 cells. Caco-2 cells were untreated (O) or exposed 
to 10 mM 3-ABA (•), MEN (□) or to a combination of MEN and 3-ABA (■). The concentration MEN 
was 25 ^M in graph A, D and G; 50 ^M in graph B, E and H; 100 ^M in C, F and I .Viability(1-A,B,C) 
, NAD+(1-D,E,F) and ATP (1-G,H,I) were measured as described in materials and methods. The [ATP] 
and [NAD+] in control cells were 38.7 ± 8.1 and 7.8 ± 1.0 nmol/mg protein, respectively. Shown are the 
means ± SD of three independent experiments (*: p<0.05, **: p<0.01 compared to MEN exposed cells).
B CA
D F
G H
Time (hrs)
Exposure of Caco-2 cells caused a rapid depletion of GSH with all concentrations of MEN. 
The addition of the PARP-inhibitor during the damaging treatment did not protect the cellular 
GSH pool (fig. 5.3).
An increase of free intracellular calcium is considered to be a major factor in the 
cytotoxicity of quinones 30. We used the intracellular calcium chelator BAPTA-AM to assess 
the role of free cytosolic calcium in PARP-mediated cell killing. Figure 5.4 shows that 
BAPTA-AM partly prevented the decrease in viability and completely prevented the depletion 
of NAD+. Although BAPTA-AM slightly decreased the cellular ATP content of control cells, 
the use of this chelator resulted in substantially higher levels of ATP in MEN-exposed cells.
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Time (hrs)
Figure 5.2. Effect o f MEN, DIM and H2O2 on DNA o f Caco-2 cells. Caco-2 cells were untreated (O) 
or exposed to 25 MEN (•), 300 ^M DIM (■) or 10 mM H2O2 (A). DNA strand breaks were 
measured as described in materials and methods. Shown are the means ± SD of four independent 
experiments (**: p<0.01 compared to untreated cells).
Time (hrs)
Figure 5.3. Effect o f 3-ABA on the GSH content o f MEN-treated Caco-2 cells. Caco-2 cells were
untreated (O) or exposed to 25 ^M (□), 50 ^M (D) and 100 ^M MEN (• ). The solid symbols 
represent the combination of MEN and 10 mM 3-ABA. GSH was extracted and measured as described 
in materials and methods. The GSH content of the control cells was 41,7±3,1 nmol/mg protein. Shown 
are the means ± SD of three independent experiments.
In order to exclude the possibility that the action of PARP is restricted to MEN-induced 
toxicity, cells were exposed for 4 hours to 300 |iM DIM or 10 mM hydrogen peroxide. Both 
agents were also capable of damaging cellular DNA (fig. 5.2). The concentrations of DIM and 
H2O2 were chosen to induce a similar degree of toxicity as 25 |iM MEN. Table 5.1 shows that 
both DIM and t^O2 decreased the viability to 60% which is comparable to the observation 
made with the experiment 25 |iM MEN. The depletion of NAD+ by both agents was also similar 
to the observed levels in the MEN treated cells. H2O2 was more effective than DIM in 
disturbing the levels of ATP. Again, 3-ABA rescued the DIM-exposed cells from a intensive 
NAD+ depletion, while the inhibitor only partly preserved the NAD+ content of the H2O2-treated 
cells. A similar pattern was observed for the ATP levels. With respect to the viability, 3-ABA
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offered a similar protection against DIM or H2O2. BAPTA-AM also partly prevented the 
decrease of viability in H2O2-treated cells but the chelator did not show this effect on DIM- 
treated cells. Chelation of calcium did also prevent the loss of NAD+ with both mediators of 
oxidative stress but the effect was more pronounced in DIM-treated cells. The ATP levels of 
BAPTA-AM and DIM-treated cells were much lower than in DIM-exposed cells. Addition of 
BAPTA-AM to H2O2-treated cells caused a small but significant increase of ATP compared to 
treatment with H2O2 alone.
Figure 5.4. Effect o f 100 pM BAPTA-AM on toxicity o f 25 pM MEN. The effect of the intracellular 
calcium chelator BAPTA-AM on MEN induced toxicity was analysed with the neutral red assay (A), 
intracellular NAD+ (B) and ATP content (C). Caco-2 cells were untreated (O) or exposed to 25 ^M 
MEN (□). BAPTA-AM was added alone (•) or simultaneously with MEN (■). Shown are the means ± 
SD of four independent experiments (*: p<0.05, **: p<0.01 compared to untreated cells; #: p<0.05, ##: 
p<0.01: compared to MEN exposed cells).
A B C
Time (hrs)
Table 5.1. Effect o f 3-ABA and BAPTA-AM on the oxidative stress induced toxicity. Caco-2 cells were 
incubated with DIM (300 ^M) or H2O2 (10 mM) for 4 hours. 3-ABA (10 mM) and BAPTA-AM (100 
^M) were added simultaneously with DIM or H2O2. Shown are %viability, %NAD and %ATP as means 
± SD of six independent experiments.
Experiment %viability %NAD+ %ATP
Control 100.0+ 3.41 100.0 ± 6.09 100.0 ± 0.98
3-ABA 96.3 ± 3.62 100.4 ± 3.69 101.9 ± 1.98
BAPTA-AM 78.0 ± 5.27** 98.4 ± 4.89 56.1 ± 6.21**
DIM 60.6 ± 2.39** 23.8 ± 5.25** 51.4 ± 3.87
DIM + 3-ABA 83.3 ± 5.30## 107.1 ± 4.16## 70.8 ± 2.04##
DIM + BAPTA-AM 60.6 ± 3.77 83.2 ± 8.81## 25.9 ± 2.92##
H2O2 59.6 ± 2.69** 16.9 ± 7.49** 23.1 ± 4.75**
H2O2 + 3-ABA 83.3 ± 3.62## 69.2 ± 5.18## 51.9 ± 2.06##
H2O2 + BAPTA-AM 83.0 ± 2.35## 57.9 ± 7.01## 30.9 ± 4.17##
**: p<0.01 compared to untreated cells.
##: p<0.01 compared to DIM or H2O2 treated cells.
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Discussion
Several toxic properties of quinones have been attributed to their ability to damage DNA via 
generation of free radicals and activated oxygen species. Several investigations have indicated 
that oxygen species such as H2O2 or the hydroxyl radical (generated from H2O2 via Fenton-type 
reactions) may be the most damaging.
Exposure to MEN, DIM and H2O2 induced single strand breaks in the DNA of Caco-2 cells. 
In most mammalian cell types, strand breaks are recognised by poly(ADP-ribose) polymerase 
17,31. The involvement of PARP in our experiments was supported by two observations. First, 
MEN caused a concentration independent depletion of the cellular NAD+ content of Caco-2 
cells. This indicates that the degradation of NAD+ was at maximum rate with a dose of 25 |iM 
MEN. Exposure to DIM and H2O2 resulted in similar levels of NAD+. Obviously, the depletion 
of NAD+ is independent of the source of oxidative stress or the concentration of MEN in this 
study. Further, 3-ABA, a potent inhibitor of PARP, was able to prevent this depletion. The 
preserving effect was more pronounced at the lower levels of MEN exposure. These cells also 
contained more ATP and had a higher viability. The preservation of the viability by ABA is 
attributable to inhibition of necrosis rather than apoptosis. In apoptosis, PARP is inactivated by 
proteases of the ICE-family 32 and this should reflect in a partial or temporal preservation of the 
NAD+ pool 33. However, we observed an unchanged rate of NAD+ depletion which indicates 
that apoptosis may play a only a modest role in our experiments. Eguchi et al 34 showed that the 
cellular ATP levels determine whether cells undergo apoptosis or necrosis. In these 
experiments, treatment of Jurkat cells with calcium ionophore A23187 induced apoptosis under 
ATP-supplying conditions but induced necrotic cell death under ATP-depleting conditions. It is 
possible that MEN decreased the ATP content of Caco-2 cells in such degree that necrotic cell 
death prevails over apoptosis. So, the decrease of neutral uptake during exposure to menadione 
is probably related to necrotic cell death. With higher concentrations of MEN, the depletion of 
NAD was still affected by 3-ABA but the decrease in ATP and viability was not prevented. It 
is likely that MEN caused extensive damage to cell components other than DNA. The active site 
of several enzymes contains one or more thiols, which are directly related to the enzymatic 
activity. MEN has been shown to directly inhibit glutathione reductase 35 and glyceraldhyde-3- 
phosphate dehydrogenase 36 It is conceivable that inactivation of such and other enzymes may 
induce cell killing at a much faster rate than over-activation of PARP alone. In spite of 
treatment with 3-ABA, some depletion of NAD+ occurred with the treatment with 50 and 100 
|iM MEN. This loss of NAD+ may result from leakage due to an increasing loss of membrane 
integrity rather than PARP activity. The use of higher concentrations of quinones may also 
explain why 3-ABA did not protect isolated hepatocytes from 50-200 |iM MEN 37 or 400 |iM 
DIM-treated hepatoma cells 30. With higher concentrations of MEN, the role of PARP in 
cytotoxicity may become questionable since this enzyme is inhibited by MEN (IC50=420^M 38).
MEN intensively depleted the cellular reduced GSH. The protection offered by 3-ABA was 
not mediated by preserving the cellular GSH content since no effect on GSH was observed with 
the use of 3-ABA. In some cell types like human peripheral lymphocytes, it was found that 3- 
ABA was able to preserve the GSH pool during treatment with hydrogen peroxide by retaining 
the levels of NADP+ 39 Glutathione reductase is responsible for the reduction of oxidised 
glutathione and utilises NADPH as a cofactor. The reduction of NADP+ to NADPH is mediated 
by the hexose monophosphate shunt (HMPS) which displays increased activity during oxidative 
stress. The experiments of Baker and Baker 40 describe a 600% rise of HMPS activity in 50 |iM 
MEN-exposed Caco-2 cells. In quinone-exposed hepatocytes, an decrease of NAD+ was 
followed by an increase of NADP+ 37. So the preservation of NAD+ may benefit the 
interconversion of NAD+ to NADP+ by NAD+-kinase. In our experiment we did not observe an
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effect of MEN or 3-ABA on the NADP+ levels (data not shown). Probably NAD+ kinase is not 
present or of any significance in intestinal tissue.
A close relationship has been found between the sustained increase of cytosolic Ca2+ and the 
toxicity of MEN and other agents that induce oxidative stress 41. The level of free calcium in the 
nucleus is connected to that of the cytosol. Nicotera et al 42 described an ATP-dependent 
mechanism by which the nuclear Ca2+ levels respond to a rise of cytosolic calcium. A 
consequence of the increased free Ca2+ in the nucleus is the activation of Ca2+ dependent 
endonucleases 43. More evidence for a MEN stimulated DNA fragmentation follows from 
experiments with isolated hepatocytes and moderate concentrations of MEN (100 |iM). 
Chromatin condensation and progressive DNA fragmentation were observed which correlated 
with the rise of cytosolic calcium 44 The results from our experiments showed that chelation of 
Ca2+ with BAPTA-AM preserved the cellular NAD+ pool and viability of MEN treated Caco-2 
cells. Similar results were obtained with H2O2 and DIM treated cells which means that 
oxidative stress interferes with the Ca2+ homeostasis and leads to a depletion of the NAD+ pool. 
This depletion can still be assigned to the activation of PARP. Poly(ADP-ribosylation) causes 
a release of DNA from the nucleosomal structure. This process is known as histone shuttling 
and facilitates the access of repair enzymes to the damaged DNA 21. Relaxation of DNA by 
PARP may also increase the accessibility for endonucleases that are activated by the rise of 
cytosolic calcium. Thus, the combination of PARP induced DNA relaxation followed by 
endonucleolytic activity results in feedback activation of more PARP. Evidence for this 
mechanism follows from experiments with isolated liver nuclei in which DNA fragmentation by 
Ca2+ dependent endonucleases was elicited by the presence of NAD+, ATP and submicromolar 
concentration Ca2+. This DNA fragmentation was inhibited by 3-aminobenzamide 45. Thus, the 
chelation of Ca2+ prevents the activation of endonucleases and indirectly PARP thereby 
preserving the NAD+ pool. There are some reports that claim that the ADP ribosylation process 
inactivates Ca2+ dependent endonucleolytic activity 46 However, there are implications that 
other calcium-dependent mechanism may damage DNA. Dybukt et al 30 showed that exposure of 
Ca2+-dependent endonuclease free murine hepatoma cells to 400 |iM DIM were protected from 
NAD+ depletion by 3-ABA and BAPTA-AM, although the loss of viability was not prevented 
by 3-ABA.
The results presented in this paper clearly show the involvement of PARP and Ca2+ in 
oxidative stress mediated death in cells derived from the human gastro-intestinal tract. MEN, 
DIM, and H2O2 induced DNA damage and caused an intensive NAD+ depletion, followed by a 
decrease of intracellular ATP and viability. Both inhibition of PARP by 3-ABA and chelation 
of Ca2+ prevented the depletion of NAD+. These cells had a higher viability and ATP-content. 
The contribution of PARP in cell killing was more evident in weakly exposed cells. This level 
of exposure is probably a better model for the level of oxidative stress present in gastro­
intestinal cells that are suffering from inflammation. It would be interesting to know whether 
PARP is active in Crohn's disease, ulcerative colitis and ischemia-reperfusion. Nicotinamide is 
a biogenic inhibitor of PARP and may offer an interesting approach for controlling this type of 
necrotic cell death.
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Chapter 6
The Role of ADP-Ribosylation in Menadione-induced 
Elevation of Mitochondrial Membrane Potential in the 
Caco-2 Cell-line.
Jurgen M. Karczewski, Ralf J. Slangen, and Jan Noordhoek.
Department o f  Toxicology, University o f  Nijmegen, Nijmegen, The Netherlands.
Abstract -The effects of menadione on mitochondria in human coloncarcinoma cell-line Caco-2 
described in this report point at a possible critical mechanism in the toxicity of menadione. Menadione- 
induced oxidative stress resulted in an increase of the mitochondrial membrane potential (MMP) which 
can be inhibited by 3-aminobenzamide, an inhibitor of poly(ADP-ribose) polymerase and the 
mitochondrial NAD+-glycohydrolase. An important factor in this process is the maintenance of the NAD+ 
level which is related with MMP through oxidative phosphorylation. Inhibitors of oxidative 
phosphorylation were used to investigate the effect of MEN on the MMP. The increase of the MMP 
was completely suppressed by the inhibition of complex II with TTFA which indicates that cells suffering 
from oxidative stress compensate their loss of NADH-dehydrogenase activity by an extra-activation of 
succinate dehydrogenase activity (complex II).
Introduction
Cell death induced by oxidative stress is associated with a disturbed energy synthesis. 
Disturbance of the glycolysis and the mitochondrial oxidative phosphorylation appear to be 
sensitive targets for reactive oxygen species 1-3. Naphthoquinones like 2-methyl-1,4- 
naphtoquinone (MEN) are well studied for their ability to induce oxidative stress in 
hepatocytes 2-5, cardiomyocytes 6 and in some cases isolated intestinal cells 7 Quinones exert 
their toxic effect via redoxcycling and arylation. Redoxcycling giving rise to a semiquinone 
involves one-electron reduction pathways catalysed by microsomal NADPH cytochrome P450 
reductase, microsomal NADH cytochrome b5 reductase, mitochondrial NADH ubiquinone 
oxido-reductase 8. Cytosolic DT-diaphorase reduces the quinone to a hydroquinone via a two- 
electron reduction. The hydroquinone and semiquinone can oxidise to the parent compound with 
the formation of superoxide anion radicals and singlet oxygen 9.The arylation reaction between 
quinones and nucleophiles like GSH is a 1,4-reductive addition of the Michael type which 
reduces the quinone to its corresponding glutathionyl hydroquinone 10.
The semiquinone of MEN and the reactive oxygen species generated by MEN were found to 
damage DNA of hepatocytes 11-13, CHO cells 14 and leukemic K562 cells 15. DNA damage is 
rapidly detected by poly(ADP-ribose)polymerase (PARP) which hydrolyses NAD+ to 
nicotinamide and ADP-ribose 16 In eukaryotic cells, the major degradative route for NAD+ 
occurs in the nucleus by PARP. The hydrolysis of mitochondrial NAD+ is mediated by an 
glycohydrolyse which is located on the outer side of the inner mitochondrial membrane 17,18. 
The rapid depletion of NAD+ following excessive DNA damage may disturb the cellular ATP 
production and eventuate in necrotic cell death 19
We have previously shown that the toxicity of low levels MEN in Caco-2 cells was 
completely suppressed by preservation of the NAD+-pool (chapter 5). This indicates that the 
depletion of NAD+is a major factor in the necrotic cell death of coloncarcinoma cell-line
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Caco-2. The cellular ATP synthesis may become affected by an inhibition of NADH:ubiquinone 
reductase via a shortage of the NAD+-pool. In hepatocytes, approximately 80% of the cellular 
NAD+-pool is extra-mitochondrial 20 The exchange of NAD+ across mitochondrial membranes 
is slow (1%/min: ref 21) and this process may therefore not replenish the mitochondrial NAD+- 
pool. Bellomo et al 3 showed that the decrease in ATP levels of MEN-treated hepatocytes is 
preceded by a decrease in the mitochondrial membrane potential (MMP). We used the permeant 
cationic dye rhodamine-123 (Rho-123) to study the role of the MMP in MEN-exposed Caco-2 
cells. The present study shows that MEN caused a dose-dependent rise of the MMP and 
preservation of the NAD+-pool prevented this rise. This MEN-induced increase of the MMP 
was mainly the result of an extra-activation of succinate dehydrogenase of the mitochondrial 
complex II.
Material and Methods
Chemicals and materials. MEN was purchased from Aldrich (Milwaukee, USA), rotenone was from 
Riedel de Haen A.G.. Rhodamine 123 was obtained from ICN (Costa Mesa, USA). Other chemicals 
were obtained were from Sigma (St. Louis, USA). All chemicals were of analytical grade. All cell culture 
materials were purchased from ICN, except for flasks and tissue culture plates that were from Greiner 
(Alphen a/d Rijn, NL) and gentamycine (Centrafarm, Etten-Leur, NL). All chemicals were of analytical 
grade. All cell culture materials were purchased from ICN, except for flasks, tissue culture plates which 
were from Greiner.
Cell culture and incubation. Caco-2 cells were maintained at 37 °C in DMEM, containing 10% (v/v) 
fetal bovine serum, 10 mM HEPES, 1% nonessential amino acids, 5 mM L-glutamine, 5 mg/ml 
gentamycine in an atmosphere containing 5% CO2. 1x105 cells were seeded in 24-wells culture plates and 
became confluent after 4 days. Cell cultures were supplied with medium every second day and used on 
day 7 of culture.
Incubations with menadione and other substances were performed in 24 wells tissue plates in an 
atmosphere as described as above. Cells were washed with Krebs-Henseleit buffer (KH, formulation in 
mM: 1.2 MgSO4.7H2O, 2.5 CaCl2.2H2O, 4.7 KCl, 94 NaCl, 11.6 D-glucose, 25 NaHCO3, 1.2 KH2PO4 
and 5 L-Glutamine, pH 7.4) and supplied with 0.5 ml KH. MEN, 3-ABA and rhodamine were added in 
dimethylsulfoxide (0.3% of final volume). Rotenone, TTFA, antimycine and nigericine were added in 
ethanol.
Determination o f mitochondrial membrane potential. Cells were loaded with 500 ^l 2^M rhodami­
ne-123 (Rho-123) in 24-wells culture plates for 30 min in an atmosphere mentioned above. During 
incubations a background concentration of 2 ^M Rho-123 was supplemented to prevent leakage. After 
the exposure period cells were washed with once PBS and were detached by adding 200 ml trypsine. 
After10 min, cells were suspended by adding an additional 800 ml PBS. The Rho-123 content was 
measured in a LS-50 Perkin-Elmer fluorescence spectrometer (Perkin Elmer, Norwalk, USA) at 
1ex=488nm and 1em=530nm.
Statistical analysis. Results are expressed as means ± SEM of three independent experiments. 
Statistical significance between two groups was determined by means of an unpaired Student’s-t-test. 
Statistical differences between groups were determined by means of a one-way analysis of variance 
(ANOVA), followed by Dunnett’s multiple-comparison test. A probability of P 0.05 was considered 
significant.
Results
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Figure 6.1. Effect o f menadione on Rho-123 uptake by Caco-2 cells. Caco-2 cells were untreated (O) 
or exposed to 25 (•), 50 (■) or 100 MEN (A). The uptake of rhodamine 123 was 
measured as described in materials and methods. Shown are the means ± SEM of three independent 
experiments (*: p<0.05, compared to menadione exposed cells).
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Figure 6.2. Effect o f nigericine on Rho-123 uptake by Caco-2 cells. Caco-2 cells were untreated (O) or 
exposed to 5 ^g/ml nigericine (•). Shown are the means ± SEM of three independent experiments (**: 
p<0.01 compared to untreated cells).
Exposure of Caco-2 to MEN resulted in increase of Rho-123 uptake, while unexposed cells 
displayed a non-significant slow increase (fig. 6.1). This MEN-induced increase was 
concentration dependent with the highest concentrations being the most active. This increased 
uptake was first observed after one-hour treatment with 50 and 100 |iM MEN. In order to 
investigate whether the increased uptake was MMP dependent, the membrane potential was 
artificially raised by nigericine. Nigericine is an ionophore of the K+/H+ exchanger and induces 
an influx of protons into the cytosol. This event will increase the MMP 22 As expected, 
exposure to nigericine resulted in a rapid increase of the Rho-123 uptake, which indicated that 
the increased uptake of Rho-123 is the result of raise of the MMP. Further, the increase of Rho- 
123 fluorescence was confirmed by fluorescence microscopy (data not shown).
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Previously, we showed that inhibition of poly(ADP-ribose) polymerase with 3-ABA was 
able to prevent toxicity of MEN in Caco-2 cells (chapter 5). We were interested whether the 
MEN-induced increase of the MMP was affected by preserving the NAD+-pool. 3-ABA itself 
had no effect on the MMP but the inhibitor was able to prevent the MEN-induced increase of 
Rho-123 uptake (fig. 6.3).
Time (hrs)
Figure 6.3. Effect o f 3-ABA on MEN-induced Rho-123 uptake. Caco-2 cells were untreated (O) or 
exposed to 25 |iM MEN (•). 3-ABA (10 mM) was added alone (□) or simultaneously with 25 |iM 
menadione (■). Shown are the means ± SEM of three independent experiments (*: p<0.05, **: p<0.01 
compared to untreated cells; #: p<0.05, ##: p<0.01: compared to menadione exposed cells).
The depletion of cellular protein thiols was not prevented by 3-ABA (data not shown). 
Obviously, direct arylation by MEN or oxidation of proteins that are part of the respiratory 
chain is not prevented by 3-ABA. To investigate whether a disturbed metabolic substrate- 
respiratory complex interaction may explain the rise of the MMP, specific inhibitors of the 
respiratory chain were used. The action of PARP and the mitochondrial glycosidase rapidly 
deplete the cellular NAD+ pool. The shortage of NAD+ may decrease the NADH:ubiquinone 
reductase activity of Complex I. Rotenone was used to inactivate this complex and may 
simulate the shortage of NAD+. Surprisingly, rotenone had a similar effect as MEN on the 
uptake of Rho-123 (fig. 6.4). The combined effect of MEN and rotenone exceeded the sum of 
their individual actions.
Time (hrs)
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Figure 6.4. Effect o f rotenone on MEN-induced Rho-123 uptake. Caco-2 cells were untreated (O) or 
exposed to 25 MEN (•). Rotenone (100 ^M) was added alone (□) or simultaneously with MEN 
(■). Shown are the means ± SEM of three independent experiments (**: p<0.01 compared to untreated 
cells; #: p<0.05, ##: p£0.01: compared to menadione exposed cells).
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Figure 6.5. Effect o f antimycin on MEN-induced Rho-123 uptake. Caco-2 cells were untreated (O) or 
exposed to 25 ^M MEN (•). 750 ng/ml antimycin was added alone (□) or simultaneously with 
menadione (■). Shown are the means ± SEM of three independent experiments (**: p<0.01 compared 
to untreated cells; #: p<0.05: compared to menadione exposed cells).
The metabolic inactivation of complex I by MEN may affect the activity of the other complexes 
of the respiratory chain. In an attempt to estimate the importance of the complexes downstream 
of complex I, the activity of complex II and III were inhibited by thenoyl trifluoroacetone 
(TTFA) and antimycin, respectively (see also fig. 6.7). Antimycin alone had no effect on the 
uptake of Rho-123 but in combination with MEN, it potentiated the MEN-induced Rho-123 
uptake (fig. 6.5). Inhibition of the complex II by TTFA completely blocked the MEN-induced 
increase of MMP (fig. 6 .6 ). TTFA itself did not affect the uptake of Rho-123.
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Figure 6 .6 . Effect o f TTFA on 25 pM menadione induced Rho-123 uptake. Caco-2 cells were untreated 
(O) or exposed to 25 |iM MEN (•). 250 |iM TTFA was added alone (□) or simultaneously with 
menadione (■). Shown are the means ± SEM of three independent experiments (*: p<0.05, **: p<0.01 
compared to untreated cells; #: p<0.05, ##: p<0.01: compared to menadione exposed cells).
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succinate fumarate
glutamate •*------------------------glutamine
Figure 6.7. Scheme o f the mitochondrial respiratory chain. This scheme shows the site of entry of 
NADH and succinate derived from the metabolism of glutamine. The site of action of the respiratory 
chain inhibitors rotenone, TTFA and antimycin are depicted by the broken arrows. Q, ubiquinone; cyt c, 
cytochrome c.
Discussion
Several reports describe a decrease of the MMP in MEN-exposed mitochondria 23-28. In this 
report, we describe a increase instead of a decrease of MMP in MEN-treated Caco-2 cells. A 
MEN-mediated loss of the MMP is for a greater part observed with isolated mitochondria or in 
experiments using isolated hepatocytes and much higher concentrations of MEN (Toxopeus et 
al, in prep). An explanation for the differences with other studies is the use of whole cells and 
the use of sub-toxic concentration of MEN.
It is well documented that MEN interferes with the ability of isolated hepatic mitochondria 
to accumulate and retain calcium 29-31. The mechanism by which mitochondria realise the sudden 
release of calcium is still a matter of debate. The group of Richter suggests a mechanism in 
which mitochondrial NAD(P)H oxidation is followed by hydrolysis of NAD+ to nicotinamide 
and ADP-ribose. ADP-ribosylation of a yet to be defined mitochondrial protein is responsible
/■) I r y ^  O-l-
for the release of Ca - . The alternative explanation for the rapid release of Ca and the 
sudden collapse of the MMP involves the induction of a non-specific pore. Henry et a l 26 
showed that the MEN-mediated release of mitochondrial Ca2+ involves a permeability 
transition pore (PTP) that can be inhibited by cyclosporine A. The opening of this pore is 
mediated by oxidation of vicinal thiols by pro-oxidants including MEN. In this process the
25 28 2+
MMP is augmented which increases the probability of pore opening , . The released Ca may 
be sequestered by intact mitochondria and induce the activity of several enzymes including the 
dehydrogenases of the citric acid cycle 35. The increased H  output by these mitochondria is 
responsible for the observed increased uptake of Rho-123.
The observation that 3-ABA inhibits the increase of the MMP may fit in both models. The 
hydrolysis of mitochondrial NAD+ is mediated by a glycohydrolyse, which is located on the 
outer side of the inner mitochondrial membrane 16,17 This mitochondrial NAD+-glycohydrolase 
is inhibited by 3-ABA 36 3-ABA prevents the hydrolysis of NAD+ and subsequent ribosylation 
of mitochondrial proteins. On the other hand, the preservation of NAD+ may result in the 
maintenance of NADH which inhibits the opening of the PTP 37
Inhibition of the respiratory chain with rotenone prevents the phosphorylation of ADP with 
NAD+-linked substrates. The irreversible inhibition of complex I by rotenone leads to
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generation of the superoxide radical 38,39. A similar radical production was observed in 
succinate and antimycin-treated mitochondria 40 In vitro, MEN interferes with mitochondrial 
respiration by accepting electrons from the NADH-ubiquinone complex resulting in cyanide 
insensitive oxygen respiration 8,41,42 Two events can occur in MEN and rotenone treated 
mitochondria. First, MEN is supposed to by-pass the rotenone-block and restore the 
phosphorylation by accepting electrons from the complex I and donating these electrons to 
complex III 43. Further, MEN can accept electrons from complex I and reduce molecular 
oxygen. This can lead to an uncontrolled NADH consumption and an increased generation of 
radicals. Both MEN and rotenone showed an increase of Rho-123 uptake while exposure to a 
combination of these agents induced an extra increase of the MMP. An explanation for this 
observation may be that the combination of rotenone and MEN induce a higher rate of radical 
production than treatment with MEN or rotenone alone. Increased levels of radicals result in a 
higher rate of pyridine oxidation, thiol oxidation and release of Ca2+.
Antimycin blocks the transfer of electrons from the cytochrome b562 of complex III to the 
ubisemiquinone in order to regenerate ubiquinol. Ubisemiquinone is considered to be a source 
of radicals in antimycin treated mitochondria 40,44 In our experiments, we did not observe an 
effect of antimycin on the MMP. It is possible that the radical production in antimycin-treated 
mitochondria is too low in comparison to effect of MEN and no effect on the MMP is 
detectable. Exposure of mitochondria to MEN and antimycin resulted in significantly higher 
uptake of Rho-123 than with MEN-treated mitochondria. The oxidation of MEN can no longer 
proceed via the ubiquinone-pathway but the electrons are donated directly to oxygen. The 
increased Rho-123 uptake with antimycin and MEN may therefore be the result of a higher 
radical production.
Highly proliferating intestinal cells including the Caco-2 cell utilise besides glucose other 
substrates like glutamine as substrate for the oxidative phosphorylation. The mitochondrial 
matrix enzyme glutaminase can convert glutamine into glutamate, which enters the citric acid 
cycle via succinate 45. The MEN-induced increase of the MMP was completely suppressed by 
inhibition of complex II with TTFA. This indicates that succinate dehydrogenase is the 
predominant dehydrogenase that becomes activated in Caco-2 cells suffering from oxidative 
stress. Similarly, glutamine delayed the onset of cell death in MEN-exposed hepatocytes 2 
Further evidence for a role of glutamine follows from the observations made during necrotic 
cell death induced by the cytokine TNF. A major step in the cytotoxic mechanism of TNF is the 
formation of reactive oxygen species in the mitochondria. Their crucial role was demonstrated 
by the interference of inhibitors of the electron transport chain with the necrotic response 46. 
Recently, it was shown that glutamine utilising L929 cells were more sensitive to TNF than 
glutamine-deficient cells. These cells displayed a higher mitochondrial activity and an 
enhanced production of reactive oxygen species 47
In summary, MEN induced a dose-dependent increase of the MMP, which is prevented by 3- 
ABA, an inhibitor of PARP and the mitochondrial NAD+-glycohydrolase. This shows that 
preservation of the cellular NAD+-content plays a pivotal role in the maintenance of the MMP 
in the toxicity of MEN. Inhibition of complex I by rotenone and complex III with antimycin 
potentiated the MEN-induced rise of the MMP while the increase of the MMP was completely 
suppressed by the inhibition of complex II with TTFA. This indicates that the MEN-mediated 
loss of complex I activity is an inducing factor for the succinate dehydrogenase activity of 
complex II.
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Abstract - Apoptosis was induced in coloncarcinoma cell-line Caco-2 by low concentration of 
the redox cycling quinone menadione. Cell cycle analysis revealed no G 1 arrest and cells 
seemed to disappear at the G2/M phase. A G® T transition was found at codon 204 of the 
tumor suppressor gene p53 resulting in a change of a glutamine in a stopcodon. Apoptosis in 
Caco-2 cells is presumably p53-independent but dependent on synthesis of macromolecules 
since cycloheximide was able to inhibit apoptosis. Pre-treatment with the antioxidants trolox or 
N-acetylcysteine reduced the rate of apoptosis. The results support the hypothesis that oxidative 
stress induces p53-independent apoptosis.
Introduction
Apoptosis in the intestine has been identified as a disposal mechanism for redundant cells 1. 
With a genotoxic insult like irradiation and exposure to alkylating agents, the rate of apoptosis 
was dramatically increased 2-7 Such DNA-damage causes p53 levels to rise which induces 
growth arrest and allows the cell to repair its damaged DNA or to undergo apoptosis 6. The 
efficacy of anticancer drugs is believed to be closely related to the p53 status of the tumour 8. 
As a complication, P53 mutations are found in 50-55% and 75% of all human cancers and 
colorectal cancers, respectively 9.
The role of oxidative stress in apoptosis is not entirely clear. Apoptosis is observed during 
exposure to a variety of chemicals or conditions that are known for their ability to generate 
oxidative stress 10-12 Further, in some cases antioxidants were able to prevent or delay 
apoptosis 13-18. Several reports suggest that the proto-oncoprotein Bcl-2 has antioxidant 
properties or can prevent the formation of reactive oxygen species and in this way inhibit 
apoptosis 10,18-20
Menadione (MEN) is toxic to cells by endogenous generation of reactive oxygen species and 
arylation to cellular thiols 21. Although MEN has been reported to be mutagenic in Salmonella 
tester strain TA104 22, no initiation of carcinogenesis was observed in rat liver 23. MEN was 
shown to exhibit anticancer activity in rodents and human cancer cell lines, a variety of patient 
tumor explants 24,25. Further, MEN was combined with mitomycine C in order to modulate the 
glutathione mediated resistance to alkylating agent chemotherapy with modest success in phase
II trial 26,27 Quinones used in cancer therapy with similar mechanisms of toxicity were found to 
induce apoptosis in HeLa cells , and coloncarcinoma cell lines HT29 and BE .
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Nothing is known about the involvement of oxidative stress in the apoptotic mechanism in 
the intestine and in particular of cells derived from the intestinal tract. So we used the colon- 
derived coloncarcinoma cell line Caco-2 as a model to study the effects of exposure to MEN on 
the intestinal epithelium. Microscopical examination showed beside necrosis the presence of 
non-necrotic cells with typical apoptotic morphology. In this report, we describe a p53- 
independent apoptotic pathway that is activated by oxidative stress and inhibited by 
antioxidants.
Materials and Methods
Chemicals and Materials. MEN was purchased from Aldrich (Milwaukee, USA). 
Monobromobimane was from Calbiochem (La Jolla, USA). Other chemicals and enzymes were obtained 
were from Sigma (St. Louis, USA). All chemicals were of analytical grade. All cell culture materials were 
purchased from ICN (Costa Mesa, USA), except for flasks and tissue culture plates that were from 
Greiner (Alphen a/d Rijn, NL) and gentamicine (Centrafarm, Etten-Leur, NL).
Cell culture and incubation. Caco-2 cells were maintained at 37 °C in DMEM, containing 10% (v/v) 
fetal bovine serum, 10 mM HEPES, 1% nonessential amino acids, 5 mM L-glutamine, 5 ^g/ml 
gentamicine in an atmosphere containing 5% CO2. 1x105 cells were seeded in 24-wells culture plates for 
biochemical assays and in Leighton tubes for microscopical examination. Cell cultures were supplied with 
fresh medium every 24h and used on third day. Incubations with MEN were performed in 24 wells 
tissue plates in an atmosphere as described as above. Cells were washed with Krebs-Henseleit buffer 
(KH, formulation in mM: 1.2 MgSO4.7H2O, 2.5 CaCl2.2H2O, 4.7 KCl, 94 NaCl, 11.6 D-glucose, 25 
NaHCO3, 1.2 KH2PO4 and 5 L-Glutamine, pH 7.4) and supplied with 0.5 ml KH. Substrates were 
added in dimethylsulfoximide (0.3% of final volume).
Determination o f Apoptosis. Cells were incubated with 20 ^M propidium iodide (PI) and 20 ^M 
Hoechst 33258 (bisbenzimide) for 30 min at 37 °C. Morphology of ±500 nuclei was evaluated with 
fluorescence microscopy (Axioskop with Plan-Neofluar objectives, Zeiss, Germany). Penetration of PI 
into the nucleus was considered as a marker for necrosis. Apoptosis was expressed as percentage cells 
with apoptotic nuclei of total number of cells.
Cell cycle analysis. After treatment with MEN, cells were trypsinized and washed with PBS. The 
pellet was resuspended in 0.5 ml ice-cold hypotonic solution containing 0.87 mg/ml sodium citrate- 
dihydrat, 0.1 mg/ml ribonuclease A, 20 mg/ml propidium iodide and 0.1% triton X-100. Cell were kept 
on ice overnight and the DNA content of 6000-10000 cells was estimated on a Coulter Epics Elite 
(Coulter, Hialeah, USA, 1ex=488 nm, 15 mW; 1em=610 nm).
PCR-SSCP and sequence analysis. PCR-SSCP analysis was performed to investigate p53 mutations 
in exons 5-9 31. Exons 8 and 9 were amplified together. The intron primers for amplification were: exon 
5, sense, 5’-TCA CTT GTG CCC TGA CTT-3’; antisense, 5’-GAG GAA TCA GAG GCC TGG-3’; 
exon 6 , sense, 5’-GAG ACG ACA GGG CTG GTT-3’; antisense, 5’-GAG ACC CCA GTT GCA AAC- 
3’; exon 7, sense, 5’-CCA AGG CGC ACT GGC CTC-3’; antisense, 5’-GCG GCA AGC AGA GGC 
TGG-3’; and exon 8 and 9, sense, 5’-CCT TAC TGC CTC TTG CTT-3’; antisense, 5’-AAA CTT 
TCC ACT TGA TAA-3’.
DNA was isolated with the QIAamp tissue kit (Qiagen, Chatsworth, USA). A 2 ^l aliquot of purified 
DNA was subjected to 40 cycles of PCR; 0.5 min at 95 °C, 2 min at 55°C and 1.3 min at 72°C.
Exon 5,6,8, and 9 were amplified in a 50 ^l solution containing 50 mM KCl, 10 mM Tris-HCl (pH 
8 .8), 1.75 mM MgCl2, 250 ^M deoxynucleotide triphosphates, 10 pmole of each primer, 3 ^Ci [a- 
32P]dATP and 1.5 units Taq polymerase ( Perkin Elmer, Norwalk,CT, USA). Exon 7 was amplified in 
the same buffer containing 1.4 mM MgCl2.. Five ^l of the PCR product were diluted in 15 ^l loading 
buffer (96% formamide, 20 mM EDTA, 0.05% bromophenol blue, and xylene cyanol), boiled for 3 min, 
and then quenched (10 min) on ice before loading (2 l^/lane). Each sample was applied to a 5% 
polyacrylamide (49:1)/Tris-Borate EDTA (0.5x) gel with 10% (v/v) glycerol. Subsequently, 
electrophoresis was performed at room temperature for 16h at 6 W (exons 8 and 9) and 5 W (exons 5­
7).
Sequencing of the double-stranded PCR products that showed a mobility shift on the SSCP gel was 
performed as follows. Direct sequencing of the amplified product was performed in cases where the
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intensity of the mutant DNA fragment was >50% of the wild type DNA fragment. Whenever the 
intensity of the shifted DNA fragment was <50%, the mutant fragment was excised from the 
polyacrylamide gel and the gel piece was immersed in 100 ml of a 20 mM Tris (pH 8.0), 1 mM EDTA 
solution and heated at 80°C for 15 min,. The extract was briefly vortexed and incubated overnight at 
4°C. After brief centrifugation, 10 ml of the supernatant were subjected to PCR reamplification for 45 
cycles.
Before sequencing, the amplified PCR products were subjected to electrophoresis on a 2% low- 
melting agarose gel and further purified with the Magic Preps DNA purification system (Promega, 
Madison, WI). For sequencing in the AmpliCycle system (Perkin Elmer), we used internal primers: exon
5, sense, 5’-TGT CTCCTT CCT CTT CCT AC-3’; exon 6, sense, 5’-GGT CCC CAG GCC TCT 
GAT TC-3’; exon 7, sense, 5’-TCT TGG GCC TGT GTT GTC TC-3’; exon 8 , sense, 5’-TTG CTT 
CTC TTT TCC TAT CC-3’; exon 9, sense, 5’-CAC CTT TCC TTG CCT CTT TC-3’. Electrohoresis 
was performed was performed on a 6% polyacrylamide (19:1) gel containing 7 M Urea.
Cellular ATP and NAD+ content. ATP and NAD+ were separated using a Spectra-Physics HPLC 
system consisting of a SP8800 ternary pump, a SP8875 autosampler and a SP4600 integrator. Cells 
were treated with 300 ml 5% (v/v) perchloric acid and neutralised with 700 ml 0.8 M potassium 
phosphate buffer. Insoluble material was removed by centrifugation (5 min, 13000 g) and stored at -80 
°C until use. 20 ml extract were injected on a Spectra Physics HPLC system using a Chrompack 15 cm 
5RP18 column at 40 °C and a flow of 1 ml/min. The elution buffer was a 0.1 M potassium phosphate 
buffer, pH 6.0 and was filtered through a 0.45 mm filter before use. ATP and NAD+ were detected by a 
Kratos Spectroflow 773 UV detector at 260 nm.
GSH, GSSG, RSSG, extracellular GSH and extracellular GSSG. Reduced glutathione was 
determined by HPLC after derivatization with monobromobimane (mBBr) as described by Cotgreave 
and Moldeus 32. After incubation cells were washed with KH and 100 ml aqua pure was added to the 
well. GSH was derivatized by adding 100 ml 2 mBBr dissolved in 50 mM N-ethylmorpholine and 
incubating this mixture for 5 min in the dark. Protein was denaturated by inclusion of 25 ml 40% 
trichloroacetic acid (TCA) en removed by centrifugation (5 min, 13.000 g). For determination of RSSG, 
500 ^l of cell material were precipitated with 25 ml 40% TCA and separated by centrifugation. The pellet 
was washed 3 times with 500 ml 5% TCA and resuspended in 100 ml 1% SDS in PBS. After 
neutralisation with 10 ml saturated NaHCO3, mixed disulphides were reduced with 5 ml 25 mM 
dithiothreitol (DTT). After 45 min incubation, GSH was labelled with 100 ml 5 mM mBBr and measured 
as described. In order to measure total GSH (GSH+GSSG+RSSG), 100 ml cell material were treated 
with 10 ml 20% TCA to inactivate GSH metabolising enzymes. After buffering with 100 ml 1 M sodium 
biphosphate (pH 6.0), 100 ml sample were reduced with 10 ml 25 mM DTT and labelled with 100 ml 10 
mM mBBr. GSSG was calculated using the equation: GSSG=TGSH-GSH-RSSG.
For the determination of extracellular and total extracellular glutathione (GSH+GSSG), 250 ml aliquots of 
KH buffer were taken at the appropriate time from the culture plate. Extracellular GSH was quantified 
by a direct derivatization of 100 ml buffer with 100 ml 2 mM mBBr and proteins were removed by 
adding 10 ml 40% TCA. For the estimation of total extracellular GSH, 100 ml KH were reduced with 10 
ml 25 mM DTT in 45 minutes at room temperature. The mixture was labelled with 100 ml 5 mM mBBr 
and deproteinized with 10 ml 40% TCA. Extracellular GSSG was calculated by subtracting extracellular 
GSH from total extracellular GSH.
Glutathione derivatives were separated by HPLC under the conditions described above using a 
5RP18 column at 40 °C and a flow rate of 1 ml/min. Buffer A was 128 ml methanol and 2.5 ml acetic 
acid diluted to 1 l with aqua pure, adjusted to pH 3.9 with 5 N NaOH. Buffer B was 900 ml methanol 
and 2.5 ml acetic acid, diluted to 1 l with aqua pure. A linear gradient from 0% B at 0 min, 50 % B at 8 
min to 0 % B at 17 min was used to elute the GSH derivatives that were detected using a Shimadzu RF- 
530 fluorescence detector at 1ex=385 nm and 1em=480 nm.
Cellular Protein. Cellular protein was quantified with the Bradford method 33 using BSA as a 
standard.
Statistical analysis. Results are expressed as means ± SD of three to six independent experiments. 
Statistical significance between two groups was determined by means of an unpaired Student’s-t-test. 
Statistical differences between groups were determined by means of a one-way analysis of variance 
(ANOVA), followed by Dunnett’s multiple-comparison test. A probability of P 0.05 was considered 
significant.
113
P53-independent Apoptosis in Coloncarcinoma Cell-line Caco-2
Results
With fluorescence microscopy and the use two different dyes, four distinct populations of 
cells could be discriminated in the incubates of MEN-treated Caco-2 cells. Bisbenzimide 
(Hoechst 33258) is a membrane permeable stain and is fluorescent after binding to especially 
A-T regions of the DNA of all nuclei. This dye facilitates the morphological examination of the 
nucleus which can be non-dividing, dividing (when chromosomes can be distinguished) or 
condensed/fragmented. Necrosis was discriminated from apoptosis by the use of propidium 
iodide since this dye can only penetrate the membranes of necrotic cells. Primary necrosis was 
characterised by round, sometimes enlarged bright orange-coloured nuclei, while secondary 
necrosis was recognisable as cells with orange-coloured condensed and fragmented nuclei. The 
images in figure 7.1 show examples of all four types of cell death. Typically, apoptotic cells 
seemed to round up and detach from the substrate. The greater part of the detached cells in the 
culture medium were necrotic or secondary necrotic.
Figure 7.1. (See inserted photopage). Effect o f MEN on Caco-2 cells. Caco-2 cells were cultured and 
treated as described in material and methods. After a 2 hours incubation fluorescent images were taken 
of control (A) and MEN-treated (25 mM) (B) Caco-2 cells. Note the fragmented nuclei in (B) indicated 
by arrows and the red-stained nuclei of necrotic cells indicated by arrowheads. Magnification: 250x.
Apoptosis is generally considered to be an active process and in many cases, protein 
synthesis is a precondition for this type of cell death. In order to investigate the involvement of 
protein synthesis in MEN-induced apoptosis in Caco-2 cells, the protein synthesis inhibitor 
cycloheximide (CHX) was applied together with MEN. Figure 7.2 shows that about 15% of the 
cell culture is apoptotic after 1 hour of exposure to 25 mM MEN and remained so in the further 
course of the experiments. CHX was able to reduce the rate of apoptosis induced by MEN (fig 
7.2). This effect was significant up to 4 hours of exposure. The results show that protein 
synthesis is involved in MEN-induced apoptosis. Since the rate of apoptosis is only diminished 
by CHX and not totally inhibited is an indication that proteins involved in the apoptotic process 
are to some extent present in the cell. Exposure of cells to CHX or DMSO alone did not change 
the number of apoptotic cells compared to non-exposed cells and was less than 0.5% in all 
experiments (data not shown).
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Figure 7.2. Effect o f cycloheximide on MEN-induced apoptosis. Apoptosis was determined as described 
in material and methods. Caco-2 cells were incubated with 25 (iM MEN in the absence ( I I) or 
presence (CHI) of the protein synthesis inhibitor cycloheximide (50 |ig/ml). Shown are the means ± SD 
of three independent experiments.
To investigate to functionality of the cellular checkpoints, cell cycle analysis was performed 
on MEN-treated Caco-2 cells. If the P53 protein still has biological activity, an increase of 
cells in the G1-phase of the cell cycle would be expected. Figure 7.3 shows that no increase of 
cells in the G1-phase was found during 4 hours of exposure to 25 |iM MEN indicating that p53 
in the Caco-2 cell-line is not active. Instead of a G1 blockade, cells entered the S-phase and 
started to synthesise DNA. Further, exposure to MEN induced a rapid decline in the number of 
cells in the G2/M phase.
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Figure 7.3. Flow cytometric analysis o f the cell cycle distribution. Caco-2 cells were treated and 
analysed for DNA content as described in material and methods. The cell phase of control (A) and MEN 
treated (25 mM) (B) cells was determined as G1 (circle), S (square) and G2/M (triangle). Shown is one 
representative experiment of three.
98% of base substitution mutations in p53 found in tumours occur in a 600 base pair region 
of the gene product (codons 110 to 307). This sequence encompasses exons 5 through 8 , where 
most of the evolutionarily conserved amino acids are concentrated 9. Considering the fact that 
Caco-2 cell-line is derived from a coloncarcinoma, we wanted to know if the p53 was still 
intact and is involved in the induction of apoptosis. PCR-SSCP analysis of exons 5 through 9
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was performed on DNA isolated from Caco-2 cells. Figure 7.4a shows in lane C, next to the 
wild type fragments (A and B) that correspond to exon 6 , a clear mobility shift. Further 
sequence analysis revealed a G® T transition at codon 204 resulting a change of a glutamine to 
a stopcodon (fig. 7.4b)
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Figure 7.4. Genetic analysis o f the p53 o f the Caco-2 coloncarcinoma cell-line. PCR-SSCP analysis 
of exon 6 of p53 (left). Lane A and B are wild type p53, lane C is from the Caco-2 cell line. Figure b 
depicts the sequence analysis of exon 6 . Note the G^T transition at codon 204.
MEN is toxic to cells by its ability to generate intracellular free oxygen radicals. We were 
interested whether pre-treatment of cells with antioxidants could prevent apoptosis. For this 
purpose we used the water-soluble vitamin E-analogue trolox and the thiol and GSH precursor, 
N-acetylcysteine (NAC). Figure 7.5 shows that the rate of apoptosis is diminished by both 
antioxidants, although the effect of NAC is stronger.
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Figure 7.5. Effect o f antioxidants on MEN-induced apoptosis. 10 mM N-acetylcysteine (A) or 10 mM 
trolox (B) were applied to Caco-2 cells 1 hour prior to 25 ^M MEN exposure. After 1 hour, antioxidant 
containing buffer was removed and cells were washed three times. Controls cells were pre-treated with 
KH-buffer alone. Depicted are control flZZI) and antioxidant pre-treated (^H) Caco-2 cells. Shown are 
the means ± SD of three independent experiments (*: p<0.05; **: p<0.01).
The energy metabolism of cells is particularly vulnerable to both oxidative stress and 
arylation. Several reports connect dysfunction of the mitochondria or glycolysis with apoptosis 
34 We were interested in the effect of NAC and trolox on the ATP and NAD+ contents of Caco-
2 cells after exposure to MEN. To our surprise, pre-treatment of cells with trolox resulted in 
even lower cellular ATP levels after MEN than their controls (fig. 7.6a). With NAC and MEN
9 -
6 —
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however, cells did contain significantly more ATP than the cells exposed to MEN only. Both 
antioxidants were unable to protect the cells from depletion of NAD+ (fig. 7.6b).
A  B
Figure 7.6. Effect o f antioxidants on intracellular ATP and NAD+ levels in Caco-2 cells after 2 hours 
MEN treatment. 10 mM N-acetylcysteine or 10 mM trolox were applied to Caco-2 cells 1 hour prior to 
25 pM MEN exposure. After 1 hour, antioxidant-containing buffer was removed and cells were washed 
three times. Controls cells were pre-treated with KH-buffer alone. The bars represent the ATP (left) and 
NAD+ (right) levels of control cells (I I). NAC pre-treated (EZZ3) and Trolox pre-treated (I , cells. 
Shown are the means ± SD of four independent experiments (*: p<0.05).
MEN depleted cellular glutathione levels in Caco-2 cells as shown in figure 7.7a and 7.7b. 
Both intracellular reduced glutathione and the total glutathione levels were decreased. This loss 
can be attributed to MEN‘s ability to arylate cellular thiols including glutathione Pretreatment 
of Caco-2 cells with the thiol N-acetylcysteine partly protected cells from this depletion in 
contrast to trolox. Compared to the controls, pre-treatment of cells with either NAC or trolox 
led to higher GSSG contents at expense of reduced glutathione. Although protein-bound 
glutathione (RSSG) and extracellular glutathione (ExGSH and ExGSSG) levels were relatively 
low. Exposure to 25 pM MEN resulted in all cases to lower GSH contents. A small protective 
effect was found with NAC-pre-treatment. Interestingly, beside GSSG, high amounts of reduced 
glutathione appeared in the extracellular fluid. In case of N-acetylcysteine pre-treated cells, the 
extracellular GSH was higher than with trolox. With both antioxidants cells were able to retain 
more GSSG than untreated cells.
Previously, we demonstrated the protective effect of 3-ABA in MEN toxicity (chapter 5). 3- 
ABA prevented by a competitive inhibition of PARP the extensive depletion of NAD+, which 
than remained available for the synthesis of ATP. NAC pre-treated Caco-2 had cells higher 
levels of ATP compared to control cells after 2 hours of exposure to MEN and this correlated 
with reduced apoptosis. To determine whether the action of PARP is involved in apoptosis we 
added 3-ABA at intervals of 15 min to MEN exposed cells and assessed apoptosis after 2 
hours. Addition of 3-ABA alone did not have an effect on the viability or morphology of cells. 
As depicted in figure 7.8, the inhibitory effect of 3-ABA on apoptosis was strongest when 
added simultaneously with MEN. An increasing number of apoptotic cells was found when 3- 
ABA was added later and no effect was found after 1 hour of MEN exposure.
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Figure 7.7. Effect o f antioxidants on the glutathione status in Caco-2 cells after 2 hours MEN 
treatment. 10 mM N-acetylcysteine (left) or 10 mM trolox (right) were applied to Caco-2 cells 1 hour 
prior to 25 pM MEN exposure. After 1 hour, antioxidant containing buffer was removed and cells were 
washed three times. Controls cells were pre-treated with KH-buffer alone. Depicted are reduced 
glutathione (□), protein-bound glutathione(L_J ), oxidised glutathione (I I ), extracellular reduced 
glutathione (I I) and extracellular oxidised glutathione Shown are the means ± SD of six
independent experiments (*: p<0.05 compared to controls; #: p<0.05 compared to MEN treated cells).
Time of 3-ABA addition (min)
Figure 7.8. Inhibition o f MEN-induced apoptosis by 3-aminobenzimide. Number of apoptotic cells was 
determined after 2 hours of MEN treatment. Bars are MEN (I l} or MEN and 3-ABA Q  Shown 
are the means ± SD of four independent experiments (**: p£0.01).
Cells were incubated with 5 mM mBBr 30 minutes prior to examination. This dye can easily 
penetrate membranes and will become fluorescent after binding to cellular thiols including 
GSH and cysteine. The morphology of the nuclei and viability were visualised by bisbenzimide 
and propidium iodide respectively. Figure 7.9 (C) shows that control cell contain high 
concentration of thiols. Exposure to MEN resulted in a rapid decrease of free thiols presence 
(fig. 7.9. D.). Especially necrotic cells (PI+ cells) show a translucent cytoplasm. To our 
surprise, all cells with apoptotic nuclei contained a considerable amount of fluorescent dye, 
implicating the presence of free reduced GSH in apoptotic cells.
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Figure 7.9. (See inserted photopage). Direct visualisation o f reduced thiols in Caco-2 cells. Caco-2 
cells were cultured and treated as described in material and methods. 5 minutes prior to examination 2 
mM monobromobimane was added to the cells in order to stain cellular thiols. After a 2 hours incubation 
fluorescent images were taken of control (C) and MEN-treated (25 pM) (D) Caco-2 cells. Note that cells 
with fragmented nuclei in (D) as indicated by arrows contain high levels of reduced thiols. Necrotic cells 
as indicated by arrowheads are depleted of reduced cellular thiols.
Discussion
In this report we have shown that cells of the colon carcinoma cell line Caco-2 rapidly enter 
apoptosis upon exposure to the redoxcycling and alkylating agent MEN. The viability of 
apoptotic cells was microscopically assessed with propidium iodide to ensure that membrane 
structure is still intact. Since apoptosis is an active process, synthesis of certain 
macromolecules is necessary to induce apoptosis. Although the use of cycloheximide is 
debatable, it is often used to inhibit protein synthesis to prove that this process is involved in 
apoptosis. In some cases cycloheximide CHX was found to induce apoptosis rather than inhibit 
it 35. In most of these cases, CHX was present for prolonged period and it is conceivable that 
inhibition of protein synthesis is not reconcilable with survival of cells. Short-term inhibition of 
protein synthesis was successful in reducing apoptosis in Caco-2 cells.
Although the Caco-2 displays typical morphological characteristics of apoptosis no 
internucleosomal fragmentation was found. The fragmentation of DNA into 180-200 base pair 
fragments is often considered to be a biochemical hallmark of apoptosis but this may well be a 
misconception. Apoptotic epithelial cells and thymocytes showed large fragments of 300 and
50 kb prior to a possible fragmentation to 200 integers 36,37. Moreover, morphological features
36 38 39
of apoptosis may occur in the absence of internucleosomal DNA fragmentation , , . Schulze­
Osthoff et al 40 showed that enucleated cells reveal morphological features of apoptosis after 
treatment with anti-APO-1 antibody or MEN. Several groups found that the coloncarcinoma 
cell line HT-29 displayed a 180-200 base pair ladder only after detachment from the monolayer 
30,41,42 Internucleosomal DNA fragmentation may well be absent in the Caco-2 cell-line or may 
take place after detachment from the monolayer.
The p53 gene and its protein product are frequently associated with apoptosis induced by 
DNA damage. The action of the p53 tumour suppressor protein is the transcription of the 
WAF1/CIP1 gene. The resulting protein P21 is a strong inhibitor of cyclin-dependent kinases of 
all stages in the cell cycle 43,44 The most investigated point of action is the p21-dependent G1 
arrest in which a cell can repair its DNA or undergo apoptosis. MEN is capable of inducing 
DNA damage 45,46 and should activate p21. Administration of MEN did not increase the number 
of cells in the G1-phase of the cell cycle and may imply a defective G1 checkpoint.
Sequence analysis showed a G® T transition at codon 204 resulting in a change of glutamine in 
stopcodon. The corresponding protein in the Caco-2 cell-line may therefore be truncated in the 
central domain, which contains the sequence-specific DNA binding site 47-49 Further the protein 
lacks the C-terminal domain which is responsible for p53 oligomerization and binding to both 
single-stranded DNA and RNA 48,50-52. Considering the gravity of the mutation, it is unlikely that 
p53 is of biological importance in the Caco-2 cell-line.
There is growing evidence that cells with a defective p53 gene are still able to undergo 
apoptosis. HL-60 cells lack endogenous p53 53 and are still able to rapidly undergo apoptosis 
after DNA damage 54. Thymocytes of p53 deficient mice were resistant to induction of 
apoptosis by radiation and the topoisomerase inhibitor etoposide, but retained normal 
sensitivity to glucocorticoids and calcium 55. p53-deficient mice show similar levels of 
spontaneous apoptosis in the gastrointestinal tract as the wild type mice but irradiation failed to 
induce apoptosis. In wild type mouse, the p53 gene expression correlated with the observed
119
P53-independent Apoptosis in Coloncarcinoma Cell-line Caco-2
apoptosis only in the small intestine but not in the colon 5,56 Since Caco-2 cells derive from the 
human colon, it is possible that the mechanism of p53-independent apoptosis is still present in 
this cell line.
P53-independent apoptosis may involve a bypass in the activation of p21/WAF1/Cip1 
activation. Several groups have shown that TPA, a phorbol ester that activates protein kinase C 
(PKC), induces a significant increase in the concentration of WAF1/CIP1 mRNA 57,58. Quinones 
like MEN can activate PKC 59 We found that the PKC-inhibitor staurosporine alone or in 
combination with MEN had no effect on apoptosis in Caco-2 cells, which excludes the 
involvement of PKC (data not shown). Another possibility may be the involvement of other 
signalling pathways like mitogen protein kinases. Michaeli et al 60 showed the involvement of a 
p53- and protein synthesis independent activation of WAF1/CIP1 in embryonic fibroblast after 
treatment with mitogens like EGF. This mechanism may not be involved in Caco-2 cells 
because cycloheximide decreased apoptosis in this cell-line. Further, diethylmaleate induces 
oxidative stress by depletion of cellular GSH and induces apoptosis in human Saos-2 and T98G 
cells. This type of apoptosis was found to be p53 independent, although p21 was directly 
activated by the mitogen-activated protein kinase ERK2 61.
The rapid decline of the number of cells in the G2/M phase may point at an intact G2- 
checkpoint in this cell-line and that cells enter apoptosis at this point. The G2 checkpoint was 
shown to be p53 independent in earlier studies 53. Crypt cells of irradiated p53 deficient mice 
showed a normal G2 arrest and a drop in mitosis 5. The coloncarcinoma cell line PC/JW and 
colonadenoma cell line S/RG/C2 are both deficient in p53 but showed a G2 arrest after 
irradiation 7 The main regulator of the G2-M transition is the p34cdc2 kinase 62 Okadiac acid 
(OA), an inhibitor of protein phosphatase PP1 and PP2A activates p34cdc2 and induces a 
premature state of mitosis in many types eukaryotic cells. Boe et a l 63 described the 
morphologic induction of apoptosis by OA in leukemic cells, hepatocytes, rat pituitary 
adenoma, human mammary carcinoma and human neuroblastoma cells. The same report 
describes that chromatin condensation in hepatocytes occurred without internucleosomal 
fragmentation. Other investigators reported OA induced apoptosis in rat kidney epithelial cell 
line NRK-52 with the appearance of 300 kbase pair fragments 64 Recently, it was reported that 
phosphatase inhibitors are involved in the activation of proteases of the ICE-family, which are 
critical activators of apoptosis 65. Phosphatase activity may play a role in MEN induced 
apoptosis since it was shown that MEN had a clear inhibitory effect on phosphatase activity in 
the HepG2 cell line 66 Further, hydrogen peroxide was found to inhibit protein tyrosine 
phosphatase activity in Her 14 cells 67. Interestingly, increased p34/CDC2 kinase activity was 
observed in dexamethasone induced apoptotic thymocytes and APO-1 (Fas/CD95) induced 
apoptosis in B cell-line SKW 6.4 68. All together, this may implicate a general apoptotic 
pathway, which includes a premature activation of p34cdc2 kinase next to p53-dependent 
apoptosis as suggested by Shi et a l69
Although both antioxidants were able to reduce the number of apoptotic cells, only a slight 
improvement of the cellular GSH content was observed NAC treated cells. The higher level of 
ATP in these cells may reflect the protective action of NAC on the crucial thiols in energy 
producing pathways 70 Direct visualisation of GSH in cells by fluorescence microscopy 
revealed the presence of high levels of reduced GSH in all apoptotic cells. This may rule out 
the possibility that antioxidants directly protect cells from apoptosis by improving their cellular 
GSH status. An explanation for the reduction of apoptosis in these cases may be the 
modification of the redox state of several transcription factors. The activation and nuclear 
translocation of NFkB involve the reactive oxygen intermediates and can be inhibited by high 
concentrations of NAC (20-30 mM) 71,72. Extracellular cysteine supply raised the intracellular 
GSSG levels in Molt-4 cells and GSSG was found to be a direct inhibitor of DNA binding 
activity of NFkB 73. Indeed, Caco-2 cells that were pre-treated with NAC or Trolox had high
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levels of intracellular GSSG. It is possible that these higher levels of GSSG can alter the redox 
state of transcription factors like NFkB and thus prevent apoptosis.
At lower concentrations, MEN and related quinones induce necrotic cell death via PARP 
(Chapter 5). PARP is supposed to be involved in DNA repair and in the supervision of the 
genome structure and integrity in stressed cells. In the presence of nicked DNA, PARP 
catalyses the conversion of the dinucleotide NAD+ to nicotinamide and protein-linked chains of 
ADP-ribose 74 Intensive DNA damage results in massive activation of PARP, which can 
deplete the cellular NAD+ and induce ATP depletion and necrotic cell death 75. The role of 
PARP in apoptosis is still unclear but some studies have found that PARP inhibitors delay or 
prevent apoptosis 74,76 In our study, both antioxidants did not prevent the intensive depletion of 
NAD+ by ADP-ribosylation. This depletion of NAD+ indicates that protection from apoptosis 
offered by trolox and NAC is not related to PARP. However PARP seems to be involved in 
initiation of MEN-induced apoptosis. 3-ABA, a relative selective and non-toxic inhibitor of 
PARP, reduced apoptosis when added simultaneously with MEN. Addition of 3-ABA at a later 
time resulted in less inhibition of apoptosis and after 45 minutes no inhibitory effect of 3-ABA 
was observed. This may support the hypothesis that PARP has a sort of signalling function in 
the early apoptotic process as proposed by Nosseri et a l 76. Of other importance is the PARP- 
induced histone shuttling which facilitates the access of endonucleases to the chromatin 77,78. In 
a later stage (before internucleosomal DNA fragmentation) ICE-like proteases are activated in
"7Q O -i-  0  I
apoptotic cells and cleave PARP . The Ca /Mg dependent endonuclease implicated in the 
apoptotic internucleosomal DNA fragmentation is negatively regulated by PARP 54 Loss of 
PARP in a later stage of apoptosis results in the activation of this endonuclease. Further, 
inactivation of PARP preserves cellular NAD+ and consequently ATP, which benefits the 
completion of the apoptotic process. The loss of PARP may be the reason for the 
ineffectiveness of 3-ABA in a later stage of apoptosis. However, it is evident that PARP is 
involved in the initiation of MEN-induced apoptosis and serves no further role in the 
continuation of apoptotic process.
In conclusion, Caco-2 cells are able to undergo p53-independent apoptosis after exposure to 
MEN. The mechanisms of this apoptotic process involve protein synthesis and ADP- 
ribosylation. Although antioxidants like trolox and NAC can inhibit MEN-induced apoptosis, 
apoptotic cells still contain considerable amounts of GSH. Cells may enter apoptosis at the 
G2/M phase of the cell cycle since this population disappears after MEN treatment. The 
possible role of cellular phosphatases is discussed in this report. The results give a further 
support to the hypothesis that oxidative stress can induce apoptosis.
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Chapter 8
Summary and Concluding Remarks.
Oxidative stress in the intestinal tract may arise from pathophysiological conditions such as 
ischemia-reperfusion or from xenobiotics that enter the intestine as food contaminants or drugs. 
Biotransformation generally converts lipophilic xenobiotics into more polar and excretable 
compounds. However, in some case biotransformation reactions can produce toxic metabolites. 
On the other hand, xenobiotics may participate in the cellular metabolism and become 
cytotoxic. Quinones are such compounds and are substrate for reducing enzymes and may 
covalently bind to cell constituents. Reduced quinones can transfer electrons to oxygen and 
initiate the generation of several toxic reactive oxygen species (ROS). The level of ROS 
generation, detoxification by antioxidant mechanism and the site of cellular injury determines 
cellular damage. Severe damage may result in loss of cell functions, programmed cell death, 
necrotic cell death or even inflammatory responses. Understanding of the processes involved in 
arylation and ROS-induced cell injury and the subsequent cellular reactions provides an 
opportunity for therapeutic intervention in pathophysiological situations or as an entry for the 
development of new drugs for treatment of carcinomas.
In Chapter 2, experiments are described in which isolated enterocytes from the rat small 
intestine were treated with quinones. We showed that exposure to quinones induced a rapid fall 
in GSH and the appearance of oxidised GSH and mixed protein disulphides which indicates 
oxidative stress. ATP depletion and severe cell membrane damage accompany the alterations in 
the thiol metabolism. Further, arylating and redoxcycling quinones (MEN and NQ) proved to be 
more toxic than pure redoxcyclers (DIM). The isolation procedure allowed a comparison 
between enterocytes from the crypts, halfway the villus and the villus tip. The toxicity of DIM 
was less in crypt cells in comparison with villus cells. This was in agreement with the higher 
antioxidant capabilities like DT-diaphorase activity and GSH levels in crypt cells. A constant 
release of reduced GSH from the cells into the medium was observed with control cells which 
was inhibited by the three quinones used in this study. The mechanism of this release is 
unknown but it is not related to ATP and GSH-depletion.
Unlike other cell types like hepatocytes, rat small intestinal cells are difficult to isolate. 
Viability of isolated exposed cells decreased by 20% in 60 minutes. The isolation method used 
for the experiments described in chapter 2  yielded relatively stable cells compared with cells 
that were isolated using other methods. The relatively short lifespan of these cells may have 
several causes. Velasco et al 1 showed that EDTA-treated small intestinal cells accumulate 
Ca2+ in an ATP-dependent fashion. The increased intracellular Ca2+ levels may initiate cell 
destructive processes in the cell (see also below and §1.3.2.2). Another possible factor is the 
strong dependence of attachment to a substrate for survival of epithelial cells (see §1.6.1). In 
order to avoid unwanted artefacts of the isolation procedure, further experiments were 
performed with human coloncarcinoma cell-lines such as the Caco-2 cell-line that express 
typical characteristics of the human small intestinal enterocytes.
In Chapter 3, cultures of three successive stages of the differentiating Caco-2 cells were 
used to assess the changes in vulnerability for MEN during differentiation. Caco-2 cells were 
cultured for 7, 14 and 21 days. The 7 and 21 days cultures have crypt-like and fully 
differentiated villus-cell features, respectively. The less differentiated Caco-2 cells appeared 
to be somewhat more resistant to MEN than the further differentiated cells, although no changes
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were observed in the quinone reducing capabilities during differentiation. The resistance of the 
younger cells is probably related to higher levels of reduced GSH. Similar observations were 
made in intestinal cells. Compared to villus cells, rat crypt cells have higher levels of GSH 
synthesising enzymes 2 and lower amounts of GSH utilising enzymes like glutathione 
transferases 3-5 and T-glutamyltranspeptidase 2 The levels of reduced glutathione of the isolated 
rat enterocytes were somewhat higher in untreated crypt cell compared to villus cells (chapter 
2 ).
DT-diaphorase (DTD) is considered to be a key-factor in the detoxification process of 
quinones. Quinones are converted to hydroquinones by this enzyme via a two-electron 
reduction. This reaction prevents thiol arylation since hydroquinones are unable to arylate 
thiols. Further, hydroquinones are excreted from the cell after glucuronidation or sulphation 
reactions. The data presented in Chapter 4 demonstrates that the Caco-2 cell-line is DTD- 
deficient. This makes this cell-line highly vulnerable to arylating or redoxcycling quinones 
compared with the DTD-expressing cell-line HT-29. The HT-29 cells were only vulnerable to 
NQ and MEN after inhibition of DTD with dicoumarol. The Caco-2 cell-line offered us the 
possibility to investigate the toxicity of quinones without the interference of a major 
detoxification route. Again, the arylation proved to be a major contributing factor in quinone 
toxicity. Although MEN and DIM redox cycle at the same rate, larger levels of oxidised and 
protein-associated GSH were observed in MEN-treated Caco-2 cells compared with DIM 
treated cells. This indicates that arylation enhanced the capability of quinones to induce 
oxidative stress. Some differences were found between the arylating quinones NQ and MEN. 
Although the loss of protein thiols did not differ in NQ or MEN-treated Caco-2 cells, the 
depletion of ATP was more intensive with NQ. This may correlate with the reductive output of 
the cell that was estimated by the reduction of MTT. The reductive output was initially 
increased with MEN above control levels.
The experiments described in Chapter 5 show that several mechanisms are involved in 
quinone cytotoxicity. One of these processes is poly(ADP-ribosylation), which is a post- 
translational modification of nuclear protein and enzymes, induced by DNA damage. ADP- 
ribosylation of histones causes a release of DNA from the nucleosomal structure and facilitates 
the access of repair enzymes to the damaged DNA. PARP, the major enzyme in this process is 
activated by DNA strand breaks and requires the co-factor NAD+ as substrate. The rapid 
depletion of NAD+ following excessive DNA damage may disturb the cellular ATP production 
and eventuate in necrotic cell death. By decreasing the dose of MEN to 25 pM, the PARP 
dependent cell killing became better visible. This concentration of MEN caused a moderate 
toxicity and ATP depletion. The loss of NAD+ was completely prevented by 3-ABA, an 
inhibitor of PARP, and prevented ATP depletion. PARP is activated by DNA damage, which 
was observed in hydrogen peroxide and quinone treated cells. DNA damage is possible by 
oxidative stress elicited by MEN but may also be the result of Ca2+-activated endonucleases. 
The prevention of NAD+ depletion and thus the prevention of PARP activation by chelation of 
Ca2+ confirmed that endonucleolytic activity did occur. This calcium may result from release 
from cellular stores like mitochondria and the ER or from influx via the cell membrane. The 
calcium transporters possess sensitive thiols. The Ca2+ release is probably the result of thiol 
oxidation and not thiol arylation, since both hydrogen peroxide and DIM were able to induce 
calcium-mediated NAD+ depletion. An interesting aspect is the inability of the antioxidants N- 
acetylcysteine and Trolox to prevent the loss of NAD+. This indicates that oxidative stress- 
induced DNA damage is merely an initiator of PARP activation and released is probably 
responsible for deterioration of this process. N-acetylcysteine was able to partly restore the 
ATP levels (figure 7.6a). This shows that impairment of the ATP generation is not only the 
result of PARP-mediated NAD+ depletion but also the result of direct interaction of MEN with
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ATP producing pathways. The latter form of damage became dominant with increasing 
concentrations of MEN, where 3-ABA was unable to prevent loss of viability.
The loss of NAD+ co-factor may have implications for energy synthesis. For instance the 
activity of complex I of mitochondrial function (NADH-dehydrogenase) is depend on the 
presence of the reduced form of NAD+. Chapter 6 describes the effect of menadione on the 
mitochondrial membrane potential (MMP) which is a good indicator of the mitochondrial 
performance. The MMP is the result of a H+ gradient which is maintained by continuous H+ 
pumping of the electron transport chain (see figure 6.7). Menadione-induced oxidative stress 
resulted in an increase of the MMP which can be inhibited by 3-ABA, an inhibitor of 
poly(ADP-ribose) polymerase. Thus, the depletion of NAD+ resulted in an increase of the 
MMP. This increase of the MMP was completely suppressed by inhibition of complex II with 
TTFA which indicates that cells suffering from oxidative stress compensate their loss of 
NADH-dehydrogenase activity by an extra-activation of succinate dehydrogenase activity 
(complex II). The Ca2+ chelation experiments described in chapter 5 showed that Ca2+ plays a 
significant role in cellular damage in Caco-2 cells. Free cytosolic Ca2+ is sequestered by 
mitochondria by an uniport driven by the negative electrochemical gradient in order to prevent 
a high cytosolic [Ca2+]. The sequestered Ca2+ activates mitochondrial Ca-dependent 
dehydrogenases including succinate dehydrogenase 6,7. An interesting aspect of the activation of 
the succinate dehydrogenase during oxidative stress is the relation between this enzyme and the 
antioxidant a-tocopherol (vitamin E). Complex II (succinate dehydrogenase) mediates the 
reduction of ubiquinone and this compound was found to be a reductor of the tocopherol radical 
8-10. Thus the activation of succinate dehydrogenase is not only an attempt to stabilise the ATP 
production but may also be a part of the antioxidant defence.
We showed that MEN can induce necrosis but it can also trigger programmed cell death in 
Caco-2 cells. Chapter 7 describes the double-stain technique, which distinguishes the two form 
of cell death: necrosis and apoptosis. Apoptosis proved to be protein synthesis dependent and 
thus an active cellular process in Caco-2 cells. Apoptosis was inhibitable by the antioxidant 
Trolox and N-acetylcysteine, which indicates that oxidative stress, can induce apoptosis in 
intestinal cells. MEN is capable of generating DNA damage which is generally a trigger for the 
tumor suppressor p53 to arrest cells in the G1-phase of the cell cycle. Analysis of the cell cycle 
distribution displayed no G1-arrest in MEN-treated Caco-2 cells. Genetic analysis revealed a 
mutation in the p53 gene, which functionally inactivates the tumor suppressor protein. Instead of 
a G1-arrest, cells progress through the cell cycle and the population of cells that are about to 
divide disappear. The percentage of these disappearing cells can account for the number of 
cells observed with the double-stain technique. The mechanism of apoptosis may involve a 
premature cell division. Cell division is under control of a specific kinase, which is activated 
by phosphorylation. Normally, phosphatases inhibit cell cycle progression by 
dephosphorylation this kinase but these phosphatases are sensitive to MEN. The inhibition of 
phosphatases is probably mediated via MEN-generated ROS, since H2O2 can inhibit similar 
phosphatases.
In this thesis, we show that oxidative stress is capable of inducing necrotic cell death in 
isolated enterocytes and coloncarcinoma cell-lines. Disturbances of the thiol and energy 
homeostasis are involved in cell death. DNA is probably the most important target in quinone 
induced cell death, especially when cells are exposed to lower concentrations. DNA damage 
activates PARP, which depletes NAD+ and indirectly ATP. A decrease in ATP and probably 
thiol damage result in increase of [Ca2+]i, which activates endonucleases. Additional DNA 
damage will activate more PARP and this cycle of events will continue until the cell becomes 
necrotic. Oxidative stress is capable of inducing p53-independent apoptosis. Further 
elucidation of this mechanism would be interesting since p53 is mutated in more than 50% of 
all human tumors.
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Nederlandse Samenvatting.
Oxidatieve stress is een fysiologische situatie waarin meer reactieve zuurstofvormen 
ontstaan dan de cel onschadelijk kan maken. Oxidatieve stress kan het resultaat zijn van een 
verhoogde produktie van deze zuurstofintermediairen dan wel een tekortkoming in de ontgifting 
ervan. Deze reactieve zuurstofvormen zijn instaat om schade te veroorzaken aan het erfelijk 
materiaal (DNA), eiwitten en vetzuren van o.a. membranen. Dergelijke schade kan ertoe leiden 
dat de cel niet meer zijn normale functies kan uitvoeren of zelfs tot het afsterven van cellen. 
Oxidatieve stress in het maagdarmkanaal kan optreden tijdens pathologische processen als 
ischemie-reperfusie of wordt opgewekt door lichaamsvreemde stoffen, zoals 
voedselcontaminanten of medicijnen, die in de darm terechtkomen. Normaliter worden 
dergelijke vettige verbindingen door biotransformatiereacties omgezet in wateroplosbare 
verbindingen, die vervolgens worden uitgescheiden in urine of faeces. Soms worden 
lichaamsvreemde stoffen door deze reacties omgezet tot metabolieten die giftiger zijn dan de 
oorspronkelijke stof. Anderzijds kunnen lichaamsvreemde stoffen participeren in het cellulaire 
metabolisme en daardoor giftig worden. Chinonen zijn verbindingen die elektronen kunnen 
opnemen van reducerende enzymen van de cel. Deze elektronen kunnen worden doorgegeven 
aan zuurstof, waardoor er zeer reactieve zuurstofsoorten ontstaan als waterstofperoxyde en het 
hydroxyl radicaal. Na de afgifte van het elektron is het chinon weer gereed voor opname van 
nieuwe elektronen en dit zich herhalende proces wordt “redoxcycling” genoemd. Een chinon 
kan, afhankelijk van de moleculaire structuur, direct binden aan andere moleculen. Dit proces, 
ook wel arylatie genaamd, leidt eveneens tot schade aan de cel. Kennis van de cellulaire 
gevolgen van redoxcycling en arylatie kan leiden tot nieuwe inzichten in de behandeling van 
pathofysiologische processen of tot mogelijk nieuwe ingangen van geneesmiddelen tegen 
kankercellen.
In Hoofdstuk 2 worden experimenten beschreven waarin dunne darmcellen, geïsoleerd uit 
de rat, worden blootgesteld aan chinonen. Als gevolg van deze blootstelling blijkt de 
belangrijkste cellulaire antioxidant glutathion snel op te raken en gedeeltelijk wordt terug 
gevonden in de geoxydeerde vrije- en aan eiwit gebonden vorm. Deze laatste twee glutathion 
soorten zijn een belangrijke indicatie dat er oxidatieve stress heeft plaatsgevonden. De 
veranderingen in glutathion spiegels gaan gepaard met verstoringen in de energiehuishouding 
en membraanschade. Verder is gebleken dat chinonen die kunnen aryleren en redoxcyclen 
toxischer zijn voor cellen dan chinonen die alleen kunnen redoxcyclen. Met de isolatie methode 
konden 3 soorten enterocyten worden geïsoleerd uit de dunne darm: stamcellen uit crypt, 
volledig gedifferentieerde villustip cellen en cellen die wat differentiatie betreft daar tussenin 
liggen. De toxiciteit van DIM, een stof die alleen kan redoxcyclen, bleek het geringst te zijn in 
de cryptfractie. Dit bleek te correleren met de hogere activiteit van het ontgiftende enzym DT- 
diaphorase en de glutathion (GSH) spiegels in deze cellen. Verder bleken alle celtypes 
gereduceerd glutathion uit te scheiden in het incubatiemedium en dit proces kon geremd worden 
door blootstelling van cellen aan chinonen. Het mechanisme van deze uitscheiding is nog 
onbekend.
In tegenstelling tot andere celtypes zoals hepatocyten zijn cellen uit de dunne darm zeer 
moeilijk te isoleren. De levensvatbaarheid van geïsoleerde enterocyten daalde met 20% 
gedurende een uur na de isolatie. De in hoofdstuk 2 beschreven isolatiemethode leverde 
desalniettemin in vergelijking met andere isolatiemethodes relatief stabiele cellen op. De korte 
levensduur van geïsoleerde enterocyten kan verschillende oorzaken hebben. Zo is aangetoond
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dat EDTA-behandelde intestinale cellen actief calcium gaan opnemen, wat weer allerlei 
destructieve gevolgen kan hebben voor de cel. Een andere oorzaak voor het afsterven van de 
geïsoleerde darmcellen is het verlies van binding aan een onderliggend oppervlakte. Om 
dergelijke isolatieartefacten te voorkomen werden voor verdere experimenten gebruik gemaakt 
van humane coloncarcinoma cellijnen. De Caco-2 cellijn is zo’n cellijn en beschikt over 
diverse karakteristieken van dunne darmcellen.
In hoofdstuk 3 wordt de spontane celdifferentiatie van de Caco-2 cellijn gebruikt om 
mogelijke veranderingen in gevoeligheid voor het chinon MEN te onderzoeken. Caco-2 cellen 
hebben na respectievelijk 7 en 21 dagen kweken crypt- en villus-achtige eigenschappen. De 
jongste en minst gedifferentieerde cellen zijn het minst gevoelig voor MEN. De verklaring 
hiervoor zijn de hogere GSH spiegels in deze cellen, wat overeenkomt met de bevindingen met 
geïsoleerde darmcellen. De GSH spiegels zijn hoger in cryptcellen, omdat deze cellen over 
meer GSH-aanmakende en minder GSH-verbruikende enzymen beschikken.
DT-diaphorase (DTD) wordt beschouwd als een sleutelstap in de ontgifting van chinonen. 
DTD zet chinonen via een 2-staps elektronreduktie om in hydrochinonen. Hydrochinonen zijn 
niet langer in staat tot arylatie van o.a. cellulaire thiolen en zijn bovendien substraat voor 
reacties die resulteren in de uitscheiding van chinonen. De gegevens in hoofdstuk 4 laten zien 
dat de Caco-2 cellijn deficiënt is voor het enzym DTD en dat deze cellijn veel gevoeliger is 
voor chinonen dan de HT-29 cellijn die wel over dit enzym beschikt. De Caco-2 cellijn 
verschafte ons daarmee een mogelijkheid om de toxiciteit van chinonen te onderzoeken zonder 
last te hebben van deze belangrijke ontgiftingsroute. Uit deze experimenten met drie onderling 
verschillende chinonen is gebleken dat de mogelijkheid tot arylatie een belangrijke factor is in 
de toxiciteit van chinonen. Toch blijken er verschillen te bestaan tussen chinonen die niet direct 
herleidbaar zijn de redoxcyclende of arylerende eigenschappen van een chinon. Zo blijken 
MEN en NQ even snel de voor de cel essentiële thiolen te kunnen depleteren, maar NQ bleek 
de energiehuishouding ernstiger aan te tasten dan MEN. In dit zelfde hoofdstuk laten we zien 
dat MEN juist op een actieve manier participeert in de energiehuishouding.
In hoofdstuk 5 laten we zien dat er ten minste twee verschillende mechanismen betrokken 
zijn bij celdood door lage concentraties chinonen. De poly(ADP-ribosylatie) reactie is een 
post-translationele modificatie van eiwitten uit de kern en deze reactie wordt geïnitieerd door 
schade aan het erfelijk materiaal. ADP-ribosylatie van histonen resulteert in een loslaten van 
DNA van de nucleosomale structuren, waardoor reparatieenzymen beter toegang krijgen tot het 
beschadigde DNA. Deze reactie wordt uitgevoerd door poly(ADP-ribose)polymerase (PARP) 
en dit enzym gebruikt de cellulaire co-factor NAD+ als substraat. Deze co-factor speelt een 
essentiële rol in de energie (ATP) synthese van cellen en massale DNA-schade kan leiden tot 
problemen met energiesynthese en zelfs celdood. 3-aminobenzamide (3-ABA) is een remmer 
van PARP en was in staat om celdood door lage concentraties chinonen en waterstofperoxyde 
te voorkomen. DNA-schade kan ook optreden door Ca2+-geactiveerde endonucleases. Het 
hiervoor benodigde Ca2+ komt vrij uit cellulaire opslagplaatsen als mitochondriën en het 
endoplasmatisch reticulum door de werking van chinonen. BAPTA-AM is een chelator van 
calcium en bleek net als 3-ABA in staat de cel te beschermen tegen chinonen en 
waterstofperoxyde door de NAD+-spiegels in stand te houden.
Het verlies van de co-factor NAD+ kan ernstige gevolgen hebben voor de energiesynthese 
van de cel. Vooral complex I (NADH-dehydrogenase) van de mitochondriële respiratie is 
afhankelijk van deze co-factor. Hoofdstuk 6 beschrijft de experimenten waarin het effect van 
MEN werd onderzocht op het functioneren van de mitochondriën. De mitochondriële 
membraan potentiaal (MMP) is hiervoor een goede indicator. De MMP wordt opgebouwd 
door het continu onderhouden van een H+ gradient door de electron-transport keten. MEN bleek 
in plaats van een verlaging juist een verhoging van de MMP te veroorzaken. 3-ABA bleek de 
verhoging van de MMP tegen te gaan. Met behulp van remmers van de verschillende
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complexen van de ademhalingsketen hebben we aangetoond dat de verhoging van de MMP 
werd veroorzaakt door een verhoogde activiteit van succinaat dehydrogenase oftewel complex
II. De oorzaak van deze verhoogde complex II activiteit is waarschijnlijk te wijten aan 
verhoogde calcium spiegels in de mitochondriën. Complex II activiteit is niet alleen betrokken 
bij de energiesynthese van de cel, maar speelt eveneens een rol in de reductie van het 
antioxidant vitamine E.
Het chinon MEN veroorzaakt niet alleen necrotische celdood, maar is ook in staat om 
cellen aan te zetten tot geprogrammeerde celdood ofwel apoptose. Hoofdstuk 7 beschrijft een 
techniek waarmee beide vormen van celdood te onderscheiden zijn. Apoptose in Caco-2 cellen 
blijkt eiwit synthese afhankelijk te zijn, waarmee bewezen is dat het een actief proces is. De 
antioxidanten Trolox en N-acetyl-cysteine blijken MEN-geïnduceerde apoptose te kunnen 
remmen, waarmee is aangetoond dat oxidatieve stress apoptose induceert in darmcellen. P53 is 
een belangrijk tumor suppressor eiwit en komt tot expressie door schade aan het erfelijk 
materiaal. Door dit eiwit worden cellen geremd op de G1 positie van de celcyclus. Dit bleek 
echter niet plaats te vinden in de Caco-2 cellijn, waarmee het vermoeden was gerezen dat deze 
cellijn een defect p53-gen heeft. Genetische analyse heeft inderdaad aangetoond dat er een 
puntmutatie is opgetreden in dit gen en daardoor beschikt de Caco-2 cellijn over een niet- 
functioneel P53 eiwit. Uit celcyclus experimenten is gebleken dat de populatie cellen die 
verdwijnen vanuit de G2-fase even groot is als de populatie apoptotische cellen. Apoptose in 
deze cellijn kan mogelijkerwijze worden veroorzaakt door een vroegtijdige celdeling. 
Celdeling staat onder controle van een specifieke fosfatase die gevoelig kan zijn voor 
oxidatieve stress. Voorlopige experimenten met okadiac acid, een remmer van deze fosfatase, 
hebben inderdaad aangetoond dat er sprake is van dergelijk effect.
Dit proefschrift laat zien dat oxidatieve stress necrotische en apoptotische celdood 
veroorzaakt in de coloncarcinoma cellen. Necrotische celdood gaat gepaard met een verstoring 
van de thiol- en energiehuishouding. DNA-schade blijkt een belangrijke factor te zijn in 
necrose veroorzaakt door concentraties chinonen. DNA-schade activeert PARP en verlaagt 
vervolgens de NAD+-spiegels en indirect de ATP-gehaltes. Een te drastische daling in NAD+ 
kan daardoor zelfs leiden tot celdood. Verlaagde ATP-gehaltes en eiwitbeschadigingen door 
chinonen kunnen weer leiden tot verstoringen van de Ca2+-homeostase. Een resulterende 
verhoging van de intracellulaire Ca2+-gehaltes activeren endonucleases die op hun beurt weer 
het DNA beschadigen. Deze zichzelf versterkende cyclus is de oorzaak van necrotische 
celdood bij milde oxidatieve stress en lage concentraties chinonen. Verder blijkt oxidatieve 
stress p53-onafhankelijke celdood te kunnen induceren in humane coloncarcinoma cellen. Een 
verdere opheldering van dit mechanisme is van belang aangezien p53 in meer dan 50% van 
alle humane tumoren is gemuteerd.
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Nederlandse Samenvatting.
Oxidatieve stress is een fysiologische situatie waarin meer reactieve zuurstofvormen 
ontstaan dan de cel onschadelijk kan maken. Oxidatieve stress kan het resultaat zijn van 
een verhoogde produktie van deze zuurstofintermediairen dan wel een tekortkoming in 
de ontgifting ervan. Deze reactieve zuurstofvormen zijn instaat om schade te 
veroorzaken aan het erfelijk materiaal (DNA), eiwitten en vetzuren van o.a. 
membranen. Dergelijke schade kan ertoe leiden dat de cel niet meer zijn normale 
functies kan uitvoeren of zelfs tot het afsterven van cellen. Oxidatieve stress in het 
maagdarmkanaal kan optreden tijdens pathologische processen als ischemie-reperfusie 
of wordt opgewekt door lichaamsvreemde stoffen, zoals voedselcontaminanten of 
medicijnen, die in de darm terechtkomen. Normaliter worden dergelijke vettige 
verbindingen door biotransformatiereacties omgezet in wateroplosbare verbindingen, 
die vervolgens worden uitgescheiden in urine of faeces. Soms worden 
lichaamsvreemde stoffen door deze reacties omgezet tot metabolieten die giftiger zijn 
de oorspronkelijke stof. Anderzijds kunnen lichaamsvreemde stoffen gaan participeren 
in het cellulaire metabolisme en daardoor giftig worden. Chinonen zijn verbindingen 
die elektronen kunnen opnemen van reducerende enzymen van de cel. Deze elektronen 
kunnen worden doorgegeven aan zuurstof, waardoor er zeer reactieve zuurstofsoorten 
ontstaan als waterstofperoxyde en het hydroxyl radicaal. Na de afgifte van het elektron 
is het chinon weer gereed voor opname van nieuwe elektronen en dit zich herhalende 
proces wordt “redoxcycling” genoemd. Een chinon kan, afhankelijk van de moleculaire 
structuur, direct binden aan andere moleculen. Dit proces, ook wel arylatie genaamd, 
leidt eveneens tot schade aan de cel. Kennis van de cellulaire gevolgen van 
redoxcycling en arylatie kan leiden tot nieuwe inzichten in de behandeling van 
pathofysiologische processen of tot mogelijk nieuwe ingangen van geneesmiddelen 
tegen kankercellen.
In Hoofdstuk 2 worden experimenten beschreven waarin dunne darmcellen, 
geïsoleerd uit de rat, worden blootgesteld aan chinonen. Als gevolg van deze 
blootstelling blijkt de belangrijkste cellulaire antioxidant glutathion snel op te raken en 
gedeeltelijk wordt terug gevonden in de geoxydeerde vrije- en aan eiwit gebonden 
vorm. Deze laatste twee glutathion soorten zijn een belangrijke indicatie dat er 
oxidatieve stress heeft plaatsgevonden. De veranderingen in glutathionspiegels gaan 
gepaard met verstoringen in de energiehuishouding en membraanschade. Verder is 
gebleken dat chinonen die kunnen aryleren en redoxcyclen toxischer zijn voor cellen 
dan chinonen die alleen kunnen redoxcyclen. Met de isolatie methode konden 3 soorten 
enterocyten worden geïsoleerd uit de dunne darm: stamcellen uit crypt, volledig 
gedifferentieerde villustip cellen en cellen die wat differentiatie betreft daar tussenin 
liggen. De toxiciteit van DIM, een stof die alleen kan redoxcyclen, bleek het geringst te 
zijn in de cryptfractie. Dit bleek te correleren met de hogere activiteit van het 
ontgiftende enzym DT-diaphorase en de glutathion (GSH) spiegels in deze cellen. 
Verder bleken alle celtypes gereduceerd glutathion uit te scheiden in het 
incubatiemedium en dit proces kon geremd worden door blootstelling van cellen aan 
chinonen. Het mechanisme van deze uitscheiding is nog onbekend.
In tegenstelling tot andere celtypes zoals hepatocyten zijn cellen uit de dunne darm 
zeer moeilijk te isoleren. De levensvatbaarheid van geïsoleerde enterocyten daalde met 
20% gedurende een uur na de isolatie. De in hoofdstuk 2 beschreven isolatiemethode
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leverde desalniettemin in vergelijking met andere isolatiemethodes relatief stabiele 
cellen op. De korte levensduur van geïsoleerde enterocyten kan verschillende oorzaken 
hebben. Zo is aangetoond dat EDTA-behandelde intestinale cellen actief calcium gaan 
opnemen, wat weer allerlei destructieve gevolgen kan hebben voor de cel. Een andere 
oorzaak voor het afsterven van de geïsoleerde darmcellen is het verlies van binding aan 
een onderliggend oppervlakte. Om dergelijke isolatieartefacten te voorkomen werden 
voor verdere experimenten gebruik gemaakt van humane coloncarcinoma cellijnen. De 
Caco-2 cellijn is zo’n cellijn en beschikt over diverse karakteristieken van dunne 
darmcellen.
In hoofdstuk 3 wordt de spontane celdifferentiatie van de Caco-2 cellijn gebruikt om 
mogelijke veranderingen in gevoeligheid voor het chinon MEN te onderzoeken. Caco-2 
cellen hebben na respectievelijk 7 en 21 dagen kweken crypt- en villus-achtige 
eigenschappen. De jongste en minst gedifferentieerde cellen zijn het minst gevoelig 
voor MEN. De verklaring hiervoor zijn de hogere GSH spiegels in deze cellen, wat 
overeenkomt met de bevindingen met geïsoleerde darmcellen. De GSH spiegels zijn 
hoger in cryptcellen, omdat deze cellen over meer GSH-aanmakende en minder GSH- 
verbruikende enzymen beschikken.
DT-diaphorase (DTD) wordt beschouwd als een sleutelstap in de ontgifting van 
chinonen. DTD zet chinonen via een 2-staps elektronreduktie om in hydrochinonen. 
Hydrochinonen zijn niet langer in staat tot arylatie van o.a. cellulaire thiolen en zijn 
bovendien substraat voor reacties die leiden tot uitscheiding van chinonen. De 
gegevens in hoofdstuk 4 laten zien dat de Caco-2 cellijn deficiënt is voor het enzym 
DTD en dat deze cellijn veel gevoeliger is voor chinonen dan de HT-29 cellijn die wel 
over dit enzym beschikt. De Caco-2 cellijn verschafte ons daarmee een mogelijkheid 
om de toxiciteit van chinonen te onderzoeken zonder last te hebben van deze 
belangrijke ontgiftingsroute. Uit deze experimenten met drie onderling verschillende 
chinonen is gebleken dat de mogelijkheid tot arylatie een belangrijke factor is in de 
toxiciteit van chinonen. Toch blijken er verschillen te bestaan tussen chinonen die niet 
direct herleidbaar zijn de redoxcyclende of arylerende eigenschappen van een chinon. 
Zo blijken MEN en NQ even snel de voor de cel essentiële thiolen te kunnen 
depleteren, maar NQ bleek de energiehuishouding ernstiger aan te tasten dan MEN. In 
dit zelfde hoofdstuk laten we zien dat MEN juist op een actieve manier participeert in 
de energiehuishouding.
In hoofdstuk 5 laten we zien dat er ten minste twee verschillende mechanismen 
betrokken zijn bij celdood door lage concentraties chinonen. De poly(ADP-ribosylatie) 
reactie is een post-translationele modificatie van eiwitten uit de kern en deze reactie 
wordt geïnitieerd door schade aan het erfelijk materiaal. ADP-ribosylatie van histonen 
resulteert in een loslaten van DNA van de nucleosomale structuren, waardoor 
reparatieenzymen beter toegang krijgen tot het beschadigde DNA. Deze reactie wordt 
uitgevoerd door poly(ADP-ribose)polymerase (PARP) en dit enzym gebruikt de 
cellulaire co-factor NAD+ als substraat. Deze co-factor speelt een essentiële rol in de 
energie (ATP) synthese van cellen en massale DNA-schade kan leiden tot problemen 
met energiesynthese en zelfs celdood. 3-aminobenzamide (3-ABA) is een remmer van 
PARP en was in staat om celdood door lage concentraties chinonen en 
waterstofperoxyde te voorkomen. DNA-schade kan ook optreden door Ca2+- 
geactiveerde endonucleases. Het hiervoor benodigde Ca2+ komt vrij uit cellulaire 
opslagplaatsen als mitochondriën en het endoplasmatisch reticulum door de werking 
van chinonen. BAPTA-AM is een chelator van calcium en bleek net als 3-ABA in staat
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de cel te beschermen tegen chinonen en waterstofperoxyde door de NAD-spiegels in 
stand te houden.
Het verlies van de co-factor NAD+ kan ernstige gevolgen hebben voor de 
energiesynthese van de cel. Vooral complex I (NADH-dehydrogenase) van de 
mitochondriële respiratie is afhankelijk van deze co-factor. Hoofdstuk 6 beschrijft de 
experimenten waarin het effect van MEN werd onderzocht op het functioneren van de 
mitochondriën. De mitochondriële membraan potentiaal (MMP) is hiervoor een goede 
indicator. De MMP wordt opgebouwd door het continu onderhouden van een H+ 
gradient door de electron-transport keten. MEN bleek in plaats van een verlaging juist 
een verhoging van de MMP te veroorzaken. 3-ABA bleek de verhoging van de MMP 
tegen te gaan. Met behulp van remmers van de verschillende complexen van de 
ademhalingsketen hebben we aangetoond dat de verhoging van de MMP werd 
veroorzaakt door een verhoogde activiteit van succinaat dehydrogenase oftewel 
complex II. De oorzaak van deze verhoogde complex II activiteit is waarschijnlijk te 
wijten aan verhoogde calcium spiegels in de mitochondriën. Complex II activiteit is 
niet alleen betrokken bij de energiesynthese van de cel, maar speelt eveneens een rol in 
de reductie van het antioxidant vitamine E.
Het chinon MEN veroorzaakt niet alleen necrotische celdood, maar is ook in staat om 
cellen aan te zetten tot geprogrammeerde celdood ofwel apoptose. Hoofdstuk 7 
beschrijft een techniek waarmee beide vormen van celdood te onderscheiden zijn. 
Apoptose in Caco-2 cellen blijkt eiwit synthese afhankelijk te zijn, waarmee bewezen 
is dat het een actief proces is. De antioxidanten Trolox en N-acetyl-cysteine blijken 
MEN-geïnduceerde apoptose te kunnen remmen, waarmee is aangetoond dat oxidatieve 
stress apoptose induceert in darmcellen. P53 is een belangrijk tumor suppressor eiwit 
en komt tot expressie door schade aan het erfelijk materiaal. Door dit eiwit worden 
cellen geremd op de G1 positie van de celcyclus. Dit bleek echter niet plaats te vinden 
in de Caco-2 cellijn, waarmee het vermoeden was gerezen dat deze cellijn een defect 
p53-gen heeft. Genetische analyse heeft inderdaad aangetoond dat er een puntmutatie is 
opgetreden in dit gen en daardoor beschikt de Caco-2 cellijn over een niet-functioneel 
P53 eiwit. Uit celcyclus experimenten is gebleken dat de populatie cellen die 
verdwijnen vanuit de G2-fase even groot is als de populatie apoptotische cellen. 
Apoptose in deze cellijn kan mogelijkerwijze worden veroorzaakt door een 
vroegtijdige celdeling. Celdeling staat onder controle van een specifieke fosfatase die 
gevoelig kan zijn voor oxidatieve stress. Voorlopige experimenten met okadiac acid, 
een remmer van deze fosfatase, hebben inderdaad aangetoond dat er sprake is van 
dergelijk effect.
Dit proefschrift laat zien dat oxidatieve stress necrotische en apoptotische celdood 
veroorzaakt in de coloncarcinoma cellen. Necrotische celdood gaat gepaard met een 
verstoring van de thiol- en energiehuishouding. DNA-schade blijkt een belangrijke 
factor te zijn in necrose veroorzaakt door concentraties chinonen. DNA-schade 
activeert PARP en verlaagt vervolgens de NAD+-spiegels en indirect de ATP-gehaltes. 
Een te drastische daling in NAD+ kan daardoor zelfs leiden tot celdood. Verlaagde 
ATP-gehaltes en eiwitbeschadigingen door chinonen kunnen weer leiden tot 
verstoringen van de Ca2+-homeostase. Een resulterende verhoging van de intracellulaire 
Ca2+-gehaltes activeren endonucleases die op hun beurt weer het DNA beschadigen. 
Deze zichzelf versterkende cyclus is de oorzaak van necrotische celdood bij milde 
oxidatieve stress en lage concentraties chinonen. Verder blijkt oxidatieve stress p53- 
onafhankelijke celdood te kunnen induceren in humane coloncarcinoma cellen. Een
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verdere opheldering van dit mechanisme is van belang aangezien p53 in meer dan 50% 
van alle humane tumoren is gemuteerd.
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